<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Benzodiazepine withdrawal syndrome - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf12" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Benzodiazepine_withdrawal_syndrome" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Benzodiazepine_withdrawal_syndrome" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Benzodiazepine_withdrawal_syndrome" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Benzodiazepine_withdrawal_syndrome","wgTitle":"Benzodiazepine withdrawal syndrome","wgCurRevisionId":670021438,"wgRevisionId":670021438,"wgArticleId":11683572,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 German-language sources (de)","Pages with login required references or sources","CS1 French-language sources (fr)","Articles needing more detailed references","Wikipedia articles needing page number citations from October 2013","CS1 errors: chapter ignored","Pages containing cite templates with deprecated parameters","Use dmy dates from September 2012","Articles with contributors link","All articles with unsourced statements","Articles with unsourced statements from October 2013","Interlanguage link template link number","Articles with DMOZ links","Articles that use a Medicine navs subtemplate","Pharmacology","Substance dependence","Addiction psychiatry","Withdrawal syndromes","Benzodiazepines","Adverse effects of psychoactive drugs"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Benzodiazepine_withdrawal_syndrome","wgRelevantArticleId":11683572,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgULSAcceptLanguageList":["en-au"],"wgULSCurrentAutonym":"English","wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diazepam2mgand5mgtablets.JPG/100px-Diazepam2mgand5mgtablets.JPG","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q6119887"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf12/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Benzodiazepine_withdrawal_syndrome skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Benzodiazepine withdrawal syndrome</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Benzodiazepine withdrawal syndrome</th>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Critical_care_medicine" title="Critical care medicine" class="mw-redirect">Critical care medicine</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/F13">F13</a>.3</td>
</tr>
</table>
<p><b>Benzodiazepine withdrawal syndrome</b>—often abbreviated to <b>benzo withdrawal</b>—is the cluster of <a href="/wiki/Drug_withdrawal" title="Drug withdrawal">symptoms</a> that emerge when a person who has taken <a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepines</a>, either medically or recreationally, and has developed a physical <a href="/wiki/Benzodiazepine_dependence" title="Benzodiazepine dependence">dependence</a> undergoes dosage reduction or discontinuation. Development of physical dependence and or addiction and the resulting withdrawal symptoms, some of which may last for years, may result from either drug seeking behaviors or from taking the medication as prescribed. Benzodiazepine withdrawal is characterized by sleep disturbance, irritability, increased tension and <a href="/wiki/Anxiety" title="Anxiety">anxiety</a>, <a href="/wiki/Panic_attack" title="Panic attack">panic attacks</a>, hand tremor, sweating, difficulty with concentration, confusion and cognitive difficulty, memory problems, dry retching and nausea, weight loss, <a href="/wiki/Palpitation" title="Palpitation" class="mw-redirect">palpitations</a>, headache, muscular pain and stiffness, a host of perceptual changes, <a href="/wiki/Hallucination" title="Hallucination">hallucinations</a>, <a href="/wiki/Epileptic_seizure" title="Epileptic seizure">seizures</a>, <a href="/wiki/Psychosis" title="Psychosis">psychosis</a>,<sup id="cite_ref-Petursson_1-0" class="reference"><a href="#cite_note-Petursson-1"><span>[</span>1<span>]</span></a></sup> and suicide<sup id="cite_ref-pdatheagtcau_2-0" class="reference"><a href="#cite_note-pdatheagtcau-2"><span>[</span>2<span>]</span></a></sup> (see "Signs and Symptoms" section below for full list). Further, these symptoms are notable for the manner in which they wax and wane and vary in severity from day to day or week by week instead of steadily decreasing in a straightforward monotonic manner.<sup id="cite_ref-Ashton_3-0" class="reference"><a href="#cite_note-Ashton-3"><span>[</span>3<span>]</span></a></sup></p>
<p>It is a potentially serious condition, and is complex and often protracted in time course.<sup id="cite_ref-ashman_4-0" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span>[</span>5<span>]</span></a></sup> Long-term use, defined as daily use for at least three months,<sup id="cite_ref-Voshaar_6-0" class="reference"><a href="#cite_note-Voshaar-6"><span>[</span>6<span>]</span></a></sup> is not desirable because of the associated increased risk of dependence,<sup id="cite_ref-Nutt_7-0" class="reference"><a href="#cite_note-Nutt-7"><span>[</span>7<span>]</span></a></sup> dose escalation, loss of efficacy, increased risk of accidents and falls, particularly for the elderly,<sup id="cite_ref-deGier2011_8-0" class="reference"><a href="#cite_note-deGier2011-8"><span>[</span>8<span>]</span></a></sup> as well as cognitive,<sup id="cite_ref-Authier-_9-0" class="reference"><a href="#cite_note-Authier--9"><span>[</span>9<span>]</span></a></sup> neurological, and intellectual impairments.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup> Use of short-acting hypnotics, while being effective at initiating sleep, worsen the second half of sleep due to withdrawal effects.<sup id="cite_ref-sleep_medicine_a04_11-0" class="reference"><a href="#cite_note-sleep_medicine_a04-11"><span>[</span>11<span>]</span></a></sup> Nevertheless, long-term users of benzodiazepines should not be forced to withdraw against their will.<sup id="cite_ref-ashman_4-1" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup></p>
<p>Benzodiazepine withdrawal can be severe and can provoke life-threatening withdrawal symptoms, such as seizures,<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup> particularly with abrupt or overly-rapid dosage reduction from high doses or long time users.<sup id="cite_ref-ashman_4-2" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup> A severe withdrawal response can nevertheless occur despite gradual dose reduction, or from relatively low doses in short time users,<sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup> even after a single large dose in animal models.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup> A minority of individuals will experience a <a href="/wiki/Post-acute-withdrawal_syndrome" title="Post-acute-withdrawal syndrome">protracted withdrawal syndrome</a> whose symptoms may persist at a sub-acute level for months, or years after cessation of benzodiazepines. The likelihood of developing a protracted withdrawal syndrome can be minimized by a slow, gradual reduction in dosage.<sup id="cite_ref-pwsfb_16-0" class="reference"><a href="#cite_note-pwsfb-16"><span>[</span>16<span>]</span></a></sup></p>
<p>Chronic exposure to benzodiazepines causes neural adaptations that counteract the drug's effects, leading to <a href="/wiki/Drug_tolerance" title="Drug tolerance">tolerance</a> and <a href="/wiki/Physical_dependence" title="Physical dependence">dependence</a>.<sup id="cite_ref-Allison-2003_17-0" class="reference"><a href="#cite_note-Allison-2003-17"><span>[</span>17<span>]</span></a></sup> Despite taking a constant therapeutic dose, long-term use of benzodiazepines may lead to the emergence of withdrawal-like symptoms, particularly between doses.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> When the drug is discontinued or the dosage reduced, <a href="/wiki/Withdrawal_symptoms" title="Withdrawal symptoms" class="mw-redirect">withdrawal symptoms</a> may appear and remain until the body reverses the physiological adaptations.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>19<span>]</span></a></sup> These <a href="/wiki/Rebound_effect" title="Rebound effect">rebound symptoms</a> may be identical to the symptoms for which the drug was initially taken, or may be part of discontinuation symptoms.<sup id="cite_ref-Salzman_20-0" class="reference"><a href="#cite_note-Salzman-20"><span>[</span>20<span>]</span></a></sup> In severe cases, the withdrawal reaction may exacerbate or resemble serious psychiatric and medical conditions, such as <a href="/wiki/Mania" title="Mania">mania</a>, <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a>, and, especially at high doses, <a href="/wiki/Status_epilepticus" title="Status epilepticus">seizure</a> disorders.<sup id="cite_ref-gabbards_21-0" class="reference"><a href="#cite_note-gabbards-21"><span>[</span>21<span>]</span></a></sup> Failure to recognize discontinuation symptoms can lead to false evidence for the need to take benzodiazepines, which in turn leads to withdrawal failure and reinstatement of benzodiazepines, often to higher doses.<sup id="cite_ref-gabbards_21-1" class="reference"><a href="#cite_note-gabbards-21"><span>[</span>21<span>]</span></a></sup></p>
<p>Awareness of the withdrawal reactions, individualized taper strategies according to withdrawal severity, the addition of alternative strategies such as reassurance and referral to benzodiazepine withdrawal support groups, all increase the success rate of withdrawal.<sup id="cite_ref-tbws1989_22-0" class="reference"><a href="#cite_note-tbws1989-22"><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-pmid1675688_23-0" class="reference"><a href="#cite_note-pmid1675688-23"><span>[</span>23<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Mechanism"><span class="tocnumber">2</span> <span class="toctext">Mechanism</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Prevention"><span class="tocnumber">4</span> <span class="toctext">Prevention</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Management"><span class="tocnumber">5</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Medications_and_interactions"><span class="tocnumber">5.1</span> <span class="toctext">Medications and interactions</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-7"><a href="#Prognosis"><span class="tocnumber">6</span> <span class="toctext">Prognosis</span></a>
<ul>
<li class="toclevel-2 tocsection-8"><a href="#Withdrawal_process"><span class="tocnumber">6.1</span> <span class="toctext">Withdrawal process</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Duration"><span class="tocnumber">6.2</span> <span class="toctext">Duration</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Protracted_withdrawal_syndrome"><span class="tocnumber">6.3</span> <span class="toctext">Protracted withdrawal syndrome</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-11"><a href="#Epidemiology"><span class="tocnumber">7</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-12"><a href="#Special_populations"><span class="tocnumber">8</span> <span class="toctext">Special populations</span></a>
<ul>
<li class="toclevel-2 tocsection-13"><a href="#Pediatrics"><span class="tocnumber">8.1</span> <span class="toctext">Pediatrics</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Pregnancy"><span class="tocnumber">8.2</span> <span class="toctext">Pregnancy</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#The_elderly"><span class="tocnumber">8.3</span> <span class="toctext">The elderly</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-16"><a href="#Controversy"><span class="tocnumber">9</span> <span class="toctext">Controversy</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#See_also"><span class="tocnumber">10</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-18"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-19"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diazepam2mgand5mgtablets.JPG" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diazepam2mgand5mgtablets.JPG/220px-Diazepam2mgand5mgtablets.JPG" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diazepam2mgand5mgtablets.JPG/330px-Diazepam2mgand5mgtablets.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Diazepam2mgand5mgtablets.JPG/440px-Diazepam2mgand5mgtablets.JPG 2x" data-file-width="2592" data-file-height="1944" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Diazepam2mgand5mgtablets.JPG" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Diazepam" title="Diazepam">Diazepam</a>, 2 mg and 5 mg diazepam tablets, are commonly used in the treatment of benzodiazepine withdrawal.</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Chlordiazepoxidetabletsgeneric.JPG" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/86/Chlordiazepoxidetabletsgeneric.JPG/220px-Chlordiazepoxidetabletsgeneric.JPG" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/86/Chlordiazepoxidetabletsgeneric.JPG/330px-Chlordiazepoxidetabletsgeneric.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/86/Chlordiazepoxidetabletsgeneric.JPG/440px-Chlordiazepoxidetabletsgeneric.JPG 2x" data-file-width="2592" data-file-height="1944" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Chlordiazepoxidetabletsgeneric.JPG" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Chlordiazepoxide" title="Chlordiazepoxide">Chlordiazepoxide</a>, 5 mg capsules, are sometimes used as an alternative to <a href="/wiki/Diazepam" title="Diazepam">diazepam</a> for benzodiazepine withdrawal. Like diazepam, it has a long <a href="/wiki/Elimination_half-life" title="Elimination half-life" class="mw-redirect">elimination half-life</a> and long-acting <a href="/wiki/Active_metabolites" title="Active metabolites" class="mw-redirect">active metabolites</a>.</div>
</div>
</div>
<p>Withdrawal effects caused by sedative-hypnotics discontinuation, such as benzodiazepines, barbiturates, or <a href="/wiki/Ethanol" title="Ethanol">alcohol</a>, can cause serious medical complications. They are cited to be more hazardous to withdraw from than <a href="/wiki/Opioid" title="Opioid">opioids</a>.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup> Users typically receive little advice and support for discontinuation.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup> Some withdrawal symptoms are identical to the symptoms for which the medication was originally prescribed,<sup id="cite_ref-Salzman_20-1" class="reference"><a href="#cite_note-Salzman-20"><span>[</span>20<span>]</span></a></sup> and can be acute or protracted in duration. Onset of symptoms from long <a href="/wiki/Biological_half-life" title="Biological half-life">half-life</a> benzodiazepines might be delayed for up to three weeks, although withdrawal symptoms from short-acting ones often present early, usually within 24–48 hours.<sup id="cite_ref-CSM2007_26-0" class="reference"><a href="#cite_note-CSM2007-26"><span>[</span>26<span>]</span></a></sup> There may be no fundamental differences in symptoms from either high or low dose discontinuation, but symptoms tend to be more severe from higher doses.<sup id="cite_ref-murphy_27-0" class="reference"><a href="#cite_note-murphy-27"><span>[</span>27<span>]</span></a></sup></p>
<p>Daytime reemergence and <a href="/wiki/Rebound_effect" title="Rebound effect">rebound</a> withdrawal symptoms, sometimes called interdose withdrawal, may occur once dependence has set in. Reemergence is the return of symptoms for which the drug was initially prescribed, in contrast, rebound symptoms are a return of the symptoms for which the benzodiazepine was initially taken for, but at a more intense level than before. Withdrawal symptoms, on the other hand, may appear for the first time during dose reduction, and include insomnia, anxiety, distress, weight loss, panic, depression, derealization, and paranoia, and are more commonly associated with short-acting benzodiazepines discontinuation, like triazolam.<sup id="cite_ref-gabbards_21-2" class="reference"><a href="#cite_note-gabbards-21"><span>[</span>21<span>]</span></a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span>[</span>28<span>]</span></a></sup> Daytime symptoms can occur after a few days to a few weeks of administration of nightly benzodiazepine use<sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span>[</span>30<span>]</span></a></sup> or z-drugs such as zopiclone;<sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup> withdrawal-related insomnia rebounds worse than baseline<sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup><sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span>[</span>33<span>]</span></a></sup> even when benzodiazepines are used intermittently.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup></p>
<p><b>The following symptoms may emerge during gradual or abrupt dosage reduction:</b></p>
<div class="div-col columns column-count column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2;">
<ul>
<li>Aches and <a href="/wiki/Pain" title="Pain">pains</a><sup id="cite_ref-pmid9201803_35-0" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li>Agitation and <a href="/wiki/Anxiety" title="Anxiety">restlessness</a><sup id="cite_ref-pmid9201803_35-1" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Akathisia" title="Akathisia">Akathisia</a></li>
<li><a href="/wiki/Anxiety" title="Anxiety">Anxiety</a>, possible terror and <a href="/wiki/Panic_attack" title="Panic attack">panic attacks</a><sup id="cite_ref-Petursson_1-1" class="reference"><a href="#cite_note-Petursson-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-pmid9201803_35-2" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Blurred_vision" title="Blurred vision">Blurred vision</a><sup id="cite_ref-pmid9201803_35-3" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Chest_pain" title="Chest pain">Chest pain</a><sup id="cite_ref-pmid9201803_35-4" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Depersonalization" title="Depersonalization">Depersonalization</a><sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span>[</span>36<span>]</span></a></sup></li>
<li>Depression (can be severe),<sup id="cite_ref-37" class="reference"><a href="#cite_note-37"><span>[</span>37<span>]</span></a></sup> possible <a href="/wiki/Suicide" title="Suicide">suicidal</a> ideation</li>
<li><a href="/wiki/Derealisation" title="Derealisation" class="mw-redirect">Derealisation</a> (feelings of unreality)<sup id="cite_ref-Mintzer-1999_38-0" class="reference"><a href="#cite_note-Mintzer-1999-38"><span>[</span>38<span>]</span></a></sup></li>
<li><a href="/wiki/Diarrhea" title="Diarrhea">Diarrhea</a></li>
<li><a href="/wiki/Dilated_pupils" title="Dilated pupils" class="mw-redirect">Dilated pupils</a><sup id="cite_ref-gabbards_21-3" class="reference"><a href="#cite_note-gabbards-21"><span>[</span>21<span>]</span></a></sup></li>
<li><a href="/wiki/Dizziness" title="Dizziness">Dizziness</a><sup id="cite_ref-pmid9201803_35-5" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Double_vision" title="Double vision" class="mw-redirect">Double vision</a></li>
<li><a href="/wiki/Dry_mouth" title="Dry mouth" class="mw-redirect">Dry mouth</a><sup id="cite_ref-pmid9201803_35-6" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Dysphoria" title="Dysphoria">Dysphoria</a><sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-40" class="reference"><a href="#cite_note-40"><span>[</span>40<span>]</span></a></sup></li>
<li>Electric shock sensations<sup id="cite_ref-ashman_4-3" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-tuobicp_41-0" class="reference"><a href="#cite_note-tuobicp-41"><span>[</span>41<span>]</span></a></sup></li>
<li>Elevation in <a href="/wiki/Blood_pressure" title="Blood pressure">blood pressure</a><sup id="cite_ref-42" class="reference"><a href="#cite_note-42"><span>[</span>42<span>]</span></a></sup></li>
<li><a href="/wiki/Fatigue_(medical)" title="Fatigue (medical)">Fatigue</a> and <a href="/wiki/Weakness" title="Weakness">weakness</a><sup id="cite_ref-pmid9201803_35-7" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Flu-like_symptoms" title="Flu-like symptoms" class="mw-redirect">Flu-like symptoms</a><sup id="cite_ref-pmid9201803_35-8" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Gastrointestinal" title="Gastrointestinal" class="mw-redirect">Gastrointestinal</a> problems <sup id="cite_ref-Loeb_P_43-0" class="reference"><a href="#cite_note-Loeb_P-43"><span>[</span>43<span>]</span></a></sup><sup id="cite_ref-Loeb_P_43-1" class="reference"><a href="#cite_note-Loeb_P-43"><span>[</span>43<span>]</span></a></sup><sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span>[</span>44<span>]</span></a></sup></li>
<li><a href="/wiki/Hearing_impairment" title="Hearing impairment" class="mw-redirect">Hearing impairment</a><sup id="cite_ref-pmid9201803_35-9" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li>Headache<sup id="cite_ref-Petursson_1-2" class="reference"><a href="#cite_note-Petursson-1"><span>[</span>1<span>]</span></a></sup></li>
<li><a href="/wiki/Hot_flush" title="Hot flush" class="mw-redirect">Hot</a> and <a href="/wiki/Cold_chill" title="Cold chill">cold spells</a><sup id="cite_ref-pmid9201803_35-10" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Hyperosmia" title="Hyperosmia">Hyperosmia</a><sup id="cite_ref-dobcaba_45-0" class="reference"><a href="#cite_note-dobcaba-45"><span>[</span>45<span>]</span></a></sup></li>
<li><a href="/wiki/Hypertension" title="Hypertension">Hypertension</a><sup id="cite_ref-46" class="reference"><a href="#cite_note-46"><span>[</span>46<span>]</span></a></sup></li>
<li><a href="/wiki/Hypnagogia" title="Hypnagogia">Hypnagogia</a>-hallucinations<sup id="cite_ref-pwsfb_16-1" class="reference"><a href="#cite_note-pwsfb-16"><span>[</span>16<span>]</span></a></sup></li>
<li><a href="/wiki/Hypochondriasis" title="Hypochondriasis">Hypochondriasis</a><sup id="cite_ref-pmid9201803_35-11" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li>Increased sensitivity to <a href="/wiki/Touch" title="Touch" class="mw-redirect">touch</a><sup id="cite_ref-Mintzer-1999_38-1" class="reference"><a href="#cite_note-Mintzer-1999-38"><span>[</span>38<span>]</span></a></sup></li>
<li>Increased sensitivity to sound<sup id="cite_ref-pmid9201803_35-12" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li>Increased <a href="/wiki/Urinary_frequency" title="Urinary frequency" class="mw-redirect">urinary frequency</a><sup id="cite_ref-pmid9201803_35-13" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li>Indecision<sup id="cite_ref-pmid9201803_35-14" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Insomnia" title="Insomnia">Insomnia</a><sup id="cite_ref-nouv_47-0" class="reference"><a href="#cite_note-nouv-47"><span>[</span>47<span>]</span></a></sup></li>
<li>Impaired <a href="/wiki/Concentration" title="Concentration">concentration</a><sup id="cite_ref-Petursson_1-3" class="reference"><a href="#cite_note-Petursson-1"><span>[</span>1<span>]</span></a></sup></li>
<li>Impaired <a href="/wiki/Memory" title="Memory">memory</a> and <a href="/wiki/Concentration" title="Concentration">concentration</a><sup id="cite_ref-pmid9201803_35-15" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Anorexia_(symptom)" title="Anorexia (symptom)">Loss of appetite</a> and <a href="/wiki/Weight_loss" title="Weight loss">weight loss</a><sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup></li>
<li><a href="/wiki/Metallic_taste" title="Metallic taste" class="mw-redirect">Metallic taste</a><sup id="cite_ref-dobcaba_45-1" class="reference"><a href="#cite_note-dobcaba-45"><span>[</span>45<span>]</span></a></sup></li>
<li>Mild to moderate <a href="/wiki/Aphasia" title="Aphasia">Aphasia</a><sup id="cite_ref-dobcaba_45-2" class="reference"><a href="#cite_note-dobcaba-45"><span>[</span>45<span>]</span></a></sup></li>
<li><a href="/wiki/Mood_swings" title="Mood swings" class="mw-redirect">Mood swings</a><sup id="cite_ref-pmid9201803_35-16" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Muscular_spasms" title="Muscular spasms" class="mw-redirect">Muscular spasms</a>, <a href="/wiki/Cramp" title="Cramp">cramps</a> or <a href="/wiki/Fasciculations" title="Fasciculations" class="mw-redirect">fasciculations</a><sup id="cite_ref-Lindgren_49-0" class="reference"><a href="#cite_note-Lindgren-49"><span>[</span>49<span>]</span></a></sup></li>
<li><a href="/wiki/Nausea" title="Nausea">Nausea</a> and vomiting<sup id="cite_ref-nouv_47-1" class="reference"><a href="#cite_note-nouv-47"><span>[</span>47<span>]</span></a></sup></li>
<li>Nightmares<sup id="cite_ref-nouv_47-2" class="reference"><a href="#cite_note-nouv-47"><span>[</span>47<span>]</span></a></sup></li>
<li><a href="/wiki/Numbness_and_tingling" title="Numbness and tingling" class="mw-redirect">Numbness and tingling</a><sup id="cite_ref-pmid9201803_35-17" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Obsessive_compulsive_disorder" title="Obsessive compulsive disorder" class="mw-redirect">Obsessive compulsive disorder</a><sup id="cite_ref-50" class="reference"><a href="#cite_note-50"><span>[</span>50<span>]</span></a></sup><sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span>[</span>51<span>]</span></a></sup></li>
<li><a href="/wiki/Paraesthesia" title="Paraesthesia" class="mw-redirect">Paraesthesia</a><sup id="cite_ref-Mintzer-1999_38-2" class="reference"><a href="#cite_note-Mintzer-1999-38"><span>[</span>38<span>]</span></a></sup><sup id="cite_ref-dobcaba_45-3" class="reference"><a href="#cite_note-dobcaba-45"><span>[</span>45<span>]</span></a></sup></li>
<li><a href="/wiki/Paranoia" title="Paranoia">Paranoia</a><sup id="cite_ref-dobcaba_45-4" class="reference"><a href="#cite_note-dobcaba-45"><span>[</span>45<span>]</span></a></sup></li>
<li>Perception that stationary objects are moving<sup id="cite_ref-Mintzer-1999_38-3" class="reference"><a href="#cite_note-Mintzer-1999-38"><span>[</span>38<span>]</span></a></sup></li>
<li><a href="/wiki/Perspiration" title="Perspiration">Perspiration</a><sup id="cite_ref-Petursson_1-4" class="reference"><a href="#cite_note-Petursson-1"><span>[</span>1<span>]</span></a></sup></li>
<li><a href="/wiki/Photophobia" title="Photophobia">Photophobia</a><sup id="cite_ref-dobcaba_45-5" class="reference"><a href="#cite_note-dobcaba-45"><span>[</span>45<span>]</span></a></sup></li>
<li><a href="/wiki/Postural_hypotension" title="Postural hypotension" class="mw-redirect">Postural hypotension</a><sup id="cite_ref-nouv_47-3" class="reference"><a href="#cite_note-nouv-47"><span>[</span>47<span>]</span></a></sup></li>
<li><a href="/wiki/REM_sleep_rebound" title="REM sleep rebound" class="mw-redirect">REM sleep rebound</a><sup id="cite_ref-52" class="reference"><a href="#cite_note-52"><span>[</span>52<span>]</span></a></sup></li>
<li><a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">Restless legs syndrome</a><sup id="cite_ref-pmid1675688_23-1" class="reference"><a href="#cite_note-pmid1675688-23"><span>[</span>23<span>]</span></a></sup></li>
<li>Sounds louder than usual<sup id="cite_ref-Mintzer-1999_38-4" class="reference"><a href="#cite_note-Mintzer-1999-38"><span>[</span>38<span>]</span></a></sup></li>
<li><a href="/wiki/Stiffness" title="Stiffness">Stiffness</a><sup id="cite_ref-pmid9201803_35-18" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li>Taste and smell disturbances<sup id="cite_ref-pmid9201803_35-19" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li><a href="/wiki/Tachycardia" title="Tachycardia">Tachycardia</a><sup id="cite_ref-53" class="reference"><a href="#cite_note-53"><span>[</span>53<span>]</span></a></sup></li>
<li><a href="/wiki/Tinnitus" title="Tinnitus">Tinnitus</a><sup id="cite_ref-tinnitus_54-0" class="reference"><a href="#cite_note-tinnitus-54"><span>[</span>54<span>]</span></a></sup></li>
<li><a href="/wiki/Tremor" title="Tremor">Tremor</a><sup id="cite_ref-55" class="reference"><a href="#cite_note-55"><span>[</span>55<span>]</span></a></sup><sup id="cite_ref-56" class="reference"><a href="#cite_note-56"><span>[</span>56<span>]</span></a></sup></li>
<li><a href="/wiki/Visual_disturbance" title="Visual disturbance" class="mw-redirect">Visual disturbances</a></li>
</ul>
</div>
<p><b>Rapid discontinuation may result in a more serious syndrome</b></p>
<div class="div-col columns column-count column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2;">
<ul>
<li><a href="/wiki/Catatonia" title="Catatonia">Catatonia</a>, which may result in death<sup id="cite_ref-57" class="reference"><a href="#cite_note-57"><span>[</span>57<span>]</span></a></sup><sup id="cite_ref-58" class="reference"><a href="#cite_note-58"><span>[</span>58<span>]</span></a></sup><sup id="cite_ref-59" class="reference"><a href="#cite_note-59"><span>[</span>59<span>]</span></a></sup></li>
<li><a href="/wiki/Confusion" title="Confusion" class="mw-redirect">Confusion</a><sup id="cite_ref-Uhlenhuth_EH_2006_519.E2.80.9323_60-0" class="reference"><a href="#cite_note-Uhlenhuth_EH_2006_519.E2.80.9323-60"><span>[</span>60<span>]</span></a></sup></li>
<li><a href="/wiki/Seizure" title="Seizure" class="mw-redirect">Convulsions</a>, which may result in death<sup id="cite_ref-61" class="reference"><a href="#cite_note-61"><span>[</span>61<span>]</span></a></sup><sup id="cite_ref-62" class="reference"><a href="#cite_note-62"><span>[</span>62<span>]</span></a></sup></li>
<li>Coma<sup id="cite_ref-63" class="reference"><a href="#cite_note-63"><span>[</span>63<span>]</span></a></sup> (rare)</li>
<li><a href="/wiki/Delirium_tremens" title="Delirium tremens">Delirium tremens</a><sup id="cite_ref-64" class="reference"><a href="#cite_note-64"><span>[</span>64<span>]</span></a></sup><sup id="cite_ref-Darcy_L_65-0" class="reference"><a href="#cite_note-Darcy_L-65"><span>[</span>65<span>]</span></a></sup><sup id="cite_ref-Darcy_L_65-1" class="reference"><a href="#cite_note-Darcy_L-65"><span>[</span>65<span>]</span></a></sup></li>
<li><a href="/wiki/Delusion" title="Delusion">Delusions</a><sup id="cite_ref-66" class="reference"><a href="#cite_note-66"><span>[</span>66<span>]</span></a></sup></li>
<li><a href="/wiki/Hallucinations" title="Hallucinations" class="mw-redirect">Hallucinations</a></li>
<li><a href="/wiki/Hyperthermia" title="Hyperthermia">Hyperthermia</a><sup id="cite_ref-nouv_47-4" class="reference"><a href="#cite_note-nouv-47"><span>[</span>47<span>]</span></a></sup></li>
<li><a href="/wiki/Homicide" title="Homicide">Homicide</a> ideations<sup id="cite_ref-67" class="reference"><a href="#cite_note-67"><span>[</span>67<span>]</span></a></sup></li>
<li><a href="/wiki/Mania" title="Mania">Mania</a><sup id="cite_ref-68" class="reference"><a href="#cite_note-68"><span>[</span>68<span>]</span></a></sup><sup id="cite_ref-69" class="reference"><a href="#cite_note-69"><span>[</span>69<span>]</span></a></sup></li>
<li><a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">Neuroleptic malignant syndrome</a>-like event<sup id="cite_ref-70" class="reference"><a href="#cite_note-70"><span>[</span>70<span>]</span></a></sup><sup id="cite_ref-Strawn-2007_71-0" class="reference"><a href="#cite_note-Strawn-2007-71"><span>[</span>71<span>]</span></a></sup> (rare)</li>
<li><a href="/wiki/Organic_brain_syndrome" title="Organic brain syndrome">Organic brain syndrome</a><sup id="cite_ref-72" class="reference"><a href="#cite_note-72"><span>[</span>72<span>]</span></a></sup></li>
<li><a href="/wiki/Post-traumatic_stress_disorder" title="Post-traumatic stress disorder" class="mw-redirect">Post-traumatic stress disorder</a><sup id="cite_ref-pmid1675688_23-2" class="reference"><a href="#cite_note-pmid1675688-23"><span>[</span>23<span>]</span></a></sup></li>
<li><a href="/wiki/Psychosis" title="Psychosis">Psychosis</a><sup id="cite_ref-73" class="reference"><a href="#cite_note-73"><span>[</span>73<span>]</span></a></sup><sup id="cite_ref-74" class="reference"><a href="#cite_note-74"><span>[</span>74<span>]</span></a></sup></li>
<li><a href="/wiki/Suicidal_ideation" title="Suicidal ideation">Suicidal ideation</a><sup id="cite_ref-ReferenceA_75-0" class="reference"><a href="#cite_note-ReferenceA-75"><span>[</span>75<span>]</span></a></sup></li>
<li>Suicide<sup id="cite_ref-pdatheagtcau_2-1" class="reference"><a href="#cite_note-pdatheagtcau-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-murphy_27-1" class="reference"><a href="#cite_note-murphy-27"><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-76" class="reference"><a href="#cite_note-76"><span>[</span>76<span>]</span></a></sup></li>
<li>Urges to shout, throw, break things or harm someone<sup id="cite_ref-pmid9201803_35-20" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup></li>
<li>Violence<sup id="cite_ref-77" class="reference"><a href="#cite_note-77"><span>[</span>77<span>]</span></a></sup></li>
</ul>
</div>
<p>As withdrawal progresses, patients often find their physical and mental health improves with improved mood and improved cognition.</p>
<h2><span class="mw-headline" id="Mechanism">Mechanism</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=2" title="Edit section: Mechanism">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Benzodiazepine_dependence#Mechanism" title="Benzodiazepine dependence">Benzodiazepine dependence § Mechanism</a></div>
<div class="hatnote">See also: <a href="/wiki/Alcohol_withdrawal_syndrome#Kindling" title="Alcohol withdrawal syndrome">Alcohol withdrawal syndrome § Kindling</a> and <a href="/wiki/Kindling_(sedative-hypnotic_withdrawal)" title="Kindling (sedative-hypnotic withdrawal)">Kindling (sedative-hypnotic withdrawal)</a></div>
<p>The neuroadaptive processes involved in tolerance, dependence, and withdrawal mechanisms implicate both the GABAergic and the glutamatergic systems.<sup id="cite_ref-Allison-2003_17-1" class="reference"><a href="#cite_note-Allison-2003-17"><span>[</span>17<span>]</span></a></sup> <a href="/wiki/Gamma-Aminobutyric_acid" title="Gamma-Aminobutyric acid">Gamma-Aminobutyric acid</a> (<a href="/wiki/GABA" title="GABA" class="mw-redirect">GABA</a>) is the major inhibitory neurotransmitter of the central nervous system; roughly one-quarter to one-third of synapses use GABA.<sup id="cite_ref-The_Brain_from_Top_to_Bottom_78-0" class="reference"><a href="#cite_note-The_Brain_from_Top_to_Bottom-78"><span>[</span>78<span>]</span></a></sup> GABA mediates the influx of chloride ions through <a href="/wiki/Ligand-gated_ion_channel" title="Ligand-gated ion channel">ligand-gated chloride channels</a> called <a href="/wiki/GABAA" title="GABAA" class="mw-redirect">GABA</a><sub>A</sub> receptors. When chloride enters the nerve cell, the cell membrane potential hyperpolarizes thereby inhibiting depolarization, or reduction in the firing rate of the post-synaptic nerve cell.<sup id="cite_ref-Tallman_79-0" class="reference"><a href="#cite_note-Tallman-79"><span>[</span>79<span>]</span></a></sup> Benzodiazepine potentiates the action of GABA,<sup id="cite_ref-SCHOCH_80-0" class="reference"><a href="#cite_note-SCHOCH-80"><span>[</span>80<span>]</span></a></sup> by binding a site between the α and γ subunits of the 5-subunit receptor<sup id="cite_ref-vinkerss_81-0" class="reference"><a href="#cite_note-vinkerss-81"><span>[</span>81<span>]</span></a></sup> thereby increasing the frequency of the GABA-gated chloride channel opening in the presence of GABA.<sup id="cite_ref-pmc349220_82-0" class="reference"><a href="#cite_note-pmc349220-82"><span>[</span>82<span>]</span></a></sup></p>
<p>When potentiation is sustained by long-term use, neuroadaptations occur which result in decreased GABAergic response. What is certain is that surface GABA<sub>A</sub> receptor protein levels are altered in response to benzodiazepine exposure, as is receptor turnover rate.<sup id="cite_ref-bateson_83-0" class="reference"><a href="#cite_note-bateson-83"><span>[</span>83<span>]</span></a></sup> The exact reason for the reduced responsiveness has not been elucidated but down-regulation of the number of receptors has only been observed at some receptor locations including in the <a href="/wiki/Pars_reticulata" title="Pars reticulata">pars reticulata of the substantia nigra</a>; down-regulation of the number of receptors or internalization does not appear to be the main mechanism at other locations.<sup id="cite_ref-Tietz_84-0" class="reference"><a href="#cite_note-Tietz-84"><span>[</span>84<span>]</span></a></sup> Evidence exists for other hypotheses including changes in the receptor conformation, changes in turnover, recycling, or production rates, degree of phosphorylation and receptor gene expression, subunit composition, decreased coupling mechanisms between the GABA and benzodiazepine site, decrease in GABA production, and compensatory increased gutamatergic activity.<sup id="cite_ref-Allison-2003_17-2" class="reference"><a href="#cite_note-Allison-2003-17"><span>[</span>17<span>]</span></a></sup><sup id="cite_ref-bateson_83-1" class="reference"><a href="#cite_note-bateson-83"><span>[</span>83<span>]</span></a></sup> A unified model hypothesis involves a combination of internalization of the receptor, followed by preferential degradation of certain receptor sub-units, which provides the nuclear activation for changes in receptor gene transcription.<sup id="cite_ref-bateson_83-2" class="reference"><a href="#cite_note-bateson-83"><span>[</span>83<span>]</span></a></sup></p>
<p>It has been postulated that when benzodiazepines are cleared from the brain, these neuroadaptations are "unmasked", leading to unopposed excitability of the neuron.<sup id="cite_ref-85" class="reference"><a href="#cite_note-85"><span>[</span>85<span>]</span></a></sup> <a href="/wiki/Glutamate" title="Glutamate" class="mw-redirect">Glutamate</a> is the most abundant excitatory <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a> in the vertebrate <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a>.<sup id="cite_ref-pmid10736372_86-0" class="reference"><a href="#cite_note-pmid10736372-86"><span>[</span>86<span>]</span></a></sup> Increased glutamate excitatory activity during withdrawal may lead to <a href="/wiki/Sensitization" title="Sensitization">sensitization</a> or <a href="/wiki/Kindling_(substance_withdrawal)" title="Kindling (substance withdrawal)" class="mw-redirect">kindling</a> of the CNS, possibly leading to worsening cognition and symptomatology and making each subsequent withdrawal period worse.<sup id="cite_ref-pmid11224351_87-0" class="reference"><a href="#cite_note-pmid11224351-87"><span>[</span>87<span>]</span></a></sup><sup id="cite_ref-Dunworth_SJ.2C_Mead_AN.2C_Stephens_DN_2000_1501.E2.80.931508_88-0" class="reference"><a href="#cite_note-Dunworth_SJ.2C_Mead_AN.2C_Stephens_DN_2000_1501.E2.80.931508-88"><span>[</span>88<span>]</span></a></sup><sup id="cite_ref-Rickels_K.2C_Schweizer_E.2C_Csanalosi_I.2C_Case_WG.2C_Chung_H_1988_444.E2.80.93450_89-0" class="reference"><a href="#cite_note-Rickels_K.2C_Schweizer_E.2C_Csanalosi_I.2C_Case_WG.2C_Chung_H_1988_444.E2.80.93450-89"><span>[</span>89<span>]</span></a></sup> Those who have a prior history of withdrawing from benzodiazepines are found to be less likely to succeed the next time around.<sup id="cite_ref-DoiJAMissing_90-0" class="reference"><a href="#cite_note-DoiJAMissing-90"><span>[</span>90<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=3" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>In severe cases, the withdrawal reaction or protracted withdrawal may exacerbate or resemble serious psychiatric and medical conditions, such as <a href="/wiki/Mania" title="Mania">mania</a>, <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a>, <a href="/wiki/Agitated_depression" title="Agitated depression" class="mw-redirect">agitated depression</a>, <a href="/wiki/Panic_disorder" title="Panic disorder">panic disorder</a> <a href="/wiki/Generalised_anxiety_disorder" title="Generalised anxiety disorder" class="mw-redirect">generalised anxiety disorder</a>, and <a href="/wiki/Complex_partial_seizures" title="Complex partial seizures" class="mw-redirect">complex partial seizures</a> and, especially at high doses, <a href="/wiki/Status_epilepticus" title="Status epilepticus">seizure</a> disorders.<sup id="cite_ref-gabbards_21-4" class="reference"><a href="#cite_note-gabbards-21"><span>[</span>21<span>]</span></a></sup> Failure to recognize discontinuation symptoms can lead to false evidence for the need to take benzodiazepines, which in turn leads to withdrawal failure and reinstatement of benzodiazepines, often to higher doses. Pre-existing disorder or other causes typically do not improve, where as symptoms of protracted withdrawal gradually improve over the ensuing months.<sup id="cite_ref-gabbards_21-5" class="reference"><a href="#cite_note-gabbards-21"><span>[</span>21<span>]</span></a></sup> For this reason at least six months should have elapsed after benzodiazepines cessation before re-evaluating the symptoms and updating a diagnosis.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2013)">citation needed</span></a></i>]</sup></p>
<p>Symptoms may lack a psychological cause and can fluctuate in intensity with periods of good and bad days until eventual recovery.<sup id="cite_ref-pmid6136575_91-0" class="reference"><a href="#cite_note-pmid6136575-91"><span>[</span>91<span>]</span></a></sup><sup id="cite_ref-92" class="reference"><a href="#cite_note-92"><span>[</span>92<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prevention">Prevention</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=4" title="Edit section: Prevention">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>According to the <a href="/wiki/British_National_Formulary" title="British National Formulary">British National Formulary</a>, it is better to withdraw too slowly rather than too quickly from benzodiazepines.<sup id="cite_ref-CSM2007_26-1" class="reference"><a href="#cite_note-CSM2007-26"><span>[</span>26<span>]</span></a></sup> The rate of dosage reduction is best carried out so as to minimize the symptoms' intensity and severity. Anecdotally, a slow rate of reduction may reduce the risk of developing a severe protracted syndrome.</p>
<p>Long half-life benzodiazepines like <a href="/wiki/Diazepam" title="Diazepam">diazepam</a> or <a href="/wiki/Chlordiazepoxide" title="Chlordiazepoxide">chlordiazepoxide</a> are preferred to minimize <a href="/wiki/Rebound_effects" title="Rebound effects" class="mw-redirect">rebound effects</a>, and are available in low potency dose forms. Some people may not fully stabilize between dose reductions, even when the rate of reduction is slowed. Such people sometimes simply need to persist as they may not feel better until they have been fully withdrawn from them for a period of time.<sup id="cite_ref-pmid2864096_93-0" class="reference"><a href="#cite_note-pmid2864096-93"><span>[</span>93<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=5" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Psychological interventions may provide a small but significant additional benefit over gradual dose reduction alone at post-cessation and at follow-up.<sup id="cite_ref-parrjm_94-0" class="reference"><a href="#cite_note-parrjm-94"><span>[</span>94<span>]</span></a></sup> The psychological interventions studied were relaxation training, cognitive-behavioral treatment of insomnia, and self-monitoring of consumption and symptoms, goal-setting, management of withdrawal and coping with anxiety.<sup id="cite_ref-parrjm_94-1" class="reference"><a href="#cite_note-parrjm-94"><span>[</span>94<span>]</span></a></sup></p>
<p>With sufficient motivation and the proper approach, almost anyone can successfully withdraw from benzodiazepines. However, a prolonged and severe syndrome can lead to collapsed marriages, business failures, bankruptcy, committal to a hospital, and the most serious adverse effect, suicide.<sup id="cite_ref-pdatheagtcau_2-2" class="reference"><a href="#cite_note-pdatheagtcau-2"><span>[</span>2<span>]</span></a></sup> As such, long-term users should not be forced to discontinue against their will.<sup id="cite_ref-ashman_4-4" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup> Over-rapid withdrawal, lack of explanation, and failure to reassure individuals that they are experiencing temporary withdrawal symptoms led some people to experience increased panic and fears they are going mad, with some people developing a condition similar to <a href="/wiki/Post-traumatic_stress_disorder" title="Post-traumatic stress disorder" class="mw-redirect">post-traumatic stress disorder</a> as a result. A slow withdrawal regimen, coupled with reassurance from family, friends, and peers improves the outcome.<sup id="cite_ref-ashman_4-5" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-pwsfb_16-2" class="reference"><a href="#cite_note-pwsfb-16"><span>[</span>16<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Medications_and_interactions">Medications and interactions</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=6" title="Edit section: Medications and interactions">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>While some substitutive pharmacotherapies may have promise, current evidence is insufficient to support their use.<sup id="cite_ref-parrjm_94-2" class="reference"><a href="#cite_note-parrjm-94"><span>[</span>94<span>]</span></a></sup> Some studies found that the abrupt substitution of substitutive pharmacotherapy was actually less effective than gradual dose reduction alone, and only three studies found benefits of adding either melatonin,<sup id="cite_ref-pmid10665894_95-0" class="reference"><a href="#cite_note-pmid10665894-95"><span>[</span>95<span>]</span></a></sup> paroxetine,<sup id="cite_ref-pmid16958945_96-0" class="reference"><a href="#cite_note-pmid16958945-96"><span>[</span>96<span>]</span></a></sup> or trazodone and valproate<sup id="cite_ref-pmid9952057_97-0" class="reference"><a href="#cite_note-pmid9952057-97"><span>[</span>97<span>]</span></a></sup> in conjunction with a gradual dose reduction.<sup id="cite_ref-parrjm_94-3" class="reference"><a href="#cite_note-parrjm-94"><span>[</span>94<span>]</span></a></sup></p>
<ul>
<li><a href="/wiki/Antipsychotic" title="Antipsychotic">Antipsychotics</a> are generally ineffective for benzodiazepine withdrawal-related <a href="/wiki/Psychosis" title="Psychosis">psychosis</a>.<sup id="cite_ref-tuobicp_41-1" class="reference"><a href="#cite_note-tuobicp-41"><span>[</span>41<span>]</span></a></sup><sup id="cite_ref-98" class="reference"><a href="#cite_note-98"><span>[</span>98<span>]</span></a></sup> Antipsychotics should be avoided during benzodiazepine withdrawal as they tend to aggravate withdrawal symptoms, including convulsions.<sup id="cite_ref-CSM2007_26-2" class="reference"><a href="#cite_note-CSM2007-26"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-99" class="reference"><a href="#cite_note-99"><span>[</span>99<span>]</span></a></sup><sup id="cite_ref-100" class="reference"><a href="#cite_note-100"><span>[</span>100<span>]</span></a></sup><sup id="cite_ref-101" class="reference"><a href="#cite_note-101"><span>[</span>101<span>]</span></a></sup> Some <a href="/wiki/Antipsychotic_agents" title="Antipsychotic agents" class="mw-redirect">antipsychotic agents</a> may be more risky during withdrawal than others, especially <a href="/wiki/Clozapine" title="Clozapine">clozapine</a>, <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a> or low potency <a href="/wiki/Phenothiazines" title="Phenothiazines" class="mw-redirect">phenothiazines</a> (e.g., <a href="/wiki/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>), as they lower the <a href="/wiki/Seizure_threshold" title="Seizure threshold">seizure threshold</a> and can worsen withdrawal effects; if used, extreme caution is required.<sup id="cite_ref-102" class="reference"><a href="#cite_note-102"><span>[</span>102<span>]</span></a></sup></li>
<li><a href="/wiki/Barbiturate" title="Barbiturate">Barbiturates</a> are cross tolerant to benzodiazepines and should be avoided.</li>
<li><a href="/wiki/Benzodiazepine" title="Benzodiazepine">Benzodiazepines</a> or cross tolerant drugs should be avoided after discontinuation, even occasionally. These include the <a href="/wiki/Nonbenzodiazepine" title="Nonbenzodiazepine">nonbenzodiazepines</a> <a href="/wiki/Z_drugs" title="Z drugs" class="mw-redirect">Z-drugs</a>, which have a similar mechanism of action. This is because tolerance to benzodiazepines has been demonstrated to be still present at four months to two years after withdrawal depending on personal biochemistry. Re-exposures to benzodiazepines typically resulted in a reactivation of the tolerance and benzodiazepine withdrawal syndrome.<sup id="cite_ref-pmid19062773_103-0" class="reference"><a href="#cite_note-pmid19062773-103"><span>[</span>103<span>]</span></a></sup><sup id="cite_ref-104" class="reference"><a href="#cite_note-104"><span>[</span>104<span>]</span></a></sup></li>
<li><a href="/wiki/Bupropion" title="Bupropion">Bupropion</a>, which is used primarily as an antidepressant and smoking cessation aid, is contraindicated in persons experiencing abrupt withdrawal from benzodiazepines or other sedative-hypnotics (e.g. alcohol), due to an increased risk of seizures.<sup id="cite_ref-WellbutrinPI_105-0" class="reference"><a href="#cite_note-WellbutrinPI-105"><span>[</span>105<span>]</span></a></sup></li>
<li><a href="/wiki/Buspirone" title="Buspirone">Buspirone</a> augmentation was not found to increase the discontinuation success rate.<sup id="cite_ref-Voshaar_6-1" class="reference"><a href="#cite_note-Voshaar-6"><span>[</span>6<span>]</span></a></sup></li>
<li><a href="/wiki/Caffeine" title="Caffeine">Caffeine</a> may worsen withdrawal symptoms because of its stimulatory properties.<sup id="cite_ref-ashman_4-6" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup> Interestingly, at least one animal study has shown some modulation of the benzodiazepine site by caffeine, which produces a lowering of seizure threshold.<sup id="cite_ref-106" class="reference"><a href="#cite_note-106"><span>[</span>106<span>]</span></a></sup></li>
<li><a href="/wiki/Carbamazepine" title="Carbamazepine">Carbamazepine</a>, an <a href="/wiki/Anticonvulsant" title="Anticonvulsant">anticonvulsant</a>, appears to have some beneficial effects in the treatment and management of benzodiazepine withdrawal, however, research is limited and thus the ability of experts to make recommendations on its use for benzodiazepine withdrawal is not possible at present.<sup id="cite_ref-pmid19062773_103-1" class="reference"><a href="#cite_note-pmid19062773-103"><span>[</span>103<span>]</span></a></sup></li>
<li><a href="/wiki/Ethanol" title="Ethanol">Ethanol</a>, the primary <a href="/wiki/Alcohol" title="Alcohol">alcohol</a> in <a href="/wiki/Alcoholic_beverage" title="Alcoholic beverage">alcoholic beverages</a>, even mild to moderate use, has been found to be a significant predictor of withdrawal failure, probably because of its <a href="/wiki/Cross_tolerance" title="Cross tolerance" class="mw-redirect">cross tolerance</a> with benzodiazepines.<sup id="cite_ref-ashman_4-7" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-pmid19062773_103-2" class="reference"><a href="#cite_note-pmid19062773-103"><span>[</span>103<span>]</span></a></sup><sup id="cite_ref-pmid2222130_107-0" class="reference"><a href="#cite_note-pmid2222130-107"><span>[</span>107<span>]</span></a></sup></li>
<li><a href="/wiki/Flumazenil" title="Flumazenil">Flumazenil</a> has been found to stimulate the reversal of tolerance and the normalization of receptor function. However, further research is needed in the form of randomised trials to demonstrate its role in the treatment of benzodiazepine withdrawal.<sup id="cite_ref-Denis-2006_108-0" class="reference"><a href="#cite_note-Denis-2006-108"><span>[</span>108<span>]</span></a></sup> Flumazenil stimulates the up-regulation and reverses the <a href="/wiki/Uncoupling_(neuropsychopharmacology)" title="Uncoupling (neuropsychopharmacology)">uncoupling</a> of <a href="/wiki/Benzodiazepine_receptors" title="Benzodiazepine receptors" class="mw-redirect">benzodiazepine receptors</a> to the <a href="/wiki/GABAA_receptor" title="GABAA receptor">GABA<sub>A</sub> receptor</a>, thereby reversing tolerance and reducing withdrawal symptoms and relapse rates.<sup id="cite_ref-109" class="reference"><a href="#cite_note-109"><span>[</span>109<span>]</span></a></sup><sup id="cite_ref-110" class="reference"><a href="#cite_note-110"><span>[</span>110<span>]</span></a></sup> Limited research and experience and possible risks involved, the flumazenil detoxification method is controversial and can only be done as an <a href="/wiki/Patient#Outpatients_and_inpatients" title="Patient">inpatient</a> procedure under medical supervision.</li>
</ul>
<dl>
<dd><a href="/wiki/Flumazenil" title="Flumazenil">Flumazenil</a> was found to be more effective than placebo in reducing feelings of hostility and aggression in patients who had been free of benzodiazepines for 4-266 weeks.<sup id="cite_ref-L._Saxon.2C_S._Borg_.26_A._J._Hiltunen_148.E2.80.93151_111-0" class="reference"><a href="#cite_note-L._Saxon.2C_S._Borg_.26_A._J._Hiltunen_148.E2.80.93151-111"><span>[</span>111<span>]</span></a></sup> This may suggest a role for flumazenil in treating protracted benzodiazepine withdrawal symptoms.</dd>
</dl>
<dl>
<dd>A study into the effects of the benzodiazepine receptor antagonist, flumazenil, on benzodiazepine withdrawal symptoms persisting after withdrawal was carried out by Lader and Morton. Study subjects had been benzodiazepine-free for between one month and five years, but all reported persisting withdrawal effects to varying degrees. Persistent symptoms included clouded thinking, tiredness, muscular symptoms such as neck tension, <a href="/wiki/Depersonalisation" title="Depersonalisation" class="mw-redirect">depersonalisation</a>, <a href="/wiki/Cramps" title="Cramps" class="mw-redirect">cramps</a> and <a href="/wiki/Tremor" title="Tremor">shaking</a> and the characteristic <a href="/wiki/Perceptual" title="Perceptual" class="mw-redirect">perceptual</a> symptoms of benzodiazepine withdrawal, namely, pins and needles feeling, burning skin, pain and subjective sensations of bodily distortion. Therapy with 0.2–2&#160;mg of flumazenil <a href="/wiki/Intravenously" title="Intravenously" class="mw-redirect">intravenously</a> was found to decrease these symptoms in a <a href="/wiki/Placebo" title="Placebo">placebo</a>-controlled study. This is of interest as benzodiazepine receptor antagonists are neutral and have no clinical effects. The author of the study suggested the most likely explanation is past benzodiazepine use and subsequent tolerance had locked the conformation of the GABA-BZD receptor complex into an <a href="/wiki/Inverse_agonist" title="Inverse agonist">inverse agonist</a> conformation, and the <a href="/wiki/Antagonist" title="Antagonist">antagonist</a> flumazenil resets benzodiazepine receptors to their original sensitivity. Flumazenil was found in this study to be a successful treatment for protracted benzodiazepine withdrawal syndrome, but further research is required.<sup id="cite_ref-112" class="reference"><a href="#cite_note-112"><span>[</span>112<span>]</span></a></sup> A study by Professor Borg in <a href="/wiki/Sweden" title="Sweden">Sweden</a> produced similar results in patients suffering from protracted withdrawal.<sup id="cite_ref-pmid9201803_35-21" class="reference"><a href="#cite_note-pmid9201803-35"><span>[</span>35<span>]</span></a></sup> In 2007, <a href="/wiki/Hoffmann%E2%80%93La_Roche" title="Hoffmann–La Roche" class="mw-redirect">Hoffmann–La Roche</a> the makers of flumazenil, acknowledged the existence of protracted benzodiazepine withdrawal syndromes, but did not recommended <a href="/wiki/Flumazenil" title="Flumazenil">flumazenil</a> to treat the condition.<sup id="cite_ref-113" class="reference"><a href="#cite_note-113"><span>[</span>113<span>]</span></a></sup></dd>
</dl>
<ul>
<li><a href="/wiki/Fluoroquinolone" title="Fluoroquinolone" class="mw-redirect">Fluoroquinolone</a> antibiotics have been noted by <a href="/w/index.php?title=Heather_Ashton&amp;action=edit&amp;redlink=1" class="new" title="Heather Ashton (page does not exist)">Heather Ashton</a><sup class="noprint" style="font-style: normal;">[<a href="//fr.wikipedia.org/wiki/Heather_Ashton" class="extiw" title="fr:Heather Ashton">fr</a>]</sup> and confirmed elsewhere as increasing the incidence of a serious CNS toxicity from 1 to 4% in the general population, for benzodiazepine-dependent population or in those undergoing withdrawal from them. This is probably the result of their <a href="/wiki/GABA" title="GABA" class="mw-redirect">GABA</a> antagonistic effects as they have been found to competitively displace benzodiazepines from benzodiazepine receptor sites. This antagonism can precipitate acute withdrawal symptoms, that can persist for weeks or months before subsiding. The symptoms include depression, <a href="/wiki/Anxiety" title="Anxiety">anxiety</a>, <a href="/wiki/Psychosis" title="Psychosis">psychosis</a>, <a href="/wiki/Paranoia" title="Paranoia">paranoia</a>, severe <a href="/wiki/Insomnia" title="Insomnia">insomnia</a>, <a href="/wiki/Parathesia" title="Parathesia" class="mw-redirect">parathesia</a>, <a href="/wiki/Tinnitus" title="Tinnitus">tinnitus</a>, hypersensitivity to light and sound, <a href="/wiki/Tremor" title="Tremor">tremors</a>, <a href="/wiki/Status_epilepticus" title="Status epilepticus">status epilepticus</a>, suicidal thoughts and suicide attempt. Fluoroquinolone antibiotics should be contraindicated in patients who are dependent on or in benzodiazepine withdrawal.<sup id="cite_ref-ashman_4-8" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-114" class="reference"><a href="#cite_note-114"><span>[</span>114<span>]</span></a></sup><sup id="cite_ref-pmid2167717_115-0" class="reference"><a href="#cite_note-pmid2167717-115"><span>[</span>115<span>]</span></a></sup><sup id="cite_ref-116" class="reference"><a href="#cite_note-116"><span>[</span>116<span>]</span></a></sup><sup id="cite_ref-117" class="reference"><a href="#cite_note-117"><span>[</span>117<span>]</span></a></sup> <a href="/wiki/NSAIDs" title="NSAIDs" class="mw-redirect">NSAIDs</a> have some mild GABA antagonistic properties and animal research indicate that some may even displace benzodiazepines from their binding site. However, NSAIDs taken in combination with fluoroquinolones cause a very significant increase in GABA antagonism, GABA toxicity, seizures, and other severe adverse effects (see <a href="/wiki/Adverse_effects_of_fluoroquinolones" title="Adverse effects of fluoroquinolones" class="mw-redirect">adverse effects of fluoroquinolones</a>).<sup id="cite_ref-118" class="reference"><a href="#cite_note-118"><span>[</span>118<span>]</span></a></sup><sup id="cite_ref-119" class="reference"><a href="#cite_note-119"><span>[</span>119<span>]</span></a></sup><sup id="cite_ref-120" class="reference"><a href="#cite_note-120"><span>[</span>120<span>]</span></a></sup></li>
<li><a href="/wiki/Gabapentin" title="Gabapentin">Gabapentin</a> can relieve most of the discomfort of benzodiazepine withdrawal; including anxiety, insomnia, irritability, tremor and muscle spasms. However, gabapentin may give rise to its own withdrawal syndrome upon discontinuation if taken continuously for long periods.</li>
<li><a href="/wiki/Imidazenil" title="Imidazenil">Imidazenil</a> has received some research for management of benzodiazepine withdrawal, but is not currently used in withdrawal.<sup id="cite_ref-121" class="reference"><a href="#cite_note-121"><span>[</span>121<span>]</span></a></sup></li>
<li><a href="/wiki/Imipramine" title="Imipramine">Imipramine</a> was found to statistically increase the discontinuation success rate.<sup id="cite_ref-Voshaar_6-2" class="reference"><a href="#cite_note-Voshaar-6"><span>[</span>6<span>]</span></a></sup></li>
<li><a href="/wiki/Melatonin" title="Melatonin">Melatonin</a> augmentation was found to statistically increase the discontinuation success rate for people with insomnia.<sup id="cite_ref-Voshaar_6-3" class="reference"><a href="#cite_note-Voshaar-6"><span>[</span>6<span>]</span></a></sup></li>
<li><a href="/wiki/Phenibut" title="Phenibut">Phenibut</a> may help with the anxiety, insomnia and muscle tension brought on by benzodiazepine discontinuation. However there is a commonly known 'rebound' effect felt with Phenibut that may be exacerbated for people in withdrawal, it is also not recommended to be taken for more than 3 consecutive days to avoid developing a dependency.</li>
<li><a href="/wiki/Phenobarbital" title="Phenobarbital">Phenobarbital</a>, (a <a href="/wiki/Barbiturate" title="Barbiturate">barbiturate</a>), is used at "detox" or other inpatient facilities to prevent seizures during rapid withdrawal or <a href="/wiki/Cold_turkey" title="Cold turkey">cold turkey</a>. The phenobarbital is followed by a one- to two-week taper, although a slow taper from phenobarbital is preferred.<sup id="cite_ref-gabbards_21-6" class="reference"><a href="#cite_note-gabbards-21"><span>[</span>21<span>]</span></a></sup> In a comparison study, a rapid taper using benzodiazepines was found to be superior to a phenobarbital rapid taper.<sup id="cite_ref-122" class="reference"><a href="#cite_note-122"><span>[</span>122<span>]</span></a></sup><sup id="cite_ref-123" class="reference"><a href="#cite_note-123"><span>[</span>123<span>]</span></a></sup></li>
<li><a href="/wiki/Pregabalin" title="Pregabalin">Pregabalin</a> may help reduce the severity of benzodiazepine withdrawal symptoms,<sup id="cite_ref-Oulis-2010_124-0" class="reference"><a href="#cite_note-Oulis-2010-124"><span>[</span>124<span>]</span></a></sup> and reduce the risk of relapse.<sup id="cite_ref-Oulis-2012_125-0" class="reference"><a href="#cite_note-Oulis-2012-125"><span>[</span>125<span>]</span></a></sup></li>
<li><a href="/wiki/Progesterone" title="Progesterone">Progesterone</a> has been found to be ineffective for managing benzodiazepine withdrawal.<sup id="cite_ref-Denis-2006_108-1" class="reference"><a href="#cite_note-Denis-2006-108"><span>[</span>108<span>]</span></a></sup></li>
<li><a href="/wiki/Propranolol" title="Propranolol">Propranolol</a> was not found to increase the discontinuation success rate.<sup id="cite_ref-Voshaar_6-4" class="reference"><a href="#cite_note-Voshaar-6"><span>[</span>6<span>]</span></a></sup></li>
<li><a href="/wiki/SSRI" title="SSRI" class="mw-redirect">SSRI</a> antidepressants have been found to have little value in the treatment of benzodiazepine withdrawal.<sup id="cite_ref-126" class="reference"><a href="#cite_note-126"><span>[</span>126<span>]</span></a></sup></li>
<li><a href="/wiki/Tramadol" title="Tramadol">Tramadol</a> has been found to lower the seizure threshold and should be avoided during benzodiazepine withdrawal.</li>
<li><a href="/wiki/Trazodone" title="Trazodone">Trazodone</a> was not found to increase the discontinuation success rate.<sup id="cite_ref-Voshaar_6-5" class="reference"><a href="#cite_note-Voshaar-6"><span>[</span>6<span>]</span></a></sup></li>
</ul>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=7" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote">See also: <a href="/wiki/Protracted_withdrawal_syndrome" title="Protracted withdrawal syndrome" class="mw-redirect">Protracted withdrawal syndrome</a></div>
<p>The success rate of a minimal intervention where rapid withdrawal is first tried, followed by a systematic tapered discontinuation if the first try was unsuccessful, ranges from 25 to 100% with a median of 58%.<sup id="cite_ref-Voshaar_6-6" class="reference"><a href="#cite_note-Voshaar-6"><span>[</span>6<span>]</span></a></sup> Cognitive behavioral therapy was useful to improve success rates for panic disorder, melatonin for insomnia, as was flumazenil and sodium valproate.<sup id="cite_ref-Voshaar_6-7" class="reference"><a href="#cite_note-Voshaar-6"><span>[</span>6<span>]</span></a></sup> A ten-year follow-up found that more than half of those who had successfully withdrawn from long-term use were still abstinent two years later, and that if they were able to maintain this state at two years, they were likely to maintain this state at the ten-year followup.<sup id="cite_ref-deGier2011_8-1" class="reference"><a href="#cite_note-deGier2011-8"><span>[</span>8<span>]</span></a></sup> One study found that after one year of abstinence from long-term use of benzodiazepines, cognitive, neurological and intellectual impairments had returned to normal.<sup id="cite_ref-127" class="reference"><a href="#cite_note-127"><span>[</span>127<span>]</span></a></sup></p>
<p>Those who had a prior psychiatric diagnosis had a similar success rate from a gradual taper at a two-year follow-up.<sup id="cite_ref-pmid2864096_93-1" class="reference"><a href="#cite_note-pmid2864096-93"><span>[</span>93<span>]</span></a></sup><sup id="cite_ref-128" class="reference"><a href="#cite_note-128"><span>[</span>128<span>]</span></a></sup> Withdrawal from benzodiazepines did not lead to an increased use of <a href="/wiki/Antidepressants" title="Antidepressants" class="mw-redirect">antidepressants</a>.<sup id="cite_ref-J.C3.B8rgensen-2009_129-0" class="reference"><a href="#cite_note-J.C3.B8rgensen-2009-129"><span>[</span>129<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Withdrawal_process">Withdrawal process</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=8" title="Edit section: Withdrawal process">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>It can be too difficult to withdraw from short- or intermediate-acting benzodiazepines because of the intensity of the <a href="/wiki/Rebound_effects" title="Rebound effects" class="mw-redirect">rebound</a> symptoms felt between doses.<sup id="cite_ref-ashman_4-9" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-130" class="reference"><a href="#cite_note-130"><span>[</span>130<span>]</span></a></sup><sup id="cite_ref-131" class="reference"><a href="#cite_note-131"><span>[</span>131<span>]</span></a></sup><sup id="cite_ref-132" class="reference"><a href="#cite_note-132"><span>[</span>132<span>]</span></a></sup> Moreover, short-acting benzodiazepines appear to produce a more intense withdrawal syndrome.<sup id="cite_ref-pmid2222129_133-0" class="reference"><a href="#cite_note-pmid2222129-133"><span>[</span>133<span>]</span></a></sup> For this reason, discontinuation is sometimes carried out by first substituting an <a href="/wiki/List_of_benzodiazepines#Benzodiazepine_half-life_and_equivalent_dose_table" title="List of benzodiazepines">equivalent dose</a> of a short-acting benzodiazepine to a longer-acting one like <a href="/wiki/Diazepam" title="Diazepam">diazepam</a> or <a href="/wiki/Chlordiazepoxide" title="Chlordiazepoxide">chlordiazepoxide</a>. Failure to use the correct <a href="/wiki/Benzodiazepine_equivalencies" title="Benzodiazepine equivalencies" class="mw-redirect">equivalent amount</a> can precipitate a severe withdrawal reaction.<sup id="cite_ref-selfharm_134-0" class="reference"><a href="#cite_note-selfharm-134"><span>[</span>134<span>]</span></a></sup> Benzodiazepines with a <a href="/wiki/Half-life" title="Half-life">half-life</a> of more than 24 hours include chlordiazepoxide, <a href="/wiki/Diazepam" title="Diazepam">diazepam</a>, <a href="/wiki/Clobazam" title="Clobazam">clobazam</a>, <a href="/wiki/Clonazepam" title="Clonazepam">clonazepam</a>, chlorazepinic acid, <a href="/wiki/Flurazepam" title="Flurazepam">flurazepam</a>, <a href="/wiki/Ketazolam" title="Ketazolam">ketazolam</a>, <a href="/wiki/Medazepam" title="Medazepam">medazepam</a>, <a href="/wiki/Nordazepam" title="Nordazepam">nordazepam</a>, and <a href="/wiki/Prazepam" title="Prazepam">prazepam</a>. Benzodiazepines with a half-life of less than 24 hours include <a href="/wiki/Alprazolam" title="Alprazolam">alprazolam</a>, <a href="/wiki/Bromazepam" title="Bromazepam">bromazepam</a>, <a href="/wiki/Brotizolam" title="Brotizolam">brotizolam</a>, <a href="/wiki/Flunitrazepam" title="Flunitrazepam">flunitrazepam</a>, <a href="/wiki/Loprazolam" title="Loprazolam">loprazolam</a>, <a href="/wiki/Lorazepam" title="Lorazepam">lorazepam</a>, <a href="/wiki/Lormetazepam" title="Lormetazepam">lormetazepam</a>, <a href="/wiki/Midazolam" title="Midazolam">midazolam</a>, <a href="/wiki/Nitrazepam" title="Nitrazepam">nitrazepam</a>, <a href="/wiki/Oxazepam" title="Oxazepam">oxazepam</a>, and <a href="/wiki/Temazepam" title="Temazepam">temazepam</a>.<sup id="cite_ref-deGier2011_8-2" class="reference"><a href="#cite_note-deGier2011-8"><span>[</span>8<span>]</span></a></sup> The resultant equivalent dose is then gradually reduced. The reduction rate used in the <a href="/w/index.php?title=Heather_Ashton&amp;action=edit&amp;redlink=1" class="new" title="Heather Ashton (page does not exist)">Heather Ashton</a><sup class="noprint" style="font-style: normal;">[<a href="//fr.wikipedia.org/wiki/Heather_Ashton" class="extiw" title="fr:Heather Ashton">fr</a>]</sup> protocol calls for eliminating 10% of the remaining dose every two to four weeks, depending on the severity and response to reductions with the final dose at 0.5&#160;mg dose of diazepam or 5&#160;mg dose of chlordiazepoxide.<sup id="cite_ref-ashman_4-10" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Duration">Duration</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=9" title="Edit section: Duration">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>After the last dose has been taken, the acute phase of the withdrawal generally lasts for about two months. Withdrawal symptoms, even from low-dose use, typically persist for six to twelve months and gradually improve over that period,<sup id="cite_ref-murphy_27-2" class="reference"><a href="#cite_note-murphy-27"><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-pmid2864096_93-2" class="reference"><a href="#cite_note-pmid2864096-93"><span>[</span>93<span>]</span></a></sup> however, clinically significant withdrawal symptoms may persist for years, although gradually declining.</p>
<p>A clinical trial of patients taking the benzodiazepine alprazolam for as short as eight weeks triggered protracted symptoms of memory deficits which were still present up to eight weeks after cessation of alprazolam.<sup id="cite_ref-135" class="reference"><a href="#cite_note-135"><span>[</span>135<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Protracted_withdrawal_syndrome">Protracted withdrawal syndrome</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=10" title="Edit section: Protracted withdrawal syndrome">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Protracted withdrawal syndrome refers to symptoms persisting for months or even years. A significant minority of people withdrawing from benzodiazepines, perhaps 10 to 15%, experience a <a href="/wiki/Protracted_withdrawal_syndrome" title="Protracted withdrawal syndrome" class="mw-redirect">protracted withdrawal syndrome</a> which can sometimes be severe. Symptoms may include tinnitus,<sup id="cite_ref-tinnitus_54-1" class="reference"><a href="#cite_note-tinnitus-54"><span>[</span>54<span>]</span></a></sup><sup id="cite_ref-136" class="reference"><a href="#cite_note-136"><span>[</span>136<span>]</span></a></sup> <a href="/wiki/Psychosis" title="Psychosis">psychosis</a>, cognitive deficits, <a href="/wiki/Gastrointestinal" title="Gastrointestinal" class="mw-redirect">gastrointestinal</a> complaints, insomnia, <a href="/wiki/Paraesthesia" title="Paraesthesia" class="mw-redirect">paraesthesia</a> (tingling and numbness), pain (usually in limbs and extremities), muscle pain, weakness, tension, painful tremor, shaking attacks, jerks, and <a href="/wiki/Blepharospasm" title="Blepharospasm">blepharospasm</a><sup id="cite_ref-pwsfb_16-3" class="reference"><a href="#cite_note-pwsfb-16"><span>[</span>16<span>]</span></a></sup> and may occur even without a pre-existing history of these symptoms. Tinnitus occurring during dose reduction or discontinuation of benzodiazepines is alleviated by recommencement of benzodiazepines.</p>
<p>A study testing neuropsychological factors found psychophysiological markers differering from normals, and concluded that protracted withdrawal syndrome was a genuine iatrogenic condition caused by the long-term use.<sup id="cite_ref-137" class="reference"><a href="#cite_note-137"><span>[</span>137<span>]</span></a></sup> The causes of persisting symptoms are a combination of pharmacological factors such as persisting drug induced receptor changes, psychological factors both caused by the drug and separate from the drug and possibly in some cases, particularly high dose users, structural brain damage or structural neuronal damage.<sup id="cite_ref-pwsfb_16-4" class="reference"><a href="#cite_note-pwsfb-16"><span>[</span>16<span>]</span></a></sup><sup id="cite_ref-138" class="reference"><a href="#cite_note-138"><span>[</span>138<span>]</span></a></sup> Symptoms continue to improve over time, often to the point where people eventually resume their normal lives, even after years of incapacity.<sup id="cite_ref-ashman_4-11" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup></p>
<p>A slow withdrawal rate significantly reduces the risk of a protracted and/or severe withdrawal state. Protracted withdrawal symptoms can be punctuated by periods of good days and bad days. When symptoms increase periodically during protracted withdrawal, physiological changes may be present, including <a href="/wiki/Dilated_pupils" title="Dilated pupils" class="mw-redirect">dilated pupils</a> as well as an increase in blood pressure and heart rate.<sup id="cite_ref-gabbards_21-7" class="reference"><a href="#cite_note-gabbards-21"><span>[</span>21<span>]</span></a></sup> The change in symptoms has been proposed to be due to changes in receptor sensitivity for GABA during the process of tolerance reversal.<sup id="cite_ref-ashman_4-12" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup> A <a href="/wiki/Meta-analysis" title="Meta-analysis">meta-analysis</a> found cognitive impairments due to benzodiazepine use show improvements after six months of withdrawal, but the remaining cognitive impairments may be permanent or may require more than six months to reverse.<sup id="cite_ref-139" class="reference"><a href="#cite_note-139"><span>[</span>139<span>]</span></a></sup></p>
<p>Protracted symptoms continue to fade over a period of many months or several years. There is no known cure for protracted benzodiazepine withdrawal syndrome except time,<sup id="cite_ref-pwsfb_16-5" class="reference"><a href="#cite_note-pwsfb-16"><span>[</span>16<span>]</span></a></sup> however, the medication flumazenil was found to be more effective than placebo in reducing feelings of hostility and aggression in patients who had been free of benzodiazepines for 4–266 weeks.<sup id="cite_ref-L._Saxon.2C_S._Borg_.26_A._J._Hiltunen_148.E2.80.93151_111-1" class="reference"><a href="#cite_note-L._Saxon.2C_S._Borg_.26_A._J._Hiltunen_148.E2.80.93151-111"><span>[</span>111<span>]</span></a></sup> This may suggest a role for flumazenil in treating protracted benzodiazepine withdrawal symptoms.</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=11" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The severity and length of the withdrawal syndrome is likely determined by various factors, including rate of tapering, length of use and dosage size, and possible genetic factors.<sup id="cite_ref-ashman_4-13" class="reference"><a href="#cite_note-ashman-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-140" class="reference"><a href="#cite_note-140"><span>[</span>140<span>]</span></a></sup> Those who have a prior history of withdrawing from benzodiazepines may have a <a href="/wiki/Sensitization" title="Sensitization">sensitized</a> or <a href="/wiki/Kindling_(sedative-hypnotic_withdrawal)" title="Kindling (sedative-hypnotic withdrawal)">kindled</a> central nervous system leading to worsening cognition and symptomatology, and making each subsequent withdrawal period worse.<sup id="cite_ref-pmid11224351_87-1" class="reference"><a href="#cite_note-pmid11224351-87"><span>[</span>87<span>]</span></a></sup><sup id="cite_ref-Dunworth_SJ.2C_Mead_AN.2C_Stephens_DN_2000_1501.E2.80.931508_88-1" class="reference"><a href="#cite_note-Dunworth_SJ.2C_Mead_AN.2C_Stephens_DN_2000_1501.E2.80.931508-88"><span>[</span>88<span>]</span></a></sup><sup id="cite_ref-Rickels_K.2C_Schweizer_E.2C_Csanalosi_I.2C_Case_WG.2C_Chung_H_1988_444.E2.80.93450_89-1" class="reference"><a href="#cite_note-Rickels_K.2C_Schweizer_E.2C_Csanalosi_I.2C_Case_WG.2C_Chung_H_1988_444.E2.80.93450-89"><span>[</span>89<span>]</span></a></sup><sup id="cite_ref-Vorma2005_141-0" class="reference"><a href="#cite_note-Vorma2005-141"><span>[</span>141<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Special_populations">Special populations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=12" title="Edit section: Special populations">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Pediatrics">Pediatrics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=13" title="Edit section: Pediatrics">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>A neonatal withdrawal syndrome, sometimes severe, can occur when the mother had taken benzodiazepines, especially during the <a href="/wiki/Third_trimester" title="Third trimester" class="mw-redirect">third trimester</a>. Symptoms include <a href="/wiki/Hypotonia" title="Hypotonia">hypotonia</a>, <a href="/wiki/Apnoeic" title="Apnoeic" class="mw-redirect">apnoeic</a> spells, <a href="/wiki/Cyanosis" title="Cyanosis">cyanosis</a>, and impaired <a href="/wiki/Metabolic" title="Metabolic" class="mw-redirect">metabolic</a> responses to cold stress and <a href="/wiki/Seizure" title="Seizure" class="mw-redirect">seizures</a>. The neonatal benzodiazepine withdrawal syndrome has been reported to persist from hours to months after birth.<sup id="cite_ref-142" class="reference"><a href="#cite_note-142"><span>[</span>142<span>]</span></a></sup></p>
<p>A withdrawal syndrome is seen in about 20% of <a href="/wiki/Pediatric" title="Pediatric" class="mw-redirect">pediatric</a> intensive care unit children after infusions with benzodiazepines or <a href="/wiki/Opioids" title="Opioids" class="mw-redirect">opioids</a>.<sup id="cite_ref-birchley_143-0" class="reference"><a href="#cite_note-birchley-143"><span>[</span>143<span>]</span></a></sup> The likelihood of having the syndrome correlates with total infusion duration and dose, although duration is thought to be more important.<sup id="cite_ref-pmid14513134_144-0" class="reference"><a href="#cite_note-pmid14513134-144"><span>[</span>144<span>]</span></a></sup> Treatment for withdrawal usually involves weaning over an 3 to 21 day period if the infusion lasted for more than a week.<sup id="cite_ref-pmid16699772_145-0" class="reference"><a href="#cite_note-pmid16699772-145"><span>[</span>145<span>]</span></a></sup> Symptoms include tremors, agitation, sleeplessness, inconsolable crying, diarrhea and sweating. In total, over fifty withdrawal symptoms are listed in this review article.<sup id="cite_ref-birchley_143-1" class="reference"><a href="#cite_note-birchley-143"><span>[</span>143<span>]</span></a></sup><sup id="cite_ref-pmid17541548_146-0" class="reference"><a href="#cite_note-pmid17541548-146"><span>[</span>146<span>]</span></a></sup> Environmental measures aimed at easing the symptoms of neonates with severe abstinence syndrome had little impact, but providing a quiet sleep environment helped in mild cases.<sup id="cite_ref-birchley_143-2" class="reference"><a href="#cite_note-birchley-143"><span>[</span>143<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Pregnancy">Pregnancy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=14" title="Edit section: Pregnancy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Discontinuing benzodiazepines or antidepressants abruptly due to concerns of <a href="/wiki/Teratogenic" title="Teratogenic" class="mw-redirect">teratogenic</a> effects of the medications has a high risk of causing serious complications, so is not recommended. For example, abrupt withdrawal of benzodiazepines or antidepressants has a high risk of causing extreme withdrawal symptoms, including <a href="/wiki/Suicidal_ideation" title="Suicidal ideation">suicidal ideation</a> and a severe <a href="/wiki/Rebound_effect" title="Rebound effect">rebound effect</a> of the return of the underlying <a href="/wiki/Mental_health_disorder" title="Mental health disorder" class="mw-redirect">disorder</a> if present. This can lead to hospitalisation and potentially, suicide. One study reported one-third of mothers who suddenly discontinued or very rapidly tapered their medications became acutely suicidal due to 'unbearable symptoms'. One woman had a <a href="/wiki/Medical_abortion" title="Medical abortion">medical abortion</a>, as she felt she could no longer cope, and another woman used alcohol in a bid to combat the withdrawal symptoms from benzodiazepines. <a href="/wiki/Spontaneous_abortion" title="Spontaneous abortion" class="mw-redirect">Spontaneous abortions</a> may also result from abrupt withdrawal of psychotropic medications, including benzodiazepines. The study reported physicians generally are not aware of the severe consequences of abrupt <a href="/wiki/Drug_withdrawal" title="Drug withdrawal">withdrawal</a> of <a href="/wiki/Psychotropic" title="Psychotropic" class="mw-redirect">psychotropic</a> medications such as benzodiazepines or antidepressants.<sup id="cite_ref-ReferenceA_75-1" class="reference"><a href="#cite_note-ReferenceA-75"><span>[</span>75<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="The_elderly">The elderly</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=15" title="Edit section: The elderly">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>A study of the elderly who were benzodiazepine dependent found withdrawal could be carried out with few complications and could lead to improvements in sleep and cognitive abilities. At 52 weeks after successful withdrawal, a 22% improvement in cognitive status was found, as well as improved social functioning. Those who remained on benzodiazepines experienced a 5% decline in cognitive abilities, which seemed to be faster than that seen in normal aging, suggesting the longer the intake of benzodiazepines, the worse the cognitive effects become. Some worsening of symptoms were seen in the first few months of benzodiazepine abstinence, but at a 24-week followup, elderly subjects were clearly improved compared to those who remained on benzodiazepines. Improvements in sleep were seen at the 24- and 52-week followups. The authors concluded benzodiazepines were not effective in the long term for sleep problems except in suppressing withdrawal-related <a href="/wiki/Rebound_insomnia" title="Rebound insomnia" class="mw-redirect">rebound insomnia</a>. Improvements were seen between 24 and 52 weeks after withdrawal in many factors, including improved sleep and several cognitive and performance abilities. Some cognitive abilities, which are sensitive to benzodiazepines, as well as age, such as <a href="/wiki/Episodic_memory" title="Episodic memory">episodic memory</a> did not improve. The authors, however, cited a study in younger patients who at a 3.5-year followup showed no memory impairments and speculated that certain memory functions take longer to recover from chronic benzodiazepine use and further improvements in elderly people's cognitive function may occur beyond 52 weeks after withdrawal. The reason it took 24 weeks for improvements to be seen after cessation of benzodiazepine use was due to the time it takes the brain to adapt to the benzodiazepine-free environment.<sup id="cite_ref-Baillargeon-2003_147-0" class="reference"><a href="#cite_note-Baillargeon-2003-147"><span>[</span>147<span>]</span></a></sup></p>
<p>At 24 weeks, significant improvements were found, including accuracy of information processing improved, but a decline was seen in those who remained on benzodiazepines. Further improvements were noted at the 52-week followup, indicating ongoing improvements with benzodiazepine abstinence. Younger people on benzodiazepines also experience cognitive deterioration in visual spacial memory, but are not as vulnerable as the elderly to the cognitive effects.<sup id="cite_ref-Baillargeon-2003_147-1" class="reference"><a href="#cite_note-Baillargeon-2003-147"><span>[</span>147<span>]</span></a></sup></p>
<p>Improved reaction times were noted at 52 weeks in elderly patients free from benzodiazepines. This is an important function in the elderly, especially if they drive a car due to the increased risk of road traffic accidents in benzodiazepine users.<sup id="cite_ref-Baillargeon-2003_147-2" class="reference"><a href="#cite_note-Baillargeon-2003-147"><span>[</span>147<span>]</span></a></sup></p>
<p>At the 24-week followup, 80% of people had successfully withdrawn from benzodiazepines. Part of the success was attributed to the placebo method used for part of the trial which broke the <a href="/wiki/Substance_dependence" title="Substance dependence">psychological dependence</a> on benzodiazepines when the elderly patients realised they had completed their gradual reduction several weeks previously, and had only been taking placebo tablets. This helped reassure them they could sleep without their pills.<sup id="cite_ref-Baillargeon-2003_147-3" class="reference"><a href="#cite_note-Baillargeon-2003-147"><span>[</span>147<span>]</span></a></sup></p>
<p>The authors also warned of the similarities in pharmacology and mechanism of action of the newer <a href="/wiki/Nonbenzodiazepine" title="Nonbenzodiazepine">nonbenzodiazepine</a> <a href="/wiki/Z_drugs" title="Z drugs" class="mw-redirect">Z drugs</a>.<sup id="cite_ref-Baillargeon-2003_147-4" class="reference"><a href="#cite_note-Baillargeon-2003-147"><span>[</span>147<span>]</span></a></sup></p>
<p>The <a href="/wiki/Elimination_half-life" title="Elimination half-life" class="mw-redirect">elimination half-life</a> of diazepam and chlordiazepoxide, as well as other long half-life benzodiazepines, is twice as long in the elderly compared to younger individuals. Many doctors do not adjust benzodiazepine dosage according to age in elderly patients.<sup id="cite_ref-148" class="reference"><a href="#cite_note-148"><span>[</span>148<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Controversy">Controversy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=16" title="Edit section: Controversy">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Detox facilities may be inappropriate for those who have become tolerant while taking the drug as prescribed, as opposed to recreational use. Such inpatient referrals may be traumatic for non-abusers.<sup id="cite_ref-gabbards_21-8" class="reference"><a href="#cite_note-gabbards-21"><span>[</span>21<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=17" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="noprint portal tright" style="border:solid #aaa 1px;margin:0.5em 0 0.5em 1em">
<table style="background:#f9f9f9;font-size:85%;line-height:110%;max-width:175px">
<tr style="vertical-align:middle">
<td style="text-align:center"><a href="/wiki/File:American_Lady_Against_The_Sky.jpg" class="image"><img alt="Portal icon" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/72/American_Lady_Against_The_Sky.jpg/32px-American_Lady_Against_The_Sky.jpg" width="32" height="21" class="noviewer" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/72/American_Lady_Against_The_Sky.jpg/48px-American_Lady_Against_The_Sky.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/72/American_Lady_Against_The_Sky.jpg/64px-American_Lady_Against_The_Sky.jpg 2x" data-file-width="3008" data-file-height="2000" /></a></td>
<td style="padding:0 0.2em;vertical-align:middle;font-style:italic;font-weight:bold"><a href="/wiki/Portal:Psychiatry" title="Portal:Psychiatry">Psychiatry portal</a></td>
</tr>
</table>
</div>
<div class="div-col columns column-count column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2;">
<ul>
<li><a href="/wiki/Alcohol_withdrawal_syndrome" title="Alcohol withdrawal syndrome">Alcohol withdrawal syndrome</a></li>
<li><a href="/wiki/Benzodiazepine_dependence" title="Benzodiazepine dependence">Benzodiazepine dependence</a></li>
<li><a href="/wiki/Benzodiazepine_equivalence" title="Benzodiazepine equivalence" class="mw-redirect">Benzodiazepine equivalence</a></li>
<li><a href="/wiki/Opioid_withdrawal_syndrome" title="Opioid withdrawal syndrome" class="mw-redirect">Opioid withdrawal syndrome</a></li>
<li><a href="/wiki/Physical_dependence" title="Physical dependence">Physical dependence</a></li>
<li><a href="/wiki/Post-acute-withdrawal_syndrome" title="Post-acute-withdrawal syndrome">Post-acute-withdrawal syndrome</a></li>
<li><a href="/wiki/Rebound_effect" title="Rebound effect">Rebound effect</a></li>
<li><a href="/wiki/SSRI_discontinuation_syndrome" title="SSRI discontinuation syndrome" class="mw-redirect">SSRI discontinuation syndrome</a></li>
</ul>
</div>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=18" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Petursson-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Petursson_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Petursson_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Petursson_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Petursson_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Petursson_1-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Petursson, H. (1994). "The benzodiazepine withdrawal syndrome". <i>Addiction</i> <b>89</b> (11): 1455–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1360-0443.1994.tb03743.x">10.1111/j.1360-0443.1994.tb03743.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7841856">7841856</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=The+benzodiazepine+withdrawal+syndrome&amp;rft.aufirst=H.&amp;rft.aulast=Petursson&amp;rft.au=Petursson%2C+H.&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1360-0443.1994.tb03743.x&amp;rft_id=info%3Apmid%2F7841856&amp;rft.issue=11&amp;rft.jtitle=Addiction&amp;rft.pages=1455-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=89" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pdatheagtcau-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-pdatheagtcau_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pdatheagtcau_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pdatheagtcau_2-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Colvin, Rod (26 August 2008). <a rel="nofollow" class="external text" href="http://books.google.com/?id=lalhQgAACAAJ"><i>Overcoming Prescription Drug Addiction: A Guide to Coping and Understanding</i></a> (3 ed.). United States of America: Addicus Books. pp.&#160;74–76. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-886039-88-9" title="Special:BookSources/978-1-886039-88-9">978-1-886039-88-9</a>. <q>I have treated ten thousand patients for alcohol and drug problems and have detoxed approximately 1,500 patients for benzodiazepines – the detox for the benzodiazepines is one of the hardest detoxes we do. It can take an extremely long time, about half the length of time they have been addicted – the ongoing relentless withdrawals can be so incapacitating it can cause total destruction to one’s life – marriages break up, businesses are lost, bankruptcy, hospitalization, and of course suicide is probably the most single serious side effect.</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.au=Colvin%2C+Rod&amp;rft.aufirst=Rod&amp;rft.aulast=Colvin&amp;rft.btitle=Overcoming+Prescription+Drug+Addiction%3A+A+Guide+to+Coping+and+Understanding&amp;rft.date=26+August+2008&amp;rft.edition=3&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2F%3Fid%3DlalhQgAACAAJ&amp;rft.isbn=978-1-886039-88-9&amp;rft.pages=74-76&amp;rft.place=United+States+of+America&amp;rft.pub=Addicus+Books&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ashton-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ashton_3-0">^</a></b></span> <span class="reference-text"><span class="citation web">C. Heather Ashton DM. <a rel="nofollow" class="external text" href="http://www.benzo.org.uk/manual/bzcha03.htm">"Chapter III: Benzodiazepine withdrawal symptoms, acute &amp; protracted"</a>. Institute of Neuroscience, Newcastle University<span class="reference-accessdate">. Retrieved <span class="nowrap">29 April</span> 2013</span>. <q>Benzodiazepines&#160;: How they work and how to withdraw</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.au=C.+Heather+Ashton+DM&amp;rft.aulast=C.+Heather+Ashton+DM&amp;rft.btitle=Chapter+III%3A+Benzodiazepine+withdrawal+symptoms%2C+acute+%26+protracted&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.benzo.org.uk%2Fmanual%2Fbzcha03.htm&amp;rft.pub=Institute+of+Neuroscience%2C+Newcastle+University&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ashman-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-ashman_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ashman_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ashman_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-ashman_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-ashman_4-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-ashman_4-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-ashman_4-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-ashman_4-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-ashman_4-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-ashman_4-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-ashman_4-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-ashman_4-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-ashman_4-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-ashman_4-13"><sup><i><b>n</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Professor Heather Ashton (2002). <a rel="nofollow" class="external text" href="http://benzo.org.uk/manual/index.htm">"Benzodiazepines: How They Work and How to Withdraw"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.aulast=Professor+Heather+Ashton&amp;rft.au=Professor+Heather+Ashton&amp;rft.btitle=Benzodiazepines%3A+How+They+Work+and+How+to+Withdraw&amp;rft.date=2002&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbenzo.org.uk%2Fmanual%2Findex.htm&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><span class="citation journal">O'Connor, RD (1993). "Benzodiazepine dependence--a treatment perspective and an advocacy for control". <i>NIDA research monograph</i> <b>131</b>: 266–9. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8105385">8105385</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepine+dependence--a+treatment+perspective+and+an+advocacy+for+control&amp;rft.aufirst=RD&amp;rft.aulast=O%27Connor&amp;rft.au=O%27Connor%2C+RD&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8105385&amp;rft.jtitle=NIDA+research+monograph&amp;rft.pages=266-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=131" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Voshaar-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-Voshaar_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Voshaar_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Voshaar_6-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Voshaar_6-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Voshaar_6-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Voshaar_6-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Voshaar_6-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Voshaar_6-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Voshaar, R. C. O.; Couvée, JE; Van Balkom, AJ; Mulder, PG; Zitman, FG (2006). "Strategies for discontinuing long-term benzodiazepine use: Meta-analysis". <i>The British Journal of Psychiatry</i> <b>189</b> (3): 213–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1192%2Fbjp.189.3.213">10.1192/bjp.189.3.213</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16946355">16946355</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Strategies+for+discontinuing+long-term+benzodiazepine+use%3A+Meta-analysis&amp;rft.au=Couv%C3%A9e%2C+JE&amp;rft.aufirst=R.+C.+O.&amp;rft.aulast=Voshaar&amp;rft.au=Mulder%2C+PG&amp;rft.au=Van+Balkom%2C+AJ&amp;rft.au=Voshaar%2C+R.+C.+O.&amp;rft.au=Zitman%2C+FG&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1192%2Fbjp.189.3.213&amp;rft_id=info%3Apmid%2F16946355&amp;rft.issue=3&amp;rft.jtitle=The+British+Journal+of+Psychiatry&amp;rft.pages=213-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=189" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nutt-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nutt_7-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Nutt, David (1986). "Benzodiazepine dependence in the clinic: Reason for anxiety?". <i>Trends in Pharmacological Sciences</i> <b>7</b>: 457–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0165-6147%2886%2990420-7">10.1016/0165-6147(86)90420-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepine+dependence+in+the+clinic%3A+Reason+for+anxiety%3F&amp;rft.aufirst=David&amp;rft.aulast=Nutt&amp;rft.au=Nutt%2C+David&amp;rft.date=1986&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0165-6147%2886%2990420-7&amp;rft.jtitle=Trends+in+Pharmacological+Sciences&amp;rft.pages=457-60&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-deGier2011-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-deGier2011_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-deGier2011_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-deGier2011_8-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">De Gier, N.; Gorgels, W.; Lucassen, P.; Oude Voshaar, R.; Mulder, J.; Zitman, F. (2010). "Discontinuation of long-term benzodiazepine use: 10-year follow-up". <i>Family Practice</i> <b>28</b> (3): 253–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Ffampra%2Fcmq113">10.1093/fampra/cmq113</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21193495">21193495</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Discontinuation+of+long-term+benzodiazepine+use%3A+10-year+follow-up&amp;rft.au=De+Gier%2C+N.&amp;rft.aufirst=N.&amp;rft.au=Gorgels%2C+W.&amp;rft.aulast=De+Gier&amp;rft.au=Lucassen%2C+P.&amp;rft.au=Mulder%2C+J.&amp;rft.au=Oude+Voshaar%2C+R.&amp;rft.au=Zitman%2C+F.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Ffampra%2Fcmq113&amp;rft_id=info%3Apmid%2F21193495&amp;rft.issue=3&amp;rft.jtitle=Family+Practice&amp;rft.pages=253-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=28" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Authier--9"><span class="mw-cite-backlink"><b><a href="#cite_ref-Authier-_9-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Authier, Nicolas; Boucher, Alexandra; Lamaison, Dominique; Llorca, Pierre-Michel; Descotes, Jacques; Eschalier, Alain (2009). "Second Meeting of the French CEIP (Centres d'Évaluation et d'Information sur la Pharmacodépendance). Part II: Benzodiazepine Withdrawal". <i>Thérapie</i> <b>64</b> (6): 365–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2515%2Ftherapie%2F2009051">10.2515/therapie/2009051</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20025839">20025839</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Second+Meeting+of+the+French+CEIP+%28Centres+d%27%C3%89valuation+et+d%27Information+sur+la+Pharmacod%C3%A9pendance%29.+Part+II%3A+Benzodiazepine+Withdrawal&amp;rft.au=Authier%2C+Nicolas&amp;rft.au=Boucher%2C+Alexandra&amp;rft.au=Descotes%2C+Jacques&amp;rft.au=Eschalier%2C+Alain&amp;rft.aufirst=Nicolas&amp;rft.au=Lamaison%2C+Dominique&amp;rft.aulast=Authier&amp;rft.au=Llorca%2C+Pierre-Michel&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2515%2Ftherapie%2F2009051&amp;rft_id=info%3Apmid%2F20025839&amp;rft.issue=6&amp;rft.jtitle=Th%C3%A9rapie&amp;rft.pages=365-70&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=64" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation journal">Heberlein, A.; Bleich, S.; Kornhuber, J.; Hillemacher, T. (2008). "Benzodiazepin-Abhängigkeit: Ursachen und Behandlungsmöglichkeiten" [Benzodiazepine Dependence: Causalities and Treatment Options]. <i>Fortschritte der Neurologie · Psychiatrie</i> (in German) <b>77</b> (1): 7–15. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1055%2Fs-0028-1100831">10.1055/s-0028-1100831</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19101875">19101875</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepin-Abh%C3%A4ngigkeit%3A+Ursachen+und+Behandlungsm%C3%B6glichkeiten&amp;rft.au=Bleich%2C+S.&amp;rft.aufirst=A.&amp;rft.au=Heberlein%2C+A.&amp;rft.au=Hillemacher%2C+T.&amp;rft.au=Kornhuber%2C+J.&amp;rft.aulast=Heberlein&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-0028-1100831&amp;rft_id=info%3Apmid%2F19101875&amp;rft.issue=1&amp;rft.jtitle=Fortschritte+der+Neurologie+%C2%B7+Psychiatrie&amp;rft.pages=7-15&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=77" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-sleep_medicine_a04-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-sleep_medicine_a04_11-0">^</a></b></span> <span class="reference-text"><span class="citation book">Lee-chiong, Teofilo (24 April 2008). <a rel="nofollow" class="external text" href="http://books.google.com/?id=s1F_DEbRNMcC&amp;pg=PT468"><i>Sleep Medicine: Essentials and Review</i></a>. Oxford University Press, USA. p.&#160;468. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-19-530659-7" title="Special:BookSources/0-19-530659-7">0-19-530659-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.aufirst=Teofilo&amp;rft.aulast=Lee-chiong&amp;rft.au=Lee-chiong%2C+Teofilo&amp;rft.btitle=Sleep+Medicine%3A+Essentials+and+Review&amp;rft.date=24+April+2008&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2F%3Fid%3Ds1F_DEbRNMcC%26pg%3DPT468&amp;rft.isbn=0-19-530659-7&amp;rft.pages=468&amp;rft.pub=Oxford+University+Press%2C+USA&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation book">Evans, Katie; Sullivan, Michael J. (2001). <a rel="nofollow" class="external text" href="http://books.google.com/books?id=lvUzR0obihEC&amp;pg=PA52">"Withdrawal and Medical Issues"</a>. <i>Dual Diagnosis: Counseling the Mentally Ill Substance Abuser</i> (2nd ed.). Guilford Press. pp.&#160;52–3. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-57230-446-8" title="Special:BookSources/978-1-57230-446-8">978-1-57230-446-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Withdrawal+and+Medical+Issues&amp;rft.au=Evans%2C+Katie&amp;rft.aufirst=Katie&amp;rft.aulast=Evans&amp;rft.au=Sullivan%2C+Michael+J.&amp;rft.btitle=Dual+Diagnosis%3A+Counseling+the+Mentally+Ill+Substance+Abuser&amp;rft.date=2001&amp;rft.edition=2nd&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DlvUzR0obihEC%26pg%3DPA52&amp;rft.isbn=978-1-57230-446-8&amp;rft.pages=52-3&amp;rft.pub=Guilford+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Lader, M (1987). "Long-term anxiolytic therapy: The issue of drug withdrawal". <i>The Journal of clinical psychiatry</i>. 48 Suppl: 12–6. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2891684">2891684</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Long-term+anxiolytic+therapy%3A+The+issue+of+drug+withdrawal&amp;rft.aufirst=M&amp;rft.au=Lader%2C+M&amp;rft.aulast=Lader&amp;rft.date=1987&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2891684&amp;rft.jtitle=The+Journal+of+clinical+psychiatry&amp;rft.pages=12-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=48+Suppl" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation journal">Boisse, NR; Periana, RM; Guarino, JJ; Kruger, HS; Samoriski, GM (1986). "Pharmacologic characterization of acute chlordiazepoxide dependence in the rat". <i>The Journal of Pharmacology and Experimental Therapeutics</i> <b>239</b> (3): 775–83. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3098961">3098961</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Pharmacologic+characterization+of+acute+chlordiazepoxide+dependence+in+the+rat&amp;rft.au=Boisse%2C+NR&amp;rft.aufirst=NR&amp;rft.au=Guarino%2C+JJ&amp;rft.au=Kruger%2C+HS&amp;rft.aulast=Boisse&amp;rft.au=Periana%2C+RM&amp;rft.au=Samoriski%2C+GM&amp;rft.date=1986&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F3098961&amp;rft.issue=3&amp;rft.jtitle=The+Journal+of+Pharmacology+and+Experimental+Therapeutics&amp;rft.pages=775-83&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=239" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Boisse, NR; Periana, RM; Guarino, JJ; Kruger, HS (1986). "Acute chlordiazepoxide dependence in the rat: Comparisons to chronic". <i>NIDA research monograph</i> <b>67</b>: 197–201. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3092067">3092067</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Acute+chlordiazepoxide+dependence+in+the+rat%3A+Comparisons+to+chronic&amp;rft.au=Boisse%2C+NR&amp;rft.aufirst=NR&amp;rft.au=Guarino%2C+JJ&amp;rft.au=Kruger%2C+HS&amp;rft.aulast=Boisse&amp;rft.au=Periana%2C+RM&amp;rft.date=1986&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F3092067&amp;rft.jtitle=NIDA+research+monograph&amp;rft.pages=197-201&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=67" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pwsfb-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-pwsfb_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pwsfb_16-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pwsfb_16-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pwsfb_16-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pwsfb_16-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pwsfb_16-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Professor Heather Ashton (2004). <a rel="nofollow" class="external text" href="http://www.benzo.org.uk/pws04.htm">"Protracted Withdrawal Symptoms From Benzodiazepines"</a>. Comprehensive Handbook of Drug &amp; Alcohol Addiction.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.aulast=Professor+Heather+Ashton&amp;rft.au=Professor+Heather+Ashton&amp;rft.btitle=Protracted+Withdrawal+Symptoms+From+Benzodiazepines&amp;rft.date=2004&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.benzo.org.uk%2Fpws04.htm&amp;rft.pub=Comprehensive+Handbook+of+Drug+%26+Alcohol+Addiction&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Allison-2003-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-Allison-2003_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Allison-2003_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Allison-2003_17-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Allison, C; Pratt, J.A (2003). "Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence". <i>Pharmacology &amp; Therapeutics</i> <b>98</b> (2): 171–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0163-7258%2803%2900029-9">10.1016/S0163-7258(03)00029-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12725868">12725868</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Neuroadaptive+processes+in+GABAergic+and+glutamatergic+systems+in+benzodiazepine+dependence&amp;rft.au=Allison%2C+C&amp;rft.aufirst=C&amp;rft.aulast=Allison&amp;rft.au=Pratt%2C+J.A&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0163-7258%2803%2900029-9&amp;rft_id=info%3Apmid%2F12725868&amp;rft.issue=2&amp;rft.jtitle=Pharmacology+%26+Therapeutics&amp;rft.pages=171-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=98" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Herman, JB; Brotman, AW; Rosenbaum, JF (1987). "Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines". <i>The Journal of clinical psychiatry</i>. 48 Suppl: 22–8. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2889722">2889722</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Rebound+anxiety+in+panic+disorder+patients+treated+with+shorter-acting+benzodiazepines&amp;rft.au=Brotman%2C+AW&amp;rft.aufirst=JB&amp;rft.au=Herman%2C+JB&amp;rft.aulast=Herman&amp;rft.au=Rosenbaum%2C+JF&amp;rft.date=1987&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2889722&amp;rft.jtitle=The+Journal+of+clinical+psychiatry&amp;rft.pages=22-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=48+Suppl" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><span class="citation journal">Allgulander, C; Bandelow, B; Hollander, E; Montgomery, SA; Nutt, DJ; Okasha, A; Pollack, MH; Stein, DJ; Swinson, RP; World Council Of, Anxiety (2003). "WCA recommendations for the long-term treatment of generalized anxiety disorder". <i>CNS spectrums</i> <b>8</b> (8 Suppl 1): 53–61. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14767398">14767398</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=WCA+recommendations+for+the+long-term+treatment+of+generalized+anxiety+disorder&amp;rft.au=Allgulander%2C+C&amp;rft.au=Bandelow%2C+B&amp;rft.aufirst=C&amp;rft.au=Hollander%2C+E&amp;rft.aulast=Allgulander&amp;rft.au=Montgomery%2C+SA&amp;rft.au=Nutt%2C+DJ&amp;rft.au=Okasha%2C+A&amp;rft.au=Pollack%2C+MH&amp;rft.au=Stein%2C+DJ&amp;rft.au=Swinson%2C+RP&amp;rft.au=World+Council+Of%2C+Anxiety&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F14767398&amp;rft.issue=8+Suppl+1&amp;rft.jtitle=CNS+spectrums&amp;rft.pages=53-61&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Salzman-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-Salzman_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Salzman_20-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Salzman, Carl (1993). "Benzodiazepine treatment of panic and agoraphobic symptoms: Use, dependence, toxicity, abuse". <i>Journal of Psychiatric Research</i> <b>27</b>: 97–110. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0022-3956%2893%2990021-S">10.1016/0022-3956(93)90021-S</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7908335">7908335</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepine+treatment+of+panic+and+agoraphobic+symptoms%3A+Use%2C+dependence%2C+toxicity%2C+abuse&amp;rft.aufirst=Carl&amp;rft.aulast=Salzman&amp;rft.au=Salzman%2C+Carl&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0022-3956%2893%2990021-S&amp;rft_id=info%3Apmid%2F7908335&amp;rft.jtitle=Journal+of+Psychiatric+Research&amp;rft.pages=97-110&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-gabbards-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-gabbards_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-gabbards_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-gabbards_21-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-gabbards_21-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-gabbards_21-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-gabbards_21-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-gabbards_21-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-gabbards_21-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-gabbards_21-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Gabbard, Glen O. (15 May 2007). <a rel="nofollow" class="external text" href="http://books.google.com/?id=-T2aEqfwLW4C&amp;pg=PA209"><i>Gabbard's Treatments of Psychiatric Disorders, Fourth Edition (Treatments of Psychiatric Disorders)</i></a>. American Psychiatric Publishing. pp.&#160;209–211. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-58562-216-8" title="Special:BookSources/1-58562-216-8">1-58562-216-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.aufirst=Glen+O.&amp;rft.au=Gabbard%2C+Glen+O.&amp;rft.aulast=Gabbard&amp;rft.btitle=Gabbard%27s+Treatments+of+Psychiatric+Disorders%2C+Fourth+Edition+%28Treatments+of+Psychiatric+Disorders%29&amp;rft.date=15+May+2007&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2F%3Fid%3D-T2aEqfwLW4C%26pg%3DPA209&amp;rft.isbn=1-58562-216-8&amp;rft.pages=209-211&amp;rft.pub=American+Psychiatric+Publishing&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-tbws1989-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-tbws1989_22-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Onyett, SR (1989). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1711840">"The benzodiazepine withdrawal syndrome and its management"</a>. <i>The Journal of the Royal College of General Practitioners</i> <b>39</b> (321): 160–3. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1711840">1711840</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2576073">2576073</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=The+benzodiazepine+withdrawal+syndrome+and+its+management&amp;rft.aufirst=SR&amp;rft.aulast=Onyett&amp;rft.au=Onyett%2C+SR&amp;rft.date=1989&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1711840&amp;rft_id=info%3Apmc%2F1711840&amp;rft_id=info%3Apmid%2F2576073&amp;rft.issue=321&amp;rft.jtitle=The+Journal+of+the+Royal+College+of+General+Practitioners&amp;rft.pages=160-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=39" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid1675688-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid1675688_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid1675688_23-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid1675688_23-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ashton, Heather (1991). "Protracted withdrawal syndromes from benzodiazepines". <i>Journal of Substance Abuse Treatment</i> <b>8</b> (1–2): 19–28. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0740-5472%2891%2990023-4">10.1016/0740-5472(91)90023-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1675688">1675688</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Protracted+withdrawal+syndromes+from+benzodiazepines&amp;rft.au=Ashton%2C+Heather&amp;rft.aufirst=Heather&amp;rft.aulast=Ashton&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0740-5472%2891%2990023-4&amp;rft_id=info%3Apmid%2F1675688&amp;rft.issue=1%E2%80%932&amp;rft.jtitle=Journal+of+Substance+Abuse+Treatment&amp;rft.pages=19-28&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><span class="citation book">Lindsay, S.J.E.; Powell, Graham E., eds. (28 July 1998). <a rel="nofollow" class="external text" href="http://books.google.com/?id=a6A9AAAAIAAJ&amp;pg=PA363"><i>The Handbook of Clinical Adult Psychology</i></a> (2nd ed.). Routledge. p.&#160;363. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-415-07215-1" title="Special:BookSources/978-0-415-07215-1">978-0-415-07215-1</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.btitle=The+Handbook+of+Clinical+Adult+Psychology&amp;rft.date=28+July+1998&amp;rft.edition=2nd&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2F%3Fid%3Da6A9AAAAIAAJ%26pg%3DPA363&amp;rft.isbn=978-0-415-07215-1&amp;rft.pages=363&amp;rft.pub=Routledge&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation journal">Authier, N.; Balayssac, D.; Sautereau, M.; Zangarelli, A.; Courty, P.; Somogyi, A.A.; Vennat, B.; Llorca, P.-M.; Eschalier, A. (2009). "Benzodiazepine dependence: Focus on withdrawal syndrome". <i>Annales Pharmaceutiques Françaises</i> <b>67</b> (6): 408–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.pharma.2009.07.001">10.1016/j.pharma.2009.07.001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19900604">19900604</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepine+dependence%3A+Focus+on+withdrawal+syndrome&amp;rft.au=Authier%2C+N.&amp;rft.au=Balayssac%2C+D.&amp;rft.au=Courty%2C+P.&amp;rft.au=Eschalier%2C+A.&amp;rft.aufirst=N.&amp;rft.aulast=Authier&amp;rft.au=Llorca%2C+P.-M.&amp;rft.au=Sautereau%2C+M.&amp;rft.au=Somogyi%2C+A.A.&amp;rft.au=Vennat%2C+B.&amp;rft.au=Zangarelli%2C+A.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pharma.2009.07.001&amp;rft_id=info%3Apmid%2F19900604&amp;rft.issue=6&amp;rft.jtitle=Annales+Pharmaceutiques+Fran%C3%A7aises&amp;rft.pages=408-13&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=67" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CSM2007-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-CSM2007_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CSM2007_26-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-CSM2007_26-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Committee on Safety of Medicines (2007). <a rel="nofollow" class="external text" href="http://www.bnf.org/bnf/bnf/58/3139.htm">"Hypnotics and anxiolytics"</a>. British National Formulary<span class="reference-accessdate">. Retrieved <span class="nowrap">17 September</span> 2007</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.au=Committee+on+Safety+of+Medicines&amp;rft.aulast=Committee+on+Safety+of+Medicines&amp;rft.btitle=Hypnotics+and+anxiolytics&amp;rft.date=2007&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.bnf.org%2Fbnf%2Fbnf%2F58%2F3139.htm&amp;rft.pub=British+National+Formulary&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span><span style="font-size:0.95em; font-size: 90%; color: #555">(<a href="/wiki/Wikipedia:Verifiability#Access_to_sources" title="Wikipedia:Verifiability">registration required</a>)</span></span></li>
<li id="cite_note-murphy-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-murphy_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-murphy_27-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-murphy_27-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Murphy, S. M.; Tyrer, P. (1991). "A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence". <i>The British Journal of Psychiatry</i> <b>158</b> (4): 511–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1192%2Fbjp.158.4.511">10.1192/bjp.158.4.511</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1675901">1675901</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=A+double-blind+comparison+of+the+effects+of+gradual+withdrawal+of+lorazepam%2C+diazepam+and+bromazepam+in+benzodiazepine+dependence&amp;rft.aufirst=S.+M.&amp;rft.aulast=Murphy&amp;rft.au=Murphy%2C+S.+M.&amp;rft.au=Tyrer%2C+P.&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1192%2Fbjp.158.4.511&amp;rft_id=info%3Apmid%2F1675901&amp;rft.issue=4&amp;rft.jtitle=The+British+Journal+of+Psychiatry&amp;rft.pages=511-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=158" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><span class="citation journal">Adam, Kirstine; Oswald, I. (2008). "Can a Rapidly-eliminated Hypnotic Cause Daytime Anxiety?". <i>Pharmacopsychiatry</i> <b>22</b> (3): 115–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1055%2Fs-2007-1014592">10.1055/s-2007-1014592</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2748714">2748714</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Can+a+Rapidly-eliminated+Hypnotic+Cause+Daytime+Anxiety%3F&amp;rft.au=Adam%2C+Kirstine&amp;rft.aufirst=Kirstine&amp;rft.aulast=Adam&amp;rft.au=Oswald%2C+I.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2007-1014592&amp;rft_id=info%3Apmid%2F2748714&amp;rft.issue=3&amp;rft.jtitle=Pharmacopsychiatry&amp;rft.pages=115-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation journal">Scharf, Martin B; Kales, Judith A; Bixler, EO; Jacoby, JA; Schweitzer, PK (1982). "Lorazepam—Efficacy, side effects, and rebound phenomena". <i>Clinical Pharmacology and Therapeutics</i> <b>31</b> (2): 175–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fclpt.1982.27">10.1038/clpt.1982.27</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6120058">6120058</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Lorazepam%E2%80%94Efficacy%2C+side+effects%2C+and+rebound+phenomena&amp;rft.au=Bixler%2C+EO&amp;rft.aufirst=Martin+B&amp;rft.au=Jacoby%2C+JA&amp;rft.au=Kales%2C+Judith+A&amp;rft.aulast=Scharf&amp;rft.au=Scharf%2C+Martin+B&amp;rft.au=Schweitzer%2C+PK&amp;rft.date=1982&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fclpt.1982.27&amp;rft_id=info%3Apmid%2F6120058&amp;rft.issue=2&amp;rft.jtitle=Clinical+Pharmacology+and+Therapeutics&amp;rft.pages=175-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><span class="citation journal">Walsh, James K; Schweitzer, Paula K; Parwatikar, Sadashiv (1983). "Effects of lorazepam and its withdrawal on sleep, performance, and subjective state". <i>Clinical Pharmacology and Therapeutics</i> <b>34</b> (4): 496–500. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fclpt.1983.203">10.1038/clpt.1983.203</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6617072">6617072</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Effects+of+lorazepam+and+its+withdrawal+on+sleep%2C+performance%2C+and+subjective+state&amp;rft.aufirst=James+K&amp;rft.aulast=Walsh&amp;rft.au=Parwatikar%2C+Sadashiv&amp;rft.au=Schweitzer%2C+Paula+K&amp;rft.au=Walsh%2C+James+K&amp;rft.date=1983&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fclpt.1983.203&amp;rft_id=info%3Apmid%2F6617072&amp;rft.issue=4&amp;rft.jtitle=Clinical+Pharmacology+and+Therapeutics&amp;rft.pages=496-500&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><span class="citation journal">Fontaine, Réjean; Beaudry, Paul; Le Morvan, Patrick LE; Beauclair, Linda; Chouinard, GUY (1990). "Zopiclone and Triazolam in Insomnia Associated with Generalized Anxiety Disorder". <i>International Clinical Psychopharmacology</i> <b>5</b> (3): 173–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00004850-199007000-00002">10.1097/00004850-199007000-00002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2230061">2230061</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Zopiclone+and+Triazolam+in+Insomnia+Associated+with+Generalized+Anxiety+Disorder&amp;rft.au=Beauclair%2C+Linda&amp;rft.au=Beaudry%2C+Paul&amp;rft.au=Chouinard%2C+GUY&amp;rft.aufirst=R%C3%A9jean&amp;rft.au=Fontaine%2C+R%C3%A9jean&amp;rft.aulast=Fontaine&amp;rft.au=Le+Morvan%2C+Patrick+LE&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00004850-199007000-00002&amp;rft_id=info%3Apmid%2F2230061&amp;rft.issue=3&amp;rft.jtitle=International+Clinical+Psychopharmacology&amp;rft.pages=173-83&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><span class="citation journal">Kales, Anthony; Bixler, Edward O.; Soldatos, Constantin R.; Jacoby, Judith A.; Kales, Joyce D. (1986). "Lorazepam: Effects on Sleep and Withdrawal Phenomena". <i>Pharmacology</i> <b>32</b> (3): 121–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1159%2F000138160">10.1159/000138160</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3960963">3960963</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Lorazepam%3A+Effects+on+Sleep+and+Withdrawal+Phenomena&amp;rft.au=Bixler%2C+Edward+O.&amp;rft.aufirst=Anthony&amp;rft.au=Jacoby%2C+Judith+A.&amp;rft.au=Kales%2C+Anthony&amp;rft.au=Kales%2C+Joyce+D.&amp;rft.aulast=Kales&amp;rft.au=Soldatos%2C+Constantin+R.&amp;rft.date=1986&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1159%2F000138160&amp;rft_id=info%3Apmid%2F3960963&amp;rft.issue=3&amp;rft.jtitle=Pharmacology&amp;rft.pages=121-30&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><span class="citation journal">Bonnet, M H; Arand, D L (1999). "The use of lorazepam TID for chronic insomnia". <i>International Clinical Psychopharmacology</i> <b>14</b> (2): 81–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00004850-199903000-00004">10.1097/00004850-199903000-00004</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10220122">10220122</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=The+use+of+lorazepam+TID+for+chronic+insomnia&amp;rft.au=Arand%2C+D+L&amp;rft.au=Bonnet%2C+M+H&amp;rft.aufirst=M+H&amp;rft.aulast=Bonnet&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00004850-199903000-00004&amp;rft_id=info%3Apmid%2F10220122&amp;rft.issue=2&amp;rft.jtitle=International+Clinical+Psychopharmacology&amp;rft.pages=81-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><span class="citation journal">Kales, Anthony; Manfredi, Rocco L; Vgontzas, Alexandras N; Bixler, Edward O; Vela-Bueno, Antonio; Fee, Eric C (1991). "Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines". <i>Clinical Pharmacology and Therapeutics</i> <b>49</b> (4): 468–76. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fclpt.1991.55">10.1038/clpt.1991.55</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2015735">2015735</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Rebound+insomnia+after+only+brief+and+intermittent+use+of+rapidly+eliminated+benzodiazepines&amp;rft.au=Bixler%2C+Edward+O&amp;rft.au=Fee%2C+Eric+C&amp;rft.aufirst=Anthony&amp;rft.au=Kales%2C+Anthony&amp;rft.aulast=Kales&amp;rft.au=Manfredi%2C+Rocco+L&amp;rft.au=Vela-Bueno%2C+Antonio&amp;rft.au=Vgontzas%2C+Alexandras+N&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fclpt.1991.55&amp;rft_id=info%3Apmid%2F2015735&amp;rft.issue=4&amp;rft.jtitle=Clinical+Pharmacology+and+Therapeutics&amp;rft.pages=468-76&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=49" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9201803-35"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid9201803_35-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-pmid9201803_35-21"><sup><i><b>v</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Saxon, L.; Hjemdahl, P.; Hiltunen, A. J.; Borg, S. (1997). "Effects of flumazenil in the treatment of benzodiazepine withdrawal - a double-blind pilot study". <i>Psychopharmacology</i> <b>131</b> (2): 153–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs002130050278">10.1007/s002130050278</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9201803">9201803</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Effects+of+flumazenil+in+the+treatment+of+benzodiazepine+withdrawal+-+a+double-blind+pilot+study&amp;rft.au=Borg%2C+S.&amp;rft.aufirst=L.&amp;rft.au=Hiltunen%2C+A.+J.&amp;rft.au=Hjemdahl%2C+P.&amp;rft.aulast=Saxon&amp;rft.au=Saxon%2C+L.&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs002130050278&amp;rft_id=info%3Apmid%2F9201803&amp;rft.issue=2&amp;rft.jtitle=Psychopharmacology&amp;rft.pages=153-60&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=131" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><span class="citation journal">Terao, T; Yoshimura, R; Terao, M; Abe, K (1992). "Depersonalization following nitrazepam withdrawal". <i>Biological Psychiatry</i> <b>31</b> (2): 212–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0006-3223%2892%2990209-I">10.1016/0006-3223(92)90209-I</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1737083">1737083</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Depersonalization+following+nitrazepam+withdrawal&amp;rft.au=Abe%2C+K&amp;rft.aufirst=T&amp;rft.aulast=Terao&amp;rft.au=Terao%2C+M&amp;rft.au=Terao%2C+T&amp;rft.au=Yoshimura%2C+R&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0006-3223%2892%2990209-I&amp;rft_id=info%3Apmid%2F1737083&amp;rft.issue=2&amp;rft.jtitle=Biological+Psychiatry&amp;rft.pages=212-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><span class="citation journal">Lader, Malcolm (1994). "Anxiety or depression during withdrawal of hypnotic treatments". <i>Journal of Psychosomatic Research</i> <b>38</b>: 113–23; discussion 118–23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0022-3999%2894%2990142-2">10.1016/0022-3999(94)90142-2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7799243">7799243</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Anxiety+or+depression+during+withdrawal+of+hypnotic+treatments&amp;rft.aufirst=Malcolm&amp;rft.au=Lader%2C+Malcolm&amp;rft.aulast=Lader&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0022-3999%2894%2990142-2&amp;rft_id=info%3Apmid%2F7799243&amp;rft.jtitle=Journal+of+Psychosomatic+Research&amp;rft.pages=113-23%3B+discussion+118-23&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=38" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Mintzer-1999-38"><span class="mw-cite-backlink">^ <a href="#cite_ref-Mintzer-1999_38-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Mintzer-1999_38-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Mintzer-1999_38-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Mintzer-1999_38-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Mintzer-1999_38-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Mintzer, M. Z.; Stoller, K. B.; Griffiths, R. R. (1999). "A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users". <i>Psychopharmacology</i> <b>147</b> (2): 200–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs002130051161">10.1007/s002130051161</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10591888">10591888</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=A+controlled+study+of+flumazenil-precipitated+withdrawal+in+chronic+low-dose+benzodiazepine+users&amp;rft.aufirst=M.+Z.&amp;rft.au=Griffiths%2C+R.+R.&amp;rft.aulast=Mintzer&amp;rft.au=Mintzer%2C+M.+Z.&amp;rft.au=Stoller%2C+K.+B.&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs002130051161&amp;rft_id=info%3Apmid%2F10591888&amp;rft.issue=2&amp;rft.jtitle=Psychopharmacology&amp;rft.pages=200-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=147" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><span class="citation journal">Mendelson, WB; Weingartner, H; Greenblatt, DJ; Garnett, D; Gillin, JC (1982). "A clinical study of flurazepam". <i>Sleep</i> <b>5</b> (4): 350–60. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6761826">6761826</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=A+clinical+study+of+flurazepam&amp;rft.aufirst=WB&amp;rft.au=Garnett%2C+D&amp;rft.au=Gillin%2C+JC&amp;rft.au=Greenblatt%2C+DJ&amp;rft.aulast=Mendelson&amp;rft.au=Mendelson%2C+WB&amp;rft.au=Weingartner%2C+H&amp;rft.date=1982&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F6761826&amp;rft.issue=4&amp;rft.jtitle=Sleep&amp;rft.pages=350-60&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><span class="citation journal">Schöpf, J. (2008). "Withdrawal Phenomena after Long-term Administration of Benzodiazepines a Review of Recent Investigations". <i>Pharmacopsychiatry</i> <b>16</b> (1): 1–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1055%2Fs-2007-1017439">10.1055/s-2007-1017439</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6131447">6131447</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Withdrawal+Phenomena+after+Long-term+Administration+of+Benzodiazepines+a+Review+of+Recent+Investigations&amp;rft.aufirst=J.&amp;rft.aulast=Sch%C3%B6pf&amp;rft.au=Sch%C3%B6pf%2C+J.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2007-1017439&amp;rft_id=info%3Apmid%2F6131447&amp;rft.issue=1&amp;rft.jtitle=Pharmacopsychiatry&amp;rft.pages=1-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-tuobicp-41"><span class="mw-cite-backlink">^ <a href="#cite_ref-tuobicp_41-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-tuobicp_41-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Shader, RI; Greenblatt, DJ (1981). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1401641">"The use of benzodiazepines in clinical practice"</a>. <i>British Journal of Clinical Pharmacology</i>. 11 Suppl 1 (Suppl 1): 5S–9S. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2125.1981.tb01832.x">10.1111/j.1365-2125.1981.tb01832.x</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1401641">1401641</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6133535">6133535</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=The+use+of+benzodiazepines+in+clinical+practice&amp;rft.aufirst=RI&amp;rft.au=Greenblatt%2C+DJ&amp;rft.aulast=Shader&amp;rft.au=Shader%2C+RI&amp;rft.date=1981&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1401641&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2125.1981.tb01832.x&amp;rft_id=info%3Apmc%2F1401641&amp;rft_id=info%3Apmid%2F6133535&amp;rft.issue=Suppl+1&amp;rft.jtitle=British+Journal+of+Clinical+Pharmacology&amp;rft.pages=5S-9S&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11+Suppl+1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><span class="citation journal">Mintzer, Miriam Z.; Griffiths, Roland R. (2004). "Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure". <i>Psychopharmacology</i> <b>178</b> (2–3): 259–67. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00213-004-2009-1">10.1007/s00213-004-2009-1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15452683">15452683</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Flumazenil-precipitated+withdrawal+in+healthy+volunteers+following+repeated+diazepam+exposure&amp;rft.aufirst=Miriam+Z.&amp;rft.au=Griffiths%2C+Roland+R.&amp;rft.aulast=Mintzer&amp;rft.au=Mintzer%2C+Miriam+Z.&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00213-004-2009-1&amp;rft_id=info%3Apmid%2F15452683&amp;rft.issue=2%E2%80%933&amp;rft.jtitle=Psychopharmacology&amp;rft.pages=259-67&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=178" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Loeb_P-43"><span class="mw-cite-backlink">^ <a href="#cite_ref-Loeb_P_43-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Loeb_P_43-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Loeb, P; Adnet, P; Boittiaux, P; Forget, AP; Mille, FX (1997). "Sevrage en benzodiazépines révélé par un syndrome douloureux abdominal pseudochirurgical" [Benzodiazepine withdrawal masquerading as surgical abdominal syndrome]. <i>Annales Françaises d'Anesthésie et de Réanimation</i> (in French) <b>16</b> (5): 521–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0750-7658%2897%2983345-X">10.1016/S0750-7658(97)83345-X</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Sevrage+en+benzodiaz%C3%A9pines+r%C3%A9v%C3%A9l%C3%A9+par+un+syndrome+douloureux+abdominal+pseudochirurgical&amp;rft.au=Adnet%2C+P&amp;rft.au=Boittiaux%2C+P&amp;rft.aufirst=P&amp;rft.au=Forget%2C+AP&amp;rft.aulast=Loeb&amp;rft.au=Loeb%2C+P&amp;rft.au=Mille%2C+FX&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0750-7658%2897%2983345-X&amp;rft.issue=5&amp;rft.jtitle=Annales+Fran%C3%A7aises+d%27Anesth%C3%A9sie+et+de+R%C3%A9animation&amp;rft.pages=521-2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.benzo.org.uk/manual/bzcha03.htm#16">http://www.benzo.org.uk/manual/bzcha03.htm#16</a><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citing_sources#What_information_to_include" title="Wikipedia:Citing sources"><span title="A more detailed citation is required. (October 2013)">full citation needed</span></a></i>]</sup></span></li>
<li id="cite_note-dobcaba-45"><span class="mw-cite-backlink">^ <a href="#cite_ref-dobcaba_45-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-dobcaba_45-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-dobcaba_45-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-dobcaba_45-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-dobcaba_45-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-dobcaba_45-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Pelissolo, A; Bisserbe, JC (1994). "Dependence on benzodiazepines. Clinical and biological aspects". <i>L'Encephale</i> <b>20</b> (2): 147–57. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7914165">7914165</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Dependence+on+benzodiazepines.+Clinical+and+biological+aspects&amp;rft.au=Bisserbe%2C+JC&amp;rft.aufirst=A&amp;rft.aulast=Pelissolo&amp;rft.au=Pelissolo%2C+A&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F7914165&amp;rft.issue=2&amp;rft.jtitle=L%27Encephale&amp;rft.pages=147-57&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><span class="citation journal">Biswas, AK; Feldman, BL; Davis, DH; Zintz, EA (2005). "Myocardial ischemia as a result of severe benzodiazepine and opioid withdrawal". <i>Clinical toxicology (Philadelphia, Pa.)</i> <b>43</b> (3): 207–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1081%2Fclt-200053099">10.1081/clt-200053099</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15902797">15902797</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Myocardial+ischemia+as+a+result+of+severe+benzodiazepine+and+opioid+withdrawal&amp;rft.au=Biswas%2C+AK&amp;rft.au=Davis%2C+DH&amp;rft.au=Feldman%2C+BL&amp;rft.aufirst=AK&amp;rft.aulast=Biswas&amp;rft.au=Zintz%2C+EA&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1081%2Fclt-200053099&amp;rft_id=info%3Apmid%2F15902797&amp;rft.issue=3&amp;rft.jtitle=Clinical+toxicology+%28Philadelphia%2C+Pa.%29&amp;rft.pages=207-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=43" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-nouv-47"><span class="mw-cite-backlink">^ <a href="#cite_ref-nouv_47-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-nouv_47-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-nouv_47-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-nouv_47-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-nouv_47-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Bismuth, C; Le Bellec, M; Dally, S; Lagier, G (1980). "Benzodiazepine physical dependence. 6 cases (author's transl)". <i>La Nouvelle presse medicale</i> <b>9</b> (28): 1941–5. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6106922">6106922</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepine+physical+dependence.+6+cases+%28author%27s+transl%29&amp;rft.au=Bismuth%2C+C&amp;rft.au=Dally%2C+S&amp;rft.aufirst=C&amp;rft.au=Lagier%2C+G&amp;rft.aulast=Bismuth&amp;rft.au=Le+Bellec%2C+M&amp;rft.date=1980&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F6106922&amp;rft.issue=28&amp;rft.jtitle=La+Nouvelle+presse+medicale&amp;rft.pages=1941-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation journal">Pecknold, J.C. (1993). "Discontinuation reactions to alprazolam in panic disorder". <i>Journal of Psychiatric Research</i> <b>27</b>: 155. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0022-3956%2893%2990025-W">10.1016/0022-3956(93)90025-W</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Discontinuation+reactions+to+alprazolam+in+panic+disorder&amp;rft.aufirst=J.C.&amp;rft.aulast=Pecknold&amp;rft.au=Pecknold%2C+J.C.&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0022-3956%2893%2990025-W&amp;rft.jtitle=Journal+of+Psychiatric+Research&amp;rft.pages=155&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lindgren-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lindgren_49-0">^</a></b></span> <span class="reference-text">Kliniska Färdigheter: Informationsutbytet Mellan Patient Och Läkare, LINDGREN, STEFAN, <a href="/wiki/Special:BookSources/914437271X" class="internal mw-magiclink-isbn">ISBN 91-44-37271-X</a> (Swedish)<sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources"><span title="This citation requires a reference to the specific page or range of pages in which the material appears. (October 2013)">page&#160;needed</span></a></i>]</sup></span></li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><span class="citation journal">Drummond, Lynne M.; Matthews, Helen P. (1988). "SINGLE CASE STUDY Obsessive-Compulsive Disorder Occurring as a Complication in Benzodiazepine Withdrawal". <i>The Journal of Nervous and Mental Disease</i> <b>176</b> (11): 688–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00005053-198811000-00008">10.1097/00005053-198811000-00008</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3183654">3183654</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=SINGLE+CASE+STUDY+Obsessive-Compulsive+Disorder+Occurring+as+a+Complication+in+Benzodiazepine+Withdrawal&amp;rft.au=Drummond%2C+Lynne+M.&amp;rft.aufirst=Lynne+M.&amp;rft.aulast=Drummond&amp;rft.au=Matthews%2C+Helen+P.&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00005053-198811000-00008&amp;rft_id=info%3Apmid%2F3183654&amp;rft.issue=11&amp;rft.jtitle=The+Journal+of+Nervous+and+Mental+Disease&amp;rft.pages=688-91&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=176" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><span class="citation journal">Matthews, HP; Drummond, LM (1987). "Obsessive-compulsive disorder--a complication of benzodiazepine withdrawal". <i>The British journal of psychiatry</i> <b>150</b>: 272. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3651695">3651695</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Obsessive-compulsive+disorder--a+complication+of+benzodiazepine+withdrawal&amp;rft.au=Drummond%2C+LM&amp;rft.aufirst=HP&amp;rft.aulast=Matthews&amp;rft.au=Matthews%2C+HP&amp;rft.date=1987&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F3651695&amp;rft.jtitle=The+British+journal+of+psychiatry&amp;rft.pages=272&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=150" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><span class="citation journal">Pagel, J. F.; Parnes, Bennett L. (2001). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC181172">"Medications for the Treatment of Sleep Disorders"</a>. <i>The Primary Care Companion to the Journal of Clinical Psychiatry</i> <b>3</b> (3): 118–125. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.4088%2FPCC.v03n0303">10.4088/PCC.v03n0303</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC181172">181172</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15014609">15014609</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Medications+for+the+Treatment+of+Sleep+Disorders&amp;rft.aufirst=J.+F.&amp;rft.aulast=Pagel&amp;rft.au=Pagel%2C+J.+F.&amp;rft.au=Parnes%2C+Bennett+L.&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC181172&amp;rft_id=info%3Adoi%2F10.4088%2FPCC.v03n0303&amp;rft_id=info%3Apmc%2F181172&amp;rft_id=info%3Apmid%2F15014609&amp;rft.issue=3&amp;rft.jtitle=The+Primary+Care+Companion+to+the+Journal+of+Clinical+Psychiatry&amp;rft.pages=118-125&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><span class="citation journal">Van Engelen, BG; Gimbrere, JS; Booy, LH (1993). "Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam". <i>The Annals of pharmacotherapy</i> <b>27</b> (5): 579–81. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8347907">8347907</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepine+withdrawal+reaction+in+two+children+following+discontinuation+of+sedation+with+midazolam&amp;rft.au=Booy%2C+LH&amp;rft.aufirst=BG&amp;rft.au=Gimbrere%2C+JS&amp;rft.aulast=Van+Engelen&amp;rft.au=Van+Engelen%2C+BG&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8347907&amp;rft.issue=5&amp;rft.jtitle=The+Annals+of+pharmacotherapy&amp;rft.pages=579-81&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-tinnitus-54"><span class="mw-cite-backlink">^ <a href="#cite_ref-tinnitus_54-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-tinnitus_54-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Beeley, L (1991). "Benzodiazepines and tinnitus". <i>BMJ</i> <b>302</b> (6790): 1465. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fbmj.302.6790.1465">10.1136/bmj.302.6790.1465</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepines+and+tinnitus&amp;rft.au=Beeley%2C+L&amp;rft.aufirst=L&amp;rft.aulast=Beeley&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.302.6790.1465&amp;rft.issue=6790&amp;rft.jtitle=BMJ&amp;rft.pages=1465&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=302" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><span class="citation journal">Mellor, CS; Jain, VK (1982). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1862031">"Diazepam withdrawal syndrome: Its prolonged and changing nature"</a>. <i>Canadian Medical Association journal</i> <b>127</b> (11): 1093–6. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1862031">1862031</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7139456">7139456</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Diazepam+withdrawal+syndrome%3A+Its+prolonged+and+changing+nature&amp;rft.aufirst=CS&amp;rft.au=Jain%2C+VK&amp;rft.aulast=Mellor&amp;rft.au=Mellor%2C+CS&amp;rft.date=1982&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1862031&amp;rft_id=info%3Apmc%2F1862031&amp;rft_id=info%3Apmid%2F7139456&amp;rft.issue=11&amp;rft.jtitle=Canadian+Medical+Association+journal&amp;rft.pages=1093-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=127" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><span class="citation journal">Olajide, Dele; Lader, Malcolm (2009). "Depression following withdrawal from long-term benzodiazepine use: A report of four cases". <i>Psychological Medicine</i> <b>14</b> (4): 937–40. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1017%2FS0033291700019899">10.1017/S0033291700019899</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6152745">6152745</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Depression+following+withdrawal+from+long-term+benzodiazepine+use%3A+A+report+of+four+cases&amp;rft.aufirst=Dele&amp;rft.au=Lader%2C+Malcolm&amp;rft.aulast=Olajide&amp;rft.au=Olajide%2C+Dele&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1017%2FS0033291700019899&amp;rft_id=info%3Apmid%2F6152745&amp;rft.issue=4&amp;rft.jtitle=Psychological+Medicine&amp;rft.pages=937-40&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><span class="citation journal">Rosebush, Patricia I.; Mazurek, Michael F. (1996). "Catatonia After Benzodiazepine Withdrawal". <i>Journal of Clinical Psychopharmacology</i> <b>16</b> (4): 315–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00004714-199608000-00007">10.1097/00004714-199608000-00007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8835707">8835707</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Catatonia+After+Benzodiazepine+Withdrawal&amp;rft.aufirst=Patricia+I.&amp;rft.aulast=Rosebush&amp;rft.au=Mazurek%2C+Michael+F.&amp;rft.au=Rosebush%2C+Patricia+I.&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00004714-199608000-00007&amp;rft_id=info%3Apmid%2F8835707&amp;rft.issue=4&amp;rft.jtitle=Journal+of+Clinical+Psychopharmacology&amp;rft.pages=315-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><span class="citation journal">Deuschle, M.F.; Lederbogen, F (2001). "Benzodiazepine Withdrawal - Induced Catatonia". <i>Pharmacopsychiatry</i> <b>34</b> (1): 41–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1055%2Fs-2001-15188">10.1055/s-2001-15188</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11229621">11229621</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepine+Withdrawal+-+Induced+Catatonia&amp;rft.au=Deuschle%2C+M.F.&amp;rft.aufirst=M.F.&amp;rft.aulast=Deuschle&amp;rft.au=Lederbogen%2C+F&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2001-15188&amp;rft_id=info%3Apmid%2F11229621&amp;rft.issue=1&amp;rft.jtitle=Pharmacopsychiatry&amp;rft.pages=41-2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><span class="citation journal">Kanemoto, Kousuke; Miyamoto, Toshio; Abe, Ryuji (1999). "Ictal catatonia as a manifestation of de novo absence status epilepticus following benzodiazepine withdrawal". <i>Seizure</i> <b>8</b> (6): 364–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fseiz.1999.0309">10.1053/seiz.1999.0309</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10512781">10512781</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Ictal+catatonia+as+a+manifestation+of+de+novo+absence+status+epilepticus+following+benzodiazepine+withdrawal&amp;rft.au=Abe%2C+Ryuji&amp;rft.aufirst=Kousuke&amp;rft.au=Kanemoto%2C+Kousuke&amp;rft.aulast=Kanemoto&amp;rft.au=Miyamoto%2C+Toshio&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fseiz.1999.0309&amp;rft_id=info%3Apmid%2F10512781&amp;rft.issue=6&amp;rft.jtitle=Seizure&amp;rft.pages=364-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Uhlenhuth_EH_2006_519.E2.80.9323-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-Uhlenhuth_EH_2006_519.E2.80.9323_60-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J (October 2006). "Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs". <i>J Clin Psychopharmacol</i> <b>26</b> (5): 519–523. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F01.jcp.0000236653.85791.60">10.1097/01.jcp.0000236653.85791.60</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16974197">16974197</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Abrupt+discontinuation+of+alprazolam+and+cognitive+style+in+patients+with+panic+disorder%3A+early+effects+on+mood%2C+performance%2C+and+vital+signs&amp;rft.au=Antal+EJ&amp;rft.au=Barnhill+J&amp;rft.au=Javaid+JI&amp;rft.aulast=Uhlenhuth+EH&amp;rft.au=Matuzas+W&amp;rft.au=Qualls+C&amp;rft.au=Starcevic+V&amp;rft.au=Uhlenhuth+EH&amp;rft.date=October+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F01.jcp.0000236653.85791.60&amp;rft_id=info%3Apmid%2F16974197&amp;rft.issue=5&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.pages=519-523&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><span class="citation journal">Metten, Pamela; Crabbe, John C (1999). "Genetic Determinants of Severity of Acute Withdrawal from Diazepam in Mice". <i>Pharmacology Biochemistry and Behavior</i> <b>63</b> (3): 473–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0091-3057%2899%2900017-9">10.1016/S0091-3057(99)00017-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10418790">10418790</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Genetic+Determinants+of+Severity+of+Acute+Withdrawal+from+Diazepam+in+Mice&amp;rft.au=Crabbe%2C+John+C&amp;rft.aufirst=Pamela&amp;rft.aulast=Metten&amp;rft.au=Metten%2C+Pamela&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0091-3057%2899%2900017-9&amp;rft_id=info%3Apmid%2F10418790&amp;rft.issue=3&amp;rft.jtitle=Pharmacology+Biochemistry+and+Behavior&amp;rft.pages=473-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=63" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><span class="citation journal">Haque, W; Watson, DJ; Bryant, SG (1990). "Death following suspected alprazolam withdrawal seizures: A case report". <i>Texas medicine</i> <b>86</b> (1): 44–7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2300914">2300914</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Death+following+suspected+alprazolam+withdrawal+seizures%3A+A+case+report&amp;rft.au=Bryant%2C+SG&amp;rft.aufirst=W&amp;rft.au=Haque%2C+W&amp;rft.aulast=Haque&amp;rft.au=Watson%2C+DJ&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2300914&amp;rft.issue=1&amp;rft.jtitle=Texas+medicine&amp;rft.pages=44-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=86" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><span class="citation journal">De Bard, ML (1979). "Diazepam withdrawal syndrome: A case with psychosis, seizure, and coma". <i>The American Journal of Psychiatry</i> <b>136</b> (1): 104–5. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/103443">103443</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Diazepam+withdrawal+syndrome%3A+A+case+with+psychosis%2C+seizure%2C+and+coma&amp;rft.au=De+Bard%2C+ML&amp;rft.aufirst=ML&amp;rft.aulast=De+Bard&amp;rft.date=1979&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F103443&amp;rft.issue=1&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.pages=104-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=136" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><span class="citation journal">Provini, F.; Cortelli, P.; Montagna, P.; Gambetti, P.; Lugaresi, E. (2008). "Fatal insomnia and agrypnia excitata: Sleep and the limbic system". <i>Revue Neurologique</i> <b>164</b> (8–9): 692–700. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.neurol.2007.11.003">10.1016/j.neurol.2007.11.003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18805303">18805303</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Fatal+insomnia+and+agrypnia+excitata%3A+Sleep+and+the+limbic+system&amp;rft.au=Cortelli%2C+P.&amp;rft.aufirst=F.&amp;rft.au=Gambetti%2C+P.&amp;rft.aulast=Provini&amp;rft.au=Lugaresi%2C+E.&amp;rft.au=Montagna%2C+P.&amp;rft.au=Provini%2C+F.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neurol.2007.11.003&amp;rft_id=info%3Apmid%2F18805303&amp;rft.issue=8%E2%80%939&amp;rft.jtitle=Revue+Neurologique&amp;rft.pages=692-700&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=164" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Darcy_L-65"><span class="mw-cite-backlink">^ <a href="#cite_ref-Darcy_L_65-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Darcy_L_65-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Berezak, A.; Weber, M.; Hansmann, J.; Tulasne, P.A.; Laporte, B.; Ould Ouali, A. (1984). "Dépendance physique aux benzodiazépines dans un contexte traumatologique" [Benzodiazepine physical dependence in traumatology]. <i>Annales Françaises d'Anesthésie et de Réanimation</i> (in French) <b>3</b> (5): 383–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0750-7658%2884%2980078-7">10.1016/S0750-7658(84)80078-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=D%C3%A9pendance+physique+aux+benzodiaz%C3%A9pines+dans+un+contexte+traumatologique&amp;rft.au=Berezak%2C+A.&amp;rft.aufirst=A.&amp;rft.au=Hansmann%2C+J.&amp;rft.au=Laporte%2C+B.&amp;rft.aulast=Berezak&amp;rft.au=Ould+Ouali%2C+A.&amp;rft.au=Tulasne%2C+P.A.&amp;rft.au=Weber%2C+M.&amp;rft.date=1984&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0750-7658%2884%2980078-7&amp;rft.issue=5&amp;rft.jtitle=Annales+Fran%C3%A7aises+d%27Anesth%C3%A9sie+et+de+R%C3%A9animation&amp;rft.pages=383-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><span class="citation journal">Keshavan, MS; Moodley, P; Eales, M; Joyce, E; Yeragani, VK (1988). "Delusional depression following benzodiazepine withdrawal". <i>Canadian journal of psychiatry</i> <b>33</b> (7): 626–7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3197017">3197017</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Delusional+depression+following+benzodiazepine+withdrawal&amp;rft.au=Eales%2C+M&amp;rft.aufirst=MS&amp;rft.au=Joyce%2C+E&amp;rft.au=Keshavan%2C+MS&amp;rft.aulast=Keshavan&amp;rft.au=Moodley%2C+P&amp;rft.au=Yeragani%2C+VK&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F3197017&amp;rft.issue=7&amp;rft.jtitle=Canadian+journal+of+psychiatry&amp;rft.pages=626-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><span class="citation journal">Risse, SC; Whitters, A; Burke, J; Chen, S; Scurfield, RM; Raskind, MA (1990). "Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder". <i>The Journal of clinical psychiatry</i> <b>51</b> (5): 206–9. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2335496">2335496</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Severe+withdrawal+symptoms+after+discontinuation+of+alprazolam+in+eight+patients+with+combat-induced+posttraumatic+stress+disorder&amp;rft.au=Burke%2C+J&amp;rft.au=Chen%2C+S&amp;rft.aufirst=SC&amp;rft.aulast=Risse&amp;rft.au=Raskind%2C+MA&amp;rft.au=Risse%2C+SC&amp;rft.au=Scurfield%2C+RM&amp;rft.au=Whitters%2C+A&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2335496&amp;rft.issue=5&amp;rft.jtitle=The+Journal+of+clinical+psychiatry&amp;rft.pages=206-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><span class="citation journal">Turkington, Douglas; Gill, Paul (1989). "Mania induced by lorazepam withdrawal: A report of two cases". <i>Journal of Affective Disorders</i> <b>17</b> (1): 93–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0165-0327%2889%2990028-1">10.1016/0165-0327(89)90028-1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2525581">2525581</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Mania+induced+by+lorazepam+withdrawal%3A+A+report+of+two+cases&amp;rft.aufirst=Douglas&amp;rft.au=Gill%2C+Paul&amp;rft.aulast=Turkington&amp;rft.au=Turkington%2C+Douglas&amp;rft.date=1989&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0165-0327%2889%2990028-1&amp;rft_id=info%3Apmid%2F2525581&amp;rft.issue=1&amp;rft.jtitle=Journal+of+Affective+Disorders&amp;rft.pages=93-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><span class="citation journal">Lapierre, YD; Labelle, A (1987). "Manic-like reaction induced by lorazepam withdrawal". <i>Canadian journal of psychiatry</i> <b>32</b> (8): 697–8. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3690487">3690487</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Manic-like+reaction+induced+by+lorazepam+withdrawal&amp;rft.aufirst=YD&amp;rft.au=Labelle%2C+A&amp;rft.au=Lapierre%2C+YD&amp;rft.aulast=Lapierre&amp;rft.date=1987&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F3690487&amp;rft.issue=8&amp;rft.jtitle=Canadian+journal+of+psychiatry&amp;rft.pages=697-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><span class="citation journal">Kawajiri, M; Ohyagi, Y; Furuya, H; Araki, T; Inoue, N; Esaki, S; Yamada, T; Kira, J (2002). "A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam". <i>Rinsho shinkeigaku</i> <b>42</b> (2): 136–9. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12424963">12424963</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=A+patient+with+Parkinson%27s+disease+complicated+by+hypothyroidism+who+developed+malignant+syndrome+after+discontinuation+of+etizolam&amp;rft.au=Araki%2C+T&amp;rft.au=Esaki%2C+S&amp;rft.aufirst=M&amp;rft.au=Furuya%2C+H&amp;rft.au=Inoue%2C+N&amp;rft.au=Kawajiri%2C+M&amp;rft.au=Kira%2C+J&amp;rft.aulast=Kawajiri&amp;rft.au=Ohyagi%2C+Y&amp;rft.au=Yamada%2C+T&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F12424963&amp;rft.issue=2&amp;rft.jtitle=Rinsho+shinkeigaku&amp;rft.pages=136-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=42" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Strawn-2007-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-Strawn-2007_71-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Strawn, Jeffrey; Keck Jr, PE; Caroff, SN (2007). "Neuroleptic Malignant Syndrome". <i>American Journal of Psychiatry</i> <b>164</b> (6): 870–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1176%2Fappi.ajp.164.6.870">10.1176/appi.ajp.164.6.870</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17541044">17541044</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Neuroleptic+Malignant+Syndrome&amp;rft.au=Caroff%2C+SN&amp;rft.aufirst=Jeffrey&amp;rft.au=Keck+Jr%2C+PE&amp;rft.aulast=Strawn&amp;rft.au=Strawn%2C+Jeffrey&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1176%2Fappi.ajp.164.6.870&amp;rft_id=info%3Apmid%2F17541044&amp;rft.issue=6&amp;rft.jtitle=American+Journal+of+Psychiatry&amp;rft.pages=870-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=164" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><span class="citation journal">Khan, A; Joyce, P; Jones, AV (1980). <a rel="nofollow" class="external text" href="http://www.benzo.org.uk/bwsnz.htm">"Benzodiazepine withdrawal syndromes"</a>. <i>The New Zealand medical journal</i> <b>92</b> (665): 94–6. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6107888">6107888</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepine+withdrawal+syndromes&amp;rft.aufirst=A&amp;rft.au=Jones%2C+AV&amp;rft.au=Joyce%2C+P&amp;rft.au=Khan%2C+A&amp;rft.aulast=Khan&amp;rft.date=1980&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.benzo.org.uk%2Fbwsnz.htm&amp;rft_id=info%3Apmid%2F6107888&amp;rft.issue=665&amp;rft.jtitle=The+New+Zealand+medical+journal&amp;rft.pages=94-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=92" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><span class="citation journal">Peh, LH; Mahendran, R (1989). "Psychiatric complications of Erimin abuse". <i>Singapore medical journal</i> <b>30</b> (1): 72–3. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2595393">2595393</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Psychiatric+complications+of+Erimin+abuse&amp;rft.aufirst=LH&amp;rft.aulast=Peh&amp;rft.au=Mahendran%2C+R&amp;rft.au=Peh%2C+LH&amp;rft.date=1989&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2595393&amp;rft.issue=1&amp;rft.jtitle=Singapore+medical+journal&amp;rft.pages=72-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text"><span class="citation journal">Fruensgaard, K. (1976). "Withdrawal Psychosis: A Study of 30 Consecutive Cases". <i>Acta Psychiatrica Scandinavica</i> <b>53</b> (2): 105–18. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1600-0447.1976.tb00065.x">10.1111/j.1600-0447.1976.tb00065.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3091">3091</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Withdrawal+Psychosis%3A+A+Study+of+30+Consecutive+Cases&amp;rft.aufirst=K.&amp;rft.au=Fruensgaard%2C+K.&amp;rft.aulast=Fruensgaard&amp;rft.date=1976&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0447.1976.tb00065.x&amp;rft_id=info%3Apmid%2F3091&amp;rft.issue=2&amp;rft.jtitle=Acta+Psychiatrica+Scandinavica&amp;rft.pages=105-18&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=53" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ReferenceA-75"><span class="mw-cite-backlink">^ <a href="#cite_ref-ReferenceA_75-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ReferenceA_75-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Einarson, A; Selby, P; Koren, G (2001). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1408034">"Abrupt discontinuation of psychotropic drugs during pregnancy: Fear of teratogenic risk and impact of counselling"</a>. <i>Journal of psychiatry &amp; neuroscience</i> <b>26</b> (1): 44–8. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1408034">1408034</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11212593">11212593</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Abrupt+discontinuation+of+psychotropic+drugs+during+pregnancy%3A+Fear+of+teratogenic+risk+and+impact+of+counselling&amp;rft.au=Einarson%2C+A&amp;rft.aufirst=A&amp;rft.au=Koren%2C+G&amp;rft.aulast=Einarson&amp;rft.au=Selby%2C+P&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1408034&amp;rft_id=info%3Apmc%2F1408034&amp;rft_id=info%3Apmid%2F11212593&amp;rft.issue=1&amp;rft.jtitle=Journal+of+psychiatry+%26+neuroscience&amp;rft.pages=44-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text"><span class="citation journal">Joughin, N.; Tata, P.; Collins, M.; Hooper, C.; Falkowski, J. (1991). "In-patient withdrawal from long-term benzodiazepine use". <i>Addiction</i> <b>86</b> (4): 449–55. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1360-0443.1991.tb03422.x">10.1111/j.1360-0443.1991.tb03422.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1675899">1675899</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=In-patient+withdrawal+from+long-term+benzodiazepine+use&amp;rft.au=Collins%2C+M.&amp;rft.au=Falkowski%2C+J.&amp;rft.aufirst=N.&amp;rft.au=Hooper%2C+C.&amp;rft.au=Joughin%2C+N.&amp;rft.aulast=Joughin&amp;rft.au=Tata%2C+P.&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1360-0443.1991.tb03422.x&amp;rft_id=info%3Apmid%2F1675899&amp;rft.issue=4&amp;rft.jtitle=Addiction&amp;rft.pages=449-55&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=86" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><span class="citation journal">Citrome, Leslie; Volavka, Jan (1999). "Violent Patients in the Emergency Setting". <i>Psychiatric Clinics of North America</i> <b>22</b> (4): 789–801. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0193-953X%2805%2970126-X">10.1016/S0193-953X(05)70126-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10623971">10623971</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Violent+Patients+in+the+Emergency+Setting&amp;rft.au=Citrome%2C+Leslie&amp;rft.aufirst=Leslie&amp;rft.aulast=Citrome&amp;rft.au=Volavka%2C+Jan&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0193-953X%2805%2970126-X&amp;rft_id=info%3Apmid%2F10623971&amp;rft.issue=4&amp;rft.jtitle=Psychiatric+Clinics+of+North+America&amp;rft.pages=789-801&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-The_Brain_from_Top_to_Bottom-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-The_Brain_from_Top_to_Bottom_78-0">^</a></b></span> <span class="reference-text"><span class="citation web">Dubuc, Bruno. <a rel="nofollow" class="external text" href="http://thebrain.mcgill.ca/flash/a/a_01/a_01_m/a_01_m_ana/a_01_m_ana.html#2">"Neurotransmitters"</a>. The Brain from Top to Bottom<span class="reference-accessdate">. Retrieved <span class="nowrap">29 April</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.au=Dubuc%2C+Bruno&amp;rft.aufirst=Bruno&amp;rft.aulast=Dubuc&amp;rft.btitle=Neurotransmitters&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fthebrain.mcgill.ca%2Fflash%2Fa%2Fa_01%2Fa_01_m%2Fa_01_m_ana%2Fa_01_m_ana.html%232&amp;rft.pub=The+Brain+from+Top+to+Bottom&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Tallman-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-Tallman_79-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Tallman, J F; Gallager, D W (1985). "The Gaba-Ergic System: A Locus of Benzodiazepine Action". <i>Annual Review of Neuroscience</i> <b>8</b>: 21–44. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1146%2Fannurev.ne.08.030185.000321">10.1146/annurev.ne.08.030185.000321</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2858999">2858999</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=The+Gaba-Ergic+System%3A+A+Locus+of+Benzodiazepine+Action&amp;rft.aufirst=J+F&amp;rft.au=Gallager%2C+D+W&amp;rft.aulast=Tallman&amp;rft.au=Tallman%2C+J+F&amp;rft.date=1985&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev.ne.08.030185.000321&amp;rft_id=info%3Apmid%2F2858999&amp;rft.jtitle=Annual+Review+of+Neuroscience&amp;rft.pages=21-44&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SCHOCH-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-SCHOCH_80-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Schoch, P.; Richards, J. G.; Häring, P.; Takacs, B.; Stähli, C.; Staehelin, T.; Haefely, W.; Möhler, H. (1985). "Co-localization of GABAA receptors and benzodiazepine receptors in the brain shown by monoclonal antibodies". <i>Nature</i> <b>314</b> (6007): 168–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2F314168a0">10.1038/314168a0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2983231">2983231</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Co-localization+of+GABAA+receptors+and+benzodiazepine+receptors+in+the+brain+shown+by+monoclonal+antibodies&amp;rft.aufirst=P.&amp;rft.au=Haefely%2C+W.&amp;rft.au=H%C3%A4ring%2C+P.&amp;rft.aulast=Schoch&amp;rft.au=M%C3%B6hler%2C+H.&amp;rft.au=Richards%2C+J.+G.&amp;rft.au=Schoch%2C+P.&amp;rft.au=Staehelin%2C+T.&amp;rft.au=St%C3%A4hli%2C+C.&amp;rft.au=Takacs%2C+B.&amp;rft.date=1985&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2F314168a0&amp;rft_id=info%3Apmid%2F2983231&amp;rft.issue=6007&amp;rft.jtitle=Nature&amp;rft.pages=168-71&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=314" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-vinkerss-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-vinkerss_81-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Vinkers, Christiaan H.; Olivier, Berend (2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3321276">"Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABAA Receptor Modulators?"</a>. <i>Advances in Pharmacological Sciences</i> <b>2012</b>: 1. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1155%2F2012%2F416864">10.1155/2012/416864</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3321276">3321276</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22536226">22536226</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Mechanisms+Underlying+Tolerance+after+Long-Term+Benzodiazepine+Use%3A+A+Future+for+Subtype-Selective+GABAA+Receptor+Modulators%3F&amp;rft.aufirst=Christiaan+H.&amp;rft.aulast=Vinkers&amp;rft.au=Olivier%2C+Berend&amp;rft.au=Vinkers%2C+Christiaan+H.&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3321276&amp;rft_id=info%3Adoi%2F10.1155%2F2012%2F416864&amp;rft_id=info%3Apmc%2F3321276&amp;rft_id=info%3Apmid%2F22536226&amp;rft.jtitle=Advances+in+Pharmacological+Sciences&amp;rft.pages=1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2012" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmc349220-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmc349220_82-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Study, R. E.; Barker, JL (1981). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC349220">"Diazepam and (–)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of γ-aminobutyric acid responses in cultured central neurons"</a>. <i>Proceedings of the National Academy of Sciences</i> <b>78</b> (11): 7180–4. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/1981PNAS...78.7180S">1981PNAS...78.7180S</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1073%2Fpnas.78.11.7180">10.1073/pnas.78.11.7180</a>. <a href="/wiki/JSTOR" title="JSTOR">JSTOR</a>&#160;<a rel="nofollow" class="external text" href="//www.jstor.org/stable/11434">11434</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC349220">349220</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6273918">6273918</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Diazepam+and+%28%E2%80%93%29-pentobarbital%3A+fluctuation+analysis+reveals+different+mechanisms+for+potentiation+of+%CE%B3-aminobutyric+acid+responses+in+cultured+central+neurons&amp;rft.au=Barker%2C+JL&amp;rft.aufirst=R.+E.&amp;rft.aulast=Study&amp;rft.au=Study%2C+R.+E.&amp;rft.date=1981&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC349220&amp;rft_id=info%3Abibcode%2F1981PNAS...78.7180S&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.78.11.7180&amp;rft_id=info%3Apmc%2F349220&amp;rft_id=info%3Apmid%2F6273918&amp;rft.issue=11&amp;rft.jstor=11434&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences&amp;rft.pages=7180-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=78" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-bateson-83"><span class="mw-cite-backlink">^ <a href="#cite_ref-bateson_83-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-bateson_83-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-bateson_83-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Bateson, A. (2002). "Basic Pharmacologic Mechanisms Involved in Benzodiazepine Tolerance and Withdrawal". <i>Current Pharmaceutical Design</i> <b>8</b> (1): 5–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2174%2F1381612023396681">10.2174/1381612023396681</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11812247">11812247</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Basic+Pharmacologic+Mechanisms+Involved+in+Benzodiazepine+Tolerance+and+Withdrawal&amp;rft.au=Bateson%2C+A.&amp;rft.aufirst=A.&amp;rft.aulast=Bateson&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2174%2F1381612023396681&amp;rft_id=info%3Apmid%2F11812247&amp;rft.issue=1&amp;rft.jtitle=Current+Pharmaceutical+Design&amp;rft.pages=5-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Tietz-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-Tietz_84-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Tietz, EI; Rosenberg, HC; Chiu, TH (1986). "Autoradiographic localization of benzodiazepine receptor downregulation". <i>The Journal of Pharmacology and Experimental Therapeutics</i> <b>236</b> (1): 284–92. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3001290">3001290</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Autoradiographic+localization+of+benzodiazepine+receptor+downregulation&amp;rft.au=Chiu%2C+TH&amp;rft.aufirst=EI&amp;rft.aulast=Tietz&amp;rft.au=Rosenberg%2C+HC&amp;rft.au=Tietz%2C+EI&amp;rft.date=1986&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F3001290&amp;rft.issue=1&amp;rft.jtitle=The+Journal+of+Pharmacology+and+Experimental+Therapeutics&amp;rft.pages=284-92&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=236" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><span class="citation journal">Koob, G.; Bloom, F. (1988). "Cellular and molecular mechanisms of drug dependence". <i>Science</i> <b>242</b> (4879): 715–23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1126%2Fscience.2903550">10.1126/science.2903550</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2903550">2903550</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Cellular+and+molecular+mechanisms+of+drug+dependence&amp;rft.au=Bloom%2C+F.&amp;rft.aufirst=G.&amp;rft.au=Koob%2C+G.&amp;rft.aulast=Koob&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.2903550&amp;rft_id=info%3Apmid%2F2903550&amp;rft.issue=4879&amp;rft.jtitle=Science&amp;rft.pages=715-23&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=242" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10736372-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10736372_86-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Meldrum, Brian S. (2000). <a rel="nofollow" class="external text" href="http://jn.nutrition.org/cgi/pmidlookup?view=long&amp;pmid=10736372">"Glutamate as a Neurotransmitter in the Brain: Review of Physiology and Pathology"</a>. <i>The Journal of Nutrition</i> <b>130</b> (4): 1007S–15S. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10736372">10736372</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Glutamate+as+a+Neurotransmitter+in+the+Brain%3A+Review+of+Physiology+and+Pathology&amp;rft.aufirst=Brian+S.&amp;rft.aulast=Meldrum&amp;rft.au=Meldrum%2C+Brian+S.&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjn.nutrition.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D10736372&amp;rft_id=info%3Apmid%2F10736372&amp;rft.issue=4&amp;rft.jtitle=The+Journal+of+Nutrition&amp;rft.pages=1007S-15S&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=130" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11224351-87"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid11224351_87-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11224351_87-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Stephens, D. N. (1995). "A glutamatergic hypothesis of drug dependence: extrapolations from benzodiazepine receptor ligands". <i>Behavioural Pharmacology</i> <b>6</b> (5): 425–46. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00008877-199508000-00004">10.1097/00008877-199508000-00004</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11224351">11224351</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=A+glutamatergic+hypothesis+of+drug+dependence%3A+extrapolations+from+benzodiazepine+receptor+ligands&amp;rft.aufirst=D.+N.&amp;rft.aulast=Stephens&amp;rft.au=Stephens%2C+D.+N.&amp;rft.date=1995&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00008877-199508000-00004&amp;rft_id=info%3Apmid%2F11224351&amp;rft.issue=5&amp;rft.jtitle=Behavioural+Pharmacology&amp;rft.pages=425-46&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Dunworth_SJ.2C_Mead_AN.2C_Stephens_DN_2000_1501.E2.80.931508-88"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dunworth_SJ.2C_Mead_AN.2C_Stephens_DN_2000_1501.E2.80.931508_88-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dunworth_SJ.2C_Mead_AN.2C_Stephens_DN_2000_1501.E2.80.931508_88-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Dunworth, Sarah J.; Mead, Andy N.; Stephens, David N. (2000). "Previous experience of withdrawal from chronic diazepam ameliorates the aversiveness of precipitated withdrawal and reduces withdrawal-induced c-fos expression in nucleus accumbens". <i>European Journal of Neuroscience</i> <b>12</b> (4): 1501–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.1460-9568.2000.00036.x">10.1046/j.1460-9568.2000.00036.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10762378">10762378</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Previous+experience+of+withdrawal+from+chronic+diazepam+ameliorates+the+aversiveness+of+precipitated+withdrawal+and+reduces+withdrawal-induced+c-fos+expression+in+nucleus+accumbens&amp;rft.au=Dunworth%2C+Sarah+J.&amp;rft.aufirst=Sarah+J.&amp;rft.aulast=Dunworth&amp;rft.au=Mead%2C+Andy+N.&amp;rft.au=Stephens%2C+David+N.&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1460-9568.2000.00036.x&amp;rft_id=info%3Apmid%2F10762378&amp;rft.issue=4&amp;rft.jtitle=European+Journal+of+Neuroscience&amp;rft.pages=1501-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rickels_K.2C_Schweizer_E.2C_Csanalosi_I.2C_Case_WG.2C_Chung_H_1988_444.E2.80.93450-89"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rickels_K.2C_Schweizer_E.2C_Csanalosi_I.2C_Case_WG.2C_Chung_H_1988_444.E2.80.93450_89-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rickels_K.2C_Schweizer_E.2C_Csanalosi_I.2C_Case_WG.2C_Chung_H_1988_444.E2.80.93450_89-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Rickels, Karl; Schweizer, E; Csanalosi, I; Case, WG; Chung, H (1988). "Long-term Treatment of Anxiety and Risk of Withdrawal: Prospective Comparison of Clorazepate and Buspirone". <i>Archives of General Psychiatry</i> <b>45</b> (5): 444–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchpsyc.1988.01800290060008">10.1001/archpsyc.1988.01800290060008</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2895993">2895993</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Long-term+Treatment+of+Anxiety+and+Risk+of+Withdrawal%3A+Prospective+Comparison+of+Clorazepate+and+Buspirone&amp;rft.au=Case%2C+WG&amp;rft.au=Chung%2C+H&amp;rft.au=Csanalosi%2C+I&amp;rft.aufirst=Karl&amp;rft.aulast=Rickels&amp;rft.au=Rickels%2C+Karl&amp;rft.au=Schweizer%2C+E&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchpsyc.1988.01800290060008&amp;rft_id=info%3Apmid%2F2895993&amp;rft.issue=5&amp;rft.jtitle=Archives+of+General+Psychiatry&amp;rft.pages=444-50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=45" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-DoiJAMissing-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-DoiJAMissing_90-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Vorma, Helena; Naukkarinen, Hannu H.; Sarna, Seppo J.; Kuoppasalmi, Kimmo I. (2005). "Predictors of Benzodiazepine Discontinuation in Subjects Manifesting Complicated Dependence". <i>Substance Use &amp; Misuse</i> <b>40</b> (4): 499–510. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1081%2FJA-200052433">10.1081/JA-200052433</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15830732">15830732</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Predictors+of+Benzodiazepine+Discontinuation+in+Subjects+Manifesting+Complicated+Dependence&amp;rft.aufirst=Helena&amp;rft.au=Kuoppasalmi%2C+Kimmo+I.&amp;rft.aulast=Vorma&amp;rft.au=Naukkarinen%2C+Hannu+H.&amp;rft.au=Sarna%2C+Seppo+J.&amp;rft.au=Vorma%2C+Helena&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1081%2FJA-200052433&amp;rft_id=info%3Apmid%2F15830732&amp;rft.issue=4&amp;rft.jtitle=Substance+Use+%26+Misuse&amp;rft.pages=499-510&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=40" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid6136575-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid6136575_91-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Smith, David E.; Wesson, Donald R. (1983). "Benzodiazepine Dependency Syndromes". <i>Journal of Psychoactive Drugs</i> <b>15</b> (1–2): 85–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1080%2F02791072.1983.10472127">10.1080/02791072.1983.10472127</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6136575">6136575</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepine+Dependency+Syndromes&amp;rft.aufirst=David+E.&amp;rft.aulast=Smith&amp;rft.au=Smith%2C+David+E.&amp;rft.au=Wesson%2C+Donald+R.&amp;rft.date=1983&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1080%2F02791072.1983.10472127&amp;rft_id=info%3Apmid%2F6136575&amp;rft.issue=1%E2%80%932&amp;rft.jtitle=Journal+of+Psychoactive+Drugs&amp;rft.pages=85-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text"><span class="citation journal">Landry, MJ; Smith, DE; McDuff, DR; Baughman, OL (1992). "Benzodiazepine dependence and withdrawal: Identification and medical management". <i>The Journal of the American Board of Family Practice</i> <b>5</b> (2): 167–75. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1575069">1575069</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepine+dependence+and+withdrawal%3A+Identification+and+medical+management&amp;rft.au=Baughman%2C+OL&amp;rft.aufirst=MJ&amp;rft.au=Landry%2C+MJ&amp;rft.aulast=Landry&amp;rft.au=McDuff%2C+DR&amp;rft.au=Smith%2C+DE&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1575069&amp;rft.issue=2&amp;rft.jtitle=The+Journal+of+the+American+Board+of+Family+Practice&amp;rft.pages=167-75&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid2864096-93"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid2864096_93-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid2864096_93-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid2864096_93-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Higgitt, A C; Lader, M H; Fonagy, P (1985). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1416639">"Clinical management of benzodiazepine dependence"</a>. <i>BMJ</i> <b>291</b> (6497): 688–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fbmj.291.6497.688">10.1136/bmj.291.6497.688</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1416639">1416639</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2864096">2864096</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Clinical+management+of+benzodiazepine+dependence&amp;rft.aufirst=A+C&amp;rft.au=Fonagy%2C+P&amp;rft.au=Higgitt%2C+A+C&amp;rft.au=Lader%2C+M+H&amp;rft.aulast=Higgitt&amp;rft.date=1985&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1416639&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.291.6497.688&amp;rft_id=info%3Apmc%2F1416639&amp;rft_id=info%3Apmid%2F2864096&amp;rft.issue=6497&amp;rft.jtitle=BMJ&amp;rft.pages=688-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=291" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-parrjm-94"><span class="mw-cite-backlink">^ <a href="#cite_ref-parrjm_94-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-parrjm_94-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-parrjm_94-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-parrjm_94-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Parr, Jannette M.; Kavanagh, David J.; Cahill, Lareina; Mitchell, Geoffrey; Mcd Young, Ross McD. (2009). "Effectiveness of current treatment approaches for benzodiazepine discontinuation: A meta-analysis". <i>Addiction</i> <b>104</b> (1): 13–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1360-0443.2008.02364.x">10.1111/j.1360-0443.2008.02364.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18983627">18983627</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Effectiveness+of+current+treatment+approaches+for+benzodiazepine+discontinuation%3A+A+meta-analysis&amp;rft.au=Cahill%2C+Lareina&amp;rft.aufirst=Jannette+M.&amp;rft.au=Kavanagh%2C+David+J.&amp;rft.aulast=Parr&amp;rft.au=Mcd+Young%2C+Ross+McD.&amp;rft.au=Mitchell%2C+Geoffrey&amp;rft.au=Parr%2C+Jannette+M.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1360-0443.2008.02364.x&amp;rft_id=info%3Apmid%2F18983627&amp;rft.issue=1&amp;rft.jtitle=Addiction&amp;rft.pages=13-24&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=104" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10665894-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10665894_95-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Garfinkel, Doron; Zisapel, N; Wainstein, J; Laudon, M (1999). "Facilitation of Benzodiazepine Discontinuation by Melatonin: A New Clinical Approach". <i>Archives of Internal Medicine</i> <b>159</b> (20): 2456–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchinte.159.20.2456">10.1001/archinte.159.20.2456</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10665894">10665894</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Facilitation+of+Benzodiazepine+Discontinuation+by+Melatonin%3A+A+New+Clinical+Approach&amp;rft.aufirst=Doron&amp;rft.au=Garfinkel%2C+Doron&amp;rft.aulast=Garfinkel&amp;rft.au=Laudon%2C+M&amp;rft.au=Wainstein%2C+J&amp;rft.au=Zisapel%2C+N&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchinte.159.20.2456&amp;rft_id=info%3Apmid%2F10665894&amp;rft.issue=20&amp;rft.jtitle=Archives+of+Internal+Medicine&amp;rft.pages=2456-60&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=159" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16958945-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16958945_96-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Nakao, Mutsuhiro; Takeuchi, Takeaki; Nomura, Kyoko; Teramoto, Tamio; Yano, Eiji (2006). "Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic". <i>Psychiatry and Clinical Neurosciences</i> <b>60</b> (5): 605–10. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1440-1819.2006.01565.x">10.1111/j.1440-1819.2006.01565.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16958945">16958945</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Clinical+application+of+paroxetine+for+tapering+benzodiazepine+use+in+non-major-depressive+outpatients+visiting+an+internal+medicine+clinic&amp;rft.aufirst=Mutsuhiro&amp;rft.aulast=Nakao&amp;rft.au=Nakao%2C+Mutsuhiro&amp;rft.au=Nomura%2C+Kyoko&amp;rft.au=Takeuchi%2C+Takeaki&amp;rft.au=Teramoto%2C+Tamio&amp;rft.au=Yano%2C+Eiji&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1440-1819.2006.01565.x&amp;rft_id=info%3Apmid%2F16958945&amp;rft.issue=5&amp;rft.jtitle=Psychiatry+and+Clinical+Neurosciences&amp;rft.pages=605-10&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=60" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid9952057-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9952057_97-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rickels, K.; Schweizer, E.; Garcia España, F.; Case, G.; Demartinis, N.; Greenblatt, D. (1999). "Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: Effects on withdrawal symptoms and taper outcome". <i>Psychopharmacology</i> <b>141</b> (1): 1–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs002130050798">10.1007/s002130050798</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9952057">9952057</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Trazodone+and+valproate+in+patients+discontinuing+long-term+benzodiazepine+therapy%3A+Effects+on+withdrawal+symptoms+and+taper+outcome&amp;rft.au=Case%2C+G.&amp;rft.au=Demartinis%2C+N.&amp;rft.aufirst=K.&amp;rft.au=Garcia+Espa%C3%B1a%2C+F.&amp;rft.au=Greenblatt%2C+D.&amp;rft.aulast=Rickels&amp;rft.au=Rickels%2C+K.&amp;rft.au=Schweizer%2C+E.&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs002130050798&amp;rft_id=info%3Apmid%2F9952057&amp;rft.issue=1&amp;rft.jtitle=Psychopharmacology&amp;rft.pages=1-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=141" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><span class="citation journal">Fruensgaard, K (1977). "Withdrawal psychosis after drugs. Report of a consecutive material". <i>Ugeskrift for laeger</i> <b>139</b> (29): 1719–22. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/898354">898354</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Withdrawal+psychosis+after+drugs.+Report+of+a+consecutive+material&amp;rft.aufirst=K&amp;rft.au=Fruensgaard%2C+K&amp;rft.aulast=Fruensgaard&amp;rft.date=1977&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F898354&amp;rft.issue=29&amp;rft.jtitle=Ugeskrift+for+laeger&amp;rft.pages=1719-22&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=139" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><span class="citation journal">Tagashira, Eijiro; Hiramori, Tameo; Urano, Tomoko; Nakao, Kenzo; Yanaura, Saizo (1981). "Enhancement of drug withdrawal convulsion by combinations of phenobarbital and antipsychotic agents". <i>The Japanese Journal of Pharmacology</i> <b>31</b> (5): 689–99. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1254%2Fjjp.31.689">10.1254/jjp.31.689</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6118452">6118452</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Enhancement+of+drug+withdrawal+convulsion+by+combinations+of+phenobarbital+and+antipsychotic+agents&amp;rft.aufirst=Eijiro&amp;rft.au=Hiramori%2C+Tameo&amp;rft.aulast=Tagashira&amp;rft.au=Nakao%2C+Kenzo&amp;rft.au=Tagashira%2C+Eijiro&amp;rft.au=Urano%2C+Tomoko&amp;rft.au=Yanaura%2C+Saizo&amp;rft.date=1981&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1254%2Fjjp.31.689&amp;rft_id=info%3Apmid%2F6118452&amp;rft.issue=5&amp;rft.jtitle=The+Japanese+Journal+of+Pharmacology&amp;rft.pages=689-99&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><span class="citation journal">Bobolakis, Ioannis (2000). "Neuroleptic Malignant Syndrome After Antipsychotic Drug Administration During Benzodiazepine Withdrawal". <i>Journal of Clinical Psychopharmacology</i> <b>20</b> (2): 281–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00004714-200004000-00033">10.1097/00004714-200004000-00033</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10770479">10770479</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Neuroleptic+Malignant+Syndrome+After+Antipsychotic+Drug+Administration+During+Benzodiazepine+Withdrawal&amp;rft.au=Bobolakis%2C+Ioannis&amp;rft.aufirst=Ioannis&amp;rft.aulast=Bobolakis&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00004714-200004000-00033&amp;rft_id=info%3Apmid%2F10770479&amp;rft.issue=2&amp;rft.jtitle=Journal+of+Clinical+Psychopharmacology&amp;rft.pages=281-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><span class="citation book">Randall, Michael D; Neil, Karen E (February 2004). "5". <a rel="nofollow" class="external text" href="http://books.google.com/?id=WhzmKPzxL3kC&amp;pg=PA62&amp;lpg=PA62&amp;dq=%22Benzodiazepine+withdrawal%22+management+chlordiazepoxide"><i>Disease management</i></a> (1 ed.). Pharmaceutical Press. p.&#160;62. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-85369-523-3" title="Special:BookSources/978-0-85369-523-3">978-0-85369-523-3</a><span class="reference-accessdate">. Retrieved <span class="nowrap">1 June</span> 2009</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=5&amp;rft.aufirst=Michael+D&amp;rft.aulast=Randall&amp;rft.au=Neil%2C+Karen+E&amp;rft.au=Randall%2C+Michael+D&amp;rft.btitle=Disease+management&amp;rft.date=February+2004&amp;rft.edition=1&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fbooks.google.com%2F%3Fid%3DWhzmKPzxL3kC%26pg%3DPA62%26lpg%3DPA62%26dq%3D%2522Benzodiazepine%2Bwithdrawal%2522%2Bmanagement%2Bchlordiazepoxide&amp;rft.isbn=978-0-85369-523-3&amp;rft.pages=62&amp;rft.pub=Pharmaceutical+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text"><span class="citation book">Ebadi, Manuchair (23 October 2007). "Alphabetical presentation of drugs". <a rel="nofollow" class="external text" href="http://books.google.com/?id=ihxyHbnj3qYC"><i>Desk Reference for Clinical Pharmacology</i></a> (2nd ed.). USA: CRC Press. p.&#160;512. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4200-4743-1" title="Special:BookSources/978-1-4200-4743-1">978-1-4200-4743-1</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Alphabetical+presentation+of+drugs&amp;rft.au=Ebadi%2C+Manuchair&amp;rft.aufirst=Manuchair&amp;rft.aulast=Ebadi&amp;rft.btitle=Desk+Reference+for+Clinical+Pharmacology&amp;rft.date=23+October+2007&amp;rft.edition=2nd&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fbooks.google.com%2F%3Fid%3DihxyHbnj3qYC&amp;rft.isbn=978-1-4200-4743-1&amp;rft.pages=512&amp;rft.place=USA&amp;rft.pub=CRC+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19062773-103"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19062773_103-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19062773_103-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid19062773_103-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Lader, Malcolm; Tylee, Andre; Donoghue, John (2009). "Withdrawing Benzodiazepines in Primary Care". <i>CNS Drugs</i> <b>23</b> (1): 19–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2165%2F0023210-200923010-00002">10.2165/0023210-200923010-00002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19062773">19062773</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Withdrawing+Benzodiazepines+in+Primary+Care&amp;rft.au=Donoghue%2C+John&amp;rft.aufirst=Malcolm&amp;rft.au=Lader%2C+Malcolm&amp;rft.aulast=Lader&amp;rft.au=Tylee%2C+Andre&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F0023210-200923010-00002&amp;rft_id=info%3Apmid%2F19062773&amp;rft.issue=1&amp;rft.jtitle=CNS+Drugs&amp;rft.pages=19-34&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text"><span class="citation journal">Higgitt, A.; Fonagy, P.; Lader, M. (2009). "The natural history of tolerance to the benzodiazepines". <i>Psychological Medicine. Monograph Supplement</i> <b>13</b>: 1–55. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1017%2FS0264180100000412">10.1017/S0264180100000412</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2908516">2908516</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=The+natural+history+of+tolerance+to+the+benzodiazepines&amp;rft.aufirst=A.&amp;rft.au=Fonagy%2C+P.&amp;rft.au=Higgitt%2C+A.&amp;rft.au=Lader%2C+M.&amp;rft.aulast=Higgitt&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1017%2FS0264180100000412&amp;rft_id=info%3Apmid%2F2908516&amp;rft.jtitle=Psychological+Medicine.+Monograph+Supplement&amp;rft.pages=1-55&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-WellbutrinPI-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-WellbutrinPI_105-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20090326063052/http://us.gsk.com/products/assets/us_wellbutrinXL.pdf">"Wellbutrin XL Prescribing Information"</a> <span style="font-size:85%;">(PDF)</span>. <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a>. December 2008. Archived from <a rel="nofollow" class="external text" href="http://us.gsk.com/products/assets/us_wellbutrinXL.pdf">the original</a> <span style="font-size:85%;">(PDF)</span> on 2009-03-26<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-01-16</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.btitle=Wellbutrin+XL+Prescribing+Information&amp;rft.date=December+2008&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fus.gsk.com%2Fproducts%2Fassets%2Fus_wellbutrinXL.pdf&amp;rft.pub=GlaxoSmithKline&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-106">^</a></b></span> <span class="reference-text"><span class="citation journal">Seale, Thomas W.; Carney, John M.; Rennert, Owen M.; Flux, Marinus; Skolnick, Phil (1987). "Coincidence of seizure susceptibility to caffeine and to the benzodiazepine inverse agonist, DMCM, in SWR and CBA inbred mice". <i>Pharmacology Biochemistry and Behavior</i> <b>26</b> (2): 381–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0091-3057%2887%2990133-X">10.1016/0091-3057(87)90133-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3575358">3575358</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Coincidence+of+seizure+susceptibility+to+caffeine+and+to+the+benzodiazepine+inverse+agonist%2C+DMCM%2C+in+SWR+and+CBA+inbred+mice&amp;rft.au=Carney%2C+John+M.&amp;rft.aufirst=Thomas+W.&amp;rft.au=Flux%2C+Marinus&amp;rft.aulast=Seale&amp;rft.au=Rennert%2C+Owen+M.&amp;rft.au=Seale%2C+Thomas+W.&amp;rft.au=Skolnick%2C+Phil&amp;rft.date=1987&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0091-3057%2887%2990133-X&amp;rft_id=info%3Apmid%2F3575358&amp;rft.issue=2&amp;rft.jtitle=Pharmacology+Biochemistry+and+Behavior&amp;rft.pages=381-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid2222130-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2222130_107-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Schweizer, Edward; Rickels, K; Case, WG; Greenblatt, DJ (1990). "Long-term Therapeutic Use of Benzodiazepines: II. Effects of Gradual Taper". <i>Archives of General Psychiatry</i> <b>47</b> (10): 908–15. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchpsyc.1990.01810220024003">10.1001/archpsyc.1990.01810220024003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2222130">2222130</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Long-term+Therapeutic+Use+of+Benzodiazepines%3A+II.+Effects+of+Gradual+Taper&amp;rft.au=Case%2C+WG&amp;rft.aufirst=Edward&amp;rft.au=Greenblatt%2C+DJ&amp;rft.aulast=Schweizer&amp;rft.au=Rickels%2C+K&amp;rft.au=Schweizer%2C+Edward&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchpsyc.1990.01810220024003&amp;rft_id=info%3Apmid%2F2222130&amp;rft.issue=10&amp;rft.jtitle=Archives+of+General+Psychiatry&amp;rft.pages=908-15&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=47" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Denis-2006-108"><span class="mw-cite-backlink">^ <a href="#cite_ref-Denis-2006_108-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Denis-2006_108-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Denis, Cecile; Fatseas, Melina; Lavie, Estelle; Auriacombe, Marc (2006). Denis, Cecile, ed. "Cochrane Database of Systematic Reviews" (3). pp.&#160;CD005194. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD005194.pub2">10.1002/14651858.CD005194.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16856084">16856084</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Pharmacological+interventions+for+benzodiazepine+mono-dependence+management+in+outpatient+settings&amp;rft.au=Auriacombe%2C+Marc&amp;rft.au=Denis%2C+Cecile&amp;rft.au=Fatseas%2C+Melina&amp;rft.aufirst=Cecile&amp;rft.aulast=Denis&amp;rft.au=Lavie%2C+Estelle&amp;rft.btitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.date=2006&amp;rft.genre=bookitem&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD005194.pub2&amp;rft_id=info%3Apmid%2F16856084&amp;rft.issue=3&amp;rft.pages=CD005194&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="font-size:100%" class="error citation-comment"><code style="color:inherit; border:inherit; padding:inherit;">|chapter=</code> ignored (<a href="/wiki/Help:CS1_errors#chapter_ignored" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><span class="citation journal">Gerra, G.; Zaimovic, A.; Giusti, F.; Moi, G.; Brewer, C. (2002). "Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: A randomized, placebo-controlled study". <i>Addiction Biology</i> <b>7</b> (4): 385–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1080%2F1355621021000005973">10.1080/1355621021000005973</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14578014">14578014</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Intravenous+flumazenil+versus+oxazepam+tapering+in+the+treatment+of+benzodiazepine+withdrawal%3A+A+randomized%2C+placebo-controlled+study&amp;rft.au=Brewer%2C+C.&amp;rft.aufirst=G.&amp;rft.au=Gerra%2C+G.&amp;rft.au=Giusti%2C+F.&amp;rft.aulast=Gerra&amp;rft.au=Moi%2C+G.&amp;rft.au=Zaimovic%2C+A.&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1080%2F1355621021000005973&amp;rft_id=info%3Apmid%2F14578014&amp;rft.issue=4&amp;rft.jtitle=Addiction+Biology&amp;rft.pages=385-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><span class="citation journal">Little, H.J. (1991). "The benzodiazepines: Anxiolytic and withdrawal effects". <i>Neuropeptides</i> <b>19</b>: 11–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0143-4179%2891%2990077-V">10.1016/0143-4179(91)90077-V</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1679209">1679209</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=The+benzodiazepines%3A+Anxiolytic+and+withdrawal+effects&amp;rft.aufirst=H.J.&amp;rft.aulast=Little&amp;rft.au=Little%2C+H.J.&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0143-4179%2891%2990077-V&amp;rft_id=info%3Apmid%2F1679209&amp;rft.jtitle=Neuropeptides&amp;rft.pages=11-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-L._Saxon.2C_S._Borg_.26_A._J._Hiltunen_148.E2.80.93151-111"><span class="mw-cite-backlink">^ <a href="#cite_ref-L._Saxon.2C_S._Borg_.26_A._J._Hiltunen_148.E2.80.93151_111-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-L._Saxon.2C_S._Borg_.26_A._J._Hiltunen_148.E2.80.93151_111-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal"><a href="/w/index.php?title=L._Saxon&amp;action=edit&amp;redlink=1" class="new" title="L. Saxon (page does not exist)">L. Saxon</a>, <a href="/w/index.php?title=S._Borg&amp;action=edit&amp;redlink=1" class="new" title="S. Borg (page does not exist)">S. Borg</a> &amp; <a href="/w/index.php?title=A._J._Hiltunen&amp;action=edit&amp;redlink=1" class="new" title="A. J. Hiltunen (page does not exist)">A. J. Hiltunen</a> (August 2010). "Reduction of aggression during benzodiazepine withdrawal: effects of flumazenil". <i><a href="/wiki/Pharmacology,_biochemistry,_and_behavior" title="Pharmacology, biochemistry, and behavior" class="mw-redirect">Pharmacology, biochemistry, and behavior</a></i> <b>96</b> (2): 148–151. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.pbb.2010.04.023">10.1016/j.pbb.2010.04.023</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20451546">20451546</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Reduction+of+aggression+during+benzodiazepine+withdrawal%3A+effects+of+flumazenil&amp;rft.aulast=L.+Saxon%2C+S.+Borg+%26+A.+J.+Hiltunen&amp;rft.au=L.+Saxon%2C+S.+Borg+%26+A.+J.+Hiltunen&amp;rft.date=August+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pbb.2010.04.023&amp;rft_id=info%3Apmid%2F20451546&amp;rft.issue=2&amp;rft.jtitle=Pharmacology%2C+biochemistry%2C+and+behavior&amp;rft.pages=148-151&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=96" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><span class="citation journal">Lader, M. H.; Morton, S. V. (1992). "A pilot study of the effects of flumazenil on symptoms persisting after benzodiazepine withdrawal". <i>Journal of Psychopharmacology</i> <b>6</b> (3): 357–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1177%2F026988119200600303">10.1177/026988119200600303</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22291380">22291380</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=A+pilot+study+of+the+effects+of+flumazenil+on+symptoms+persisting+after+benzodiazepine+withdrawal&amp;rft.aufirst=M.+H.&amp;rft.au=Lader%2C+M.+H.&amp;rft.aulast=Lader&amp;rft.au=Morton%2C+S.+V.&amp;rft.date=1992&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1177%2F026988119200600303&amp;rft_id=info%3Apmid%2F22291380&amp;rft.issue=3&amp;rft.jtitle=Journal+of+Psychopharmacology&amp;rft.pages=357-63&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><span class="citation web">Roche USA (October 2007). <a rel="nofollow" class="external text" href="http://www.rocheusa.com/products/romazicon/pi.pdf">"Romazicon"</a> <span style="font-size:85%;">(PDF)</span>. Roche Pharmaceuticals USA.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.aulast=Roche+USA&amp;rft.au=Roche+USA&amp;rft.btitle=Romazicon&amp;rft.date=October+2007&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.rocheusa.com%2Fproducts%2Fromazicon%2Fpi.pdf&amp;rft.pub=Roche+Pharmaceuticals+USA&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><span class="citation journal">McConnell, John Girvan (2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2435654">"Benzodiazepine tolerance, dependency, and withdrawal syndromes and interactions with fluoroquinolone antimicrobials"</a>. <i>British Journal of General Practice</i> <b>58</b> (550): 365–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3399%2Fbjgp08X280317">10.3399/bjgp08X280317</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2435654">2435654</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18482496">18482496</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepine+tolerance%2C+dependency%2C+and+withdrawal+syndromes+and+interactions+with+fluoroquinolone+antimicrobials&amp;rft.aufirst=John+Girvan&amp;rft.aulast=McConnell&amp;rft.au=McConnell%2C+John+Girvan&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2435654&amp;rft_id=info%3Adoi%2F10.3399%2Fbjgp08X280317&amp;rft_id=info%3Apmc%2F2435654&amp;rft_id=info%3Apmid%2F18482496&amp;rft.issue=550&amp;rft.jtitle=British+Journal+of+General+Practice&amp;rft.pages=365-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=58" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid2167717-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2167717_115-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Unseld, E; Ziegler, G; Gemeinhardt, A; Janssen, U; Klotz, U (1990). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1368276">"Possible interaction of fluoroquinolones with the benzodiazepine-GABAA- receptor complex"</a>. <i>British Journal of Clinical Pharmacology</i> <b>30</b> (1): 63–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2125.1990.tb03744.x">10.1111/j.1365-2125.1990.tb03744.x</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1368276">1368276</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2167717">2167717</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Possible+interaction+of+fluoroquinolones+with+the+benzodiazepine-GABAA-+receptor+complex&amp;rft.aufirst=E&amp;rft.au=Gemeinhardt%2C+A&amp;rft.au=Janssen%2C+U&amp;rft.au=Klotz%2C+U&amp;rft.aulast=Unseld&amp;rft.au=Unseld%2C+E&amp;rft.au=Ziegler%2C+G&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1368276&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2125.1990.tb03744.x&amp;rft_id=info%3Apmc%2F1368276&amp;rft_id=info%3Apmid%2F2167717&amp;rft.issue=1&amp;rft.jtitle=British+Journal+of+Clinical+Pharmacology&amp;rft.pages=63-70&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><span class="citation journal">Sternbach, Harvey; State, Rosanne (1997). "Antibiotics: Neuropsychiatric Effects and Psychotropic Interactions". <i>Harvard Review of Psychiatry</i> <b>5</b> (4): 214–26. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3109%2F10673229709000304">10.3109/10673229709000304</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9427014">9427014</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Antibiotics%3A+Neuropsychiatric+Effects+and+Psychotropic+Interactions&amp;rft.aufirst=Harvey&amp;rft.aulast=Sternbach&amp;rft.au=State%2C+Rosanne&amp;rft.au=Sternbach%2C+Harvey&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3109%2F10673229709000304&amp;rft_id=info%3Apmid%2F9427014&amp;rft.issue=4&amp;rft.jtitle=Harvard+Review+of+Psychiatry&amp;rft.pages=214-26&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><span class="citation web"><a href="/wiki/Committee_on_Safety_of_Medicines" title="Committee on Safety of Medicines">Committee on Safety of Medicines</a>; Medicines and Healthcare products Regulatory Agency (2008). <a rel="nofollow" class="external text" href="http://bnf.org/bnf/bnf/57/3944.htm">"Quinolones"</a>. United Kingdom: <a href="/wiki/British_National_Formulary" title="British National Formulary">British National Formulary</a><span class="reference-accessdate">. Retrieved <span class="nowrap">16 February</span> 2009</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.au=Committee+on+Safety+of+Medicines&amp;rft.aulast=Committee+on+Safety+of+Medicines&amp;rft.btitle=Quinolones&amp;rft.date=2008&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbnf.org%2Fbnf%2Fbnf%2F57%2F3944.htm&amp;rft.place=United+Kingdom&amp;rft.pub=British+National+Formulary&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameter <code style="color:inherit; border:inherit; padding:inherit;">|coauthors=</code> (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span><span style="font-size:0.95em; font-size: 90%; color: #555">(<a href="/wiki/Wikipedia:Verifiability#Access_to_sources" title="Wikipedia:Verifiability">registration required</a>)</span></span></li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text"><span class="citation journal">Wong, PT (1993). "Interactions of indomethacin with central GABA systems". <i>Archives internationales de pharmacodynamie et de therapie</i> <b>324</b>: 5–16. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8297186">8297186</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Interactions+of+indomethacin+with+central+GABA+systems&amp;rft.aufirst=PT&amp;rft.aulast=Wong&amp;rft.au=Wong%2C+PT&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8297186&amp;rft.jtitle=Archives+internationales+de+pharmacodynamie+et+de+therapie&amp;rft.pages=5-16&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=324" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><span class="citation book">Delanty, Norman (November 2001). <a rel="nofollow" class="external text" href="http://books.google.com/books?id=u2B3SdfE8-gC&amp;pg=PA147">"Medication associated seizures"</a>. <a rel="nofollow" class="external text" href="http://books.google.com/?id=u2B3SdfE8-gC&amp;pg=PA152&amp;lpg=PA152&amp;dq=fluoroquinolones+gabaa+nsaids"><i>Seizures: Medical Causes and Management</i></a>. Humana Press. pp.&#160;152–153. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-89603-827-0" title="Special:BookSources/0-89603-827-0">0-89603-827-0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Medication+associated+seizures&amp;rft.au=Delanty%2C+Norman&amp;rft.aufirst=Norman&amp;rft.aulast=Delanty&amp;rft.btitle=Seizures%3A+Medical+Causes+and+Management&amp;rft.date=November+2001&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fbooks.google.com%2F%3Fid%3Du2B3SdfE8-gC%26pg%3DPA152%26lpg%3DPA152%26dq%3Dfluoroquinolones%2Bgabaa%2Bnsaids&amp;rft.isbn=0-89603-827-0&amp;rft.pages=152-153&amp;rft.pub=Humana+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><span class="citation journal">Green, M. A.; Halliwell, R. F. (1997). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1564969">"Selective antagonism of the GABAAreceptor by ciprofloxacin and biphenylacetic acid"</a>. <i>British Journal of Pharmacology</i> <b>122</b> (3): 584–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.bjp.0701411">10.1038/sj.bjp.0701411</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1564969">1564969</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9351519">9351519</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Selective+antagonism+of+the+GABAAreceptor+by+ciprofloxacin+and+biphenylacetic+acid&amp;rft.aufirst=M.+A.&amp;rft.au=Green%2C+M.+A.&amp;rft.au=Halliwell%2C+R.+F.&amp;rft.aulast=Green&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1564969&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.bjp.0701411&amp;rft_id=info%3Apmc%2F1564969&amp;rft_id=info%3Apmid%2F9351519&amp;rft.issue=3&amp;rft.jtitle=British+Journal+of+Pharmacology&amp;rft.pages=584-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=122" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text"><span class="citation journal">Auta, J; Costa, E; Davis, J; Guidotti, A (2005). "Imidazenil: An antagonist of the sedative but not the anticonvulsant action of diazepam". <i>Neuropharmacology</i> <b>49</b> (3): 425–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.neuropharm.2005.04.005">10.1016/j.neuropharm.2005.04.005</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15964602">15964602</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Imidazenil%3A+An+antagonist+of+the+sedative+but+not+the+anticonvulsant+action+of+diazepam&amp;rft.au=Auta%2C+J&amp;rft.au=Costa%2C+E&amp;rft.au=Davis%2C+J&amp;rft.aufirst=J&amp;rft.au=Guidotti%2C+A&amp;rft.aulast=Auta&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuropharm.2005.04.005&amp;rft_id=info%3Apmid%2F15964602&amp;rft.issue=3&amp;rft.jtitle=Neuropharmacology&amp;rft.pages=425-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=49" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-122">^</a></b></span> <span class="reference-text"><span class="citation journal">Sullivan, Mark; Toshima, Michelle; Lynn, Pamela; Roy-Byrne, Peter (1993). "Phenobarbital Versus Clonazepam for Sedative-Hypnotic Taper in Chronic Pain Patients: A Pilot Study". <i>Annals of Clinical Psychiatry</i> <b>5</b> (2): 123–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3109%2F10401239309148974">10.3109/10401239309148974</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8348204">8348204</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Phenobarbital+Versus+Clonazepam+for+Sedative-Hypnotic+Taper+in+Chronic+Pain+Patients%3A+A+Pilot+Study&amp;rft.aufirst=Mark&amp;rft.aulast=Sullivan&amp;rft.au=Lynn%2C+Pamela&amp;rft.au=Roy-Byrne%2C+Peter&amp;rft.au=Sullivan%2C+Mark&amp;rft.au=Toshima%2C+Michelle&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3109%2F10401239309148974&amp;rft_id=info%3Apmid%2F8348204&amp;rft.issue=2&amp;rft.jtitle=Annals+of+Clinical+Psychiatry&amp;rft.pages=123-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text"><span class="citation web">Dr Ray Baker. <a rel="nofollow" class="external text" href="http://www.benzo.org.uk/can-drb.htm">"Dr Ray Baker's Article on Addiction: Benzodiazepines in Particular"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">14 February</span> 2009</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.au=Dr+Ray+Baker&amp;rft.aulast=Dr+Ray+Baker&amp;rft.btitle=Dr+Ray+Baker%27s+Article+on+Addiction%3A+Benzodiazepines+in+Particular&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.benzo.org.uk%2Fcan-drb.htm&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Oulis-2010-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-Oulis-2010_124-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Oulis, P.; Konstantakopoulos, G. (2010). "Pregabalin in the treatment of alcohol and benzodiazepines dependence.". <i>CNS Neurosci Ther</i> <b>16</b> (1): 45–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1755-5949.2009.00120.x">10.1111/j.1755-5949.2009.00120.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20070788">20070788</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Pregabalin+in+the+treatment+of+alcohol+and+benzodiazepines+dependence.&amp;rft.aufirst=P.&amp;rft.au=Konstantakopoulos%2C+G.&amp;rft.aulast=Oulis&amp;rft.au=Oulis%2C+P.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1755-5949.2009.00120.x&amp;rft_id=info%3Apmid%2F20070788&amp;rft.issue=1&amp;rft.jtitle=CNS+Neurosci+Ther&amp;rft.pages=45-50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Oulis-2012-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-Oulis-2012_125-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Oulis, P.; Konstantakopoulos, G. (Jul 2012). "Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence.". <i>Expert Opin Investig Drugs</i> <b>21</b> (7): 1019–29. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1517%2F13543784.2012.685651">10.1517/13543784.2012.685651</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22568872">22568872</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Efficacy+and+safety+of+pregabalin+in+the+treatment+of+alcohol+and+benzodiazepine+dependence.&amp;rft.aufirst=P.&amp;rft.au=Konstantakopoulos%2C+G.&amp;rft.aulast=Oulis&amp;rft.au=Oulis%2C+P.&amp;rft.date=Jul+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1517%2F13543784.2012.685651&amp;rft_id=info%3Apmid%2F22568872&amp;rft.issue=7&amp;rft.jtitle=Expert+Opin+Investig+Drugs&amp;rft.pages=1019-29&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text"><span class="citation journal">Zitman, F. G.; Couvée, JE (2001). "Chronic benzodiazepine use in general practice patients with depression: An evaluation of controlled treatment and taper-off: Report on behalf of the Dutch Chronic Benzodiazepine Working Group". <i>The British Journal of Psychiatry</i> <b>178</b> (4): 317–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1192%2Fbjp.178.4.317">10.1192/bjp.178.4.317</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11282810">11282810</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Chronic+benzodiazepine+use+in+general+practice+patients+with+depression%3A+An+evaluation+of+controlled+treatment+and+taper-off%3A+Report+on+behalf+of+the+Dutch+Chronic+Benzodiazepine+Working+Group&amp;rft.au=Couv%C3%A9e%2C+JE&amp;rft.aufirst=F.+G.&amp;rft.aulast=Zitman&amp;rft.au=Zitman%2C+F.+G.&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1192%2Fbjp.178.4.317&amp;rft_id=info%3Apmid%2F11282810&amp;rft.issue=4&amp;rft.jtitle=The+British+Journal+of+Psychiatry&amp;rft.pages=317-24&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=178" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-127">^</a></b></span> <span class="reference-text"><span class="citation journal">Tönne, U.; Hiltunen, A. J.; Vikander, B.; Engelbrektsson, K.; Bergman, H.; Bergman, I.; Leifman, H.; Borg, S. (1995). "Neuropsychological changes during steady-state drug use, withdrawal and abstinence in primary benzodiazepine-dependent patients". <i>Acta Psychiatrica Scandinavica</i> <b>91</b> (5): 299–304. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1600-0447.1995.tb09786.x">10.1111/j.1600-0447.1995.tb09786.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7639085">7639085</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Neuropsychological+changes+during+steady-state+drug+use%2C+withdrawal+and+abstinence+in+primary+benzodiazepine-dependent+patients&amp;rft.au=Bergman%2C+H.&amp;rft.au=Bergman%2C+I.&amp;rft.au=Borg%2C+S.&amp;rft.au=Engelbrektsson%2C+K.&amp;rft.aufirst=U.&amp;rft.au=Hiltunen%2C+A.+J.&amp;rft.aulast=T%C3%B6nne&amp;rft.au=Leifman%2C+H.&amp;rft.au=T%C3%B6nne%2C+U.&amp;rft.au=Vikander%2C+B.&amp;rft.date=1995&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0447.1995.tb09786.x&amp;rft_id=info%3Apmid%2F7639085&amp;rft.issue=5&amp;rft.jtitle=Acta+Psychiatrica+Scandinavica&amp;rft.pages=299-304&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=91" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-128">^</a></b></span> <span class="reference-text"><span class="citation journal">Kan, CC; Mickers, FC; Barnhoorn, D (2006). "Short- and long-term results of a systematic benzodiazepine discontinuation programme for psychiatric patients". <i>Tijdschrift voor psychiatrie</i> <b>48</b> (9): 683–93. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17007474">17007474</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Short-+and+long-term+results+of+a+systematic+benzodiazepine+discontinuation+programme+for+psychiatric+patients&amp;rft.au=Barnhoorn%2C+D&amp;rft.aufirst=CC&amp;rft.au=Kan%2C+CC&amp;rft.aulast=Kan&amp;rft.au=Mickers%2C+FC&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F17007474&amp;rft.issue=9&amp;rft.jtitle=Tijdschrift+voor+psychiatrie&amp;rft.pages=683-93&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=48" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-J.C3.B8rgensen-2009-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-J.C3.B8rgensen-2009_129-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jørgensen, VR (2009). "Benzodiazepine reduction does not imply an increased consumption of antidepressants. A survey of two medical practices". <i>Ugeskrift for laeger</i> <b>171</b> (41): 2999–3003. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19814928">19814928</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Benzodiazepine+reduction+does+not+imply+an+increased+consumption+of+antidepressants.+A+survey+of+two+medical+practices&amp;rft.aufirst=VR&amp;rft.au=J%C3%B8rgensen%2C+VR&amp;rft.aulast=J%C3%B8rgensen&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F19814928&amp;rft.issue=41&amp;rft.jtitle=Ugeskrift+for+laeger&amp;rft.pages=2999-3003&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=171" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-130">^</a></b></span> <span class="reference-text"><span class="citation book">Lal R, Gupta S, Rao R, Kattimani S (2007). <a rel="nofollow" class="external text" href="http://www.whoindia.org/LinkFiles/Mental_Health_&amp;_substance_Abuse_Emergency_management_of_Substance_Overdose_and_Withdrawal-Manual_For_Nursing_Personnel.pdf">"Emergency management of substance overdose and withdrawal"</a> <span style="font-size:85%;">(PDF)</span>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20100613203853/http://whoindia.org/LinkFiles/Mental_Health_&amp;_substance_Abuse_Emergency_management_of_Substance_Overdose_and_Withdrawal-Manual_For_Nursing_Personnel.pdf"><i>Substance Use Disorder</i></a> <span style="font-size:85%;">(PDF)</span>. World Health Organisation. p.&#160;82. Archived from <a rel="nofollow" class="external text" href="http://www.whoindia.org/en/Section20/Section22_1674.htm">the original</a> <span style="font-size:85%;">(PDF)</span> on 2010-06-13<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-06-06</span></span>. <q>Generally, a longer-acting benzodiazepine such as chlordiazepoxide or diazepam is used and the initial dose titrated downward</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Emergency+management+of+substance+overdose+and+withdrawal&amp;rft.au=Lal+R%2C+Gupta+S%2C+Rao+R%2C+Kattimani+S&amp;rft.aulast=Lal+R%2C+Gupta+S%2C+Rao+R%2C+Kattimani+S&amp;rft.btitle=Substance+Use+Disorder&amp;rft.date=2007&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fwww.whoindia.org%2Fen%2FSection20%2FSection22_1674.htm&amp;rft.pages=82&amp;rft.pub=World+Health+Organisation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text"><span class="citation journal">Noyes, Russell; Perry, Paul J.; Crowe, Raymond R.; Coryell, William H.; Clancy, John; Yamada, Thoru; Gabel, Janelle (1986). "Seizures Following the Withdrawal of Alprazolam". <i>The Journal of Nervous and Mental Disease</i> <b>174</b> (1): 50–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00005053-198601000-00009">10.1097/00005053-198601000-00009</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2867122">2867122</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Seizures+Following+the+Withdrawal+of+Alprazolam&amp;rft.au=Clancy%2C+John&amp;rft.au=Coryell%2C+William+H.&amp;rft.au=Crowe%2C+Raymond+R.&amp;rft.aufirst=Russell&amp;rft.au=Gabel%2C+Janelle&amp;rft.aulast=Noyes&amp;rft.au=Noyes%2C+Russell&amp;rft.au=Perry%2C+Paul+J.&amp;rft.au=Yamada%2C+Thoru&amp;rft.date=1986&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00005053-198601000-00009&amp;rft_id=info%3Apmid%2F2867122&amp;rft.issue=1&amp;rft.jtitle=The+Journal+of+Nervous+and+Mental+Disease&amp;rft.pages=50-2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=174" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-132">^</a></b></span> <span class="reference-text"><span class="citation journal">Noyes Jr, R; Clancy, J; Coryell, WH; Crowe, RR; Chaudhry, DR; Domingo, DV (1985). "A withdrawal syndrome after abrupt discontinuation of alprazolam". <i>The American Journal of Psychiatry</i> <b>142</b> (1): 114–6. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2857066">2857066</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=A+withdrawal+syndrome+after+abrupt+discontinuation+of+alprazolam&amp;rft.au=Chaudhry%2C+DR&amp;rft.au=Clancy%2C+J&amp;rft.au=Coryell%2C+WH&amp;rft.au=Crowe%2C+RR&amp;rft.au=Domingo%2C+DV&amp;rft.aufirst=R&amp;rft.aulast=Noyes+Jr&amp;rft.au=Noyes+Jr%2C+R&amp;rft.date=1985&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2857066&amp;rft.issue=1&amp;rft.jtitle=The+American+Journal+of+Psychiatry&amp;rft.pages=114-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=142" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid2222129-133"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2222129_133-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rickels, Karl; Schweizer, E; Case, WG; Greenblatt, DJ (1990). "Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation". <i>Archives of General Psychiatry</i> <b>47</b> (10): 899–907. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchpsyc.1990.01810220015002">10.1001/archpsyc.1990.01810220015002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2222129">2222129</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Long-term+Therapeutic+Use+of+Benzodiazepines%3A+I.+Effects+of+Abrupt+Discontinuation&amp;rft.au=Case%2C+WG&amp;rft.aufirst=Karl&amp;rft.au=Greenblatt%2C+DJ&amp;rft.aulast=Rickels&amp;rft.au=Rickels%2C+Karl&amp;rft.au=Schweizer%2C+E&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchpsyc.1990.01810220015002&amp;rft_id=info%3Apmid%2F2222129&amp;rft.issue=10&amp;rft.jtitle=Archives+of+General+Psychiatry&amp;rft.pages=899-907&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=47" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-selfharm-134"><span class="mw-cite-backlink"><b><a href="#cite_ref-selfharm_134-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Neale, G; Smith, AJ (2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2047018">"Self-harm and suicide associated with benzodiazepine usage"</a>. <i>The British journal of general practice</i> <b>57</b> (538): 407–8. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2047018">2047018</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17504594">17504594</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Self-harm+and+suicide+associated+with+benzodiazepine+usage&amp;rft.aufirst=G&amp;rft.aulast=Neale&amp;rft.au=Neale%2C+G&amp;rft.au=Smith%2C+AJ&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2047018&amp;rft_id=info%3Apmc%2F2047018&amp;rft_id=info%3Apmid%2F17504594&amp;rft.issue=538&amp;rft.jtitle=The+British+journal+of+general+practice&amp;rft.pages=407-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=57" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-135">^</a></b></span> <span class="reference-text"><span class="citation journal">Curran, H. V.; Bond, A.; O'Sullivan, G.; Bruce, M.; Marks, I.; Lelliot, P.; Shine, P.; Lader, M. (2009). "Memory functions, alprazolam and exposure therapy: A controlled longitudinal study of agoraphobia with panic disorder". <i>Psychological Medicine</i> <b>24</b> (4): 969–76. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1017%2FS0033291700029056">10.1017/S0033291700029056</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7892364">7892364</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Memory+functions%2C+alprazolam+and+exposure+therapy%3A+A+controlled+longitudinal+study+of+agoraphobia+with+panic+disorder&amp;rft.au=Bond%2C+A.&amp;rft.au=Bruce%2C+M.&amp;rft.au=Curran%2C+H.+V.&amp;rft.aufirst=H.+V.&amp;rft.au=Lader%2C+M.&amp;rft.aulast=Curran&amp;rft.au=Lelliot%2C+P.&amp;rft.au=Marks%2C+I.&amp;rft.au=O%27Sullivan%2C+G.&amp;rft.au=Shine%2C+P.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1017%2FS0033291700029056&amp;rft_id=info%3Apmid%2F7892364&amp;rft.issue=4&amp;rft.jtitle=Psychological+Medicine&amp;rft.pages=969-76&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-136">^</a></b></span> <span class="reference-text"><span class="citation journal">Busto, Usoa; Fornazzari, Luis; Naranjo, Claudio A. (1988). "Protracted Tinnitus after Discontinuation of Long-Term Therapeutic Use of Benzodiazepines". <i>Journal of Clinical Psychopharmacology</i> <b>8</b> (5): 359–362. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00004714-198810000-00010">10.1097/00004714-198810000-00010</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2903182">2903182</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Protracted+Tinnitus+after+Discontinuation+of+Long-Term+Therapeutic+Use+of+Benzodiazepines&amp;rft.au=Busto%2C+Usoa&amp;rft.aufirst=Usoa&amp;rft.au=Fornazzari%2C+Luis&amp;rft.aulast=Busto&amp;rft.au=Naranjo%2C+Claudio+A.&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00004714-198810000-00010&amp;rft_id=info%3Apmid%2F2903182&amp;rft.issue=5&amp;rft.jtitle=Journal+of+Clinical+Psychopharmacology&amp;rft.pages=359-362&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-137">^</a></b></span> <span class="reference-text"><span class="citation journal">Higgitt, A.; Fonagy, P.; Toone, B.; Shine, P. (1990). "The prolonged benzodiazepine withdrawal syndrome: Anxiety or hysteria?". <i>Acta Psychiatrica Scandinavica</i> <b>82</b> (2): 165–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1600-0447.1990.tb01375.x">10.1111/j.1600-0447.1990.tb01375.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1978465">1978465</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=The+prolonged+benzodiazepine+withdrawal+syndrome%3A+Anxiety+or+hysteria%3F&amp;rft.aufirst=A.&amp;rft.au=Fonagy%2C+P.&amp;rft.au=Higgitt%2C+A.&amp;rft.aulast=Higgitt&amp;rft.au=Shine%2C+P.&amp;rft.au=Toone%2C+B.&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0447.1990.tb01375.x&amp;rft_id=info%3Apmid%2F1978465&amp;rft.issue=2&amp;rft.jtitle=Acta+Psychiatrica+Scandinavica&amp;rft.pages=165-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=82" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-138">^</a></b></span> <span class="reference-text"><span class="citation journal">Ashton CH (March 1995). <a rel="nofollow" class="external text" href="http://www.benzo.org.uk/pha-1.htm">"Protracted Withdrawal From Benzodiazepines: The Post-Withdrawal Syndrome"</a>. <i>Psychiatric Annals</i> (benzo.org.uk) <b>25</b> (3): 174–179.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Protracted+Withdrawal+From+Benzodiazepines%3A+The+Post-Withdrawal+Syndrome&amp;rft.au=Ashton+CH&amp;rft.aulast=Ashton+CH&amp;rft.date=March+1995&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.benzo.org.uk%2Fpha-1.htm&amp;rft.issue=3&amp;rft.jtitle=Psychiatric+Annals&amp;rft.pages=174-179&amp;rft.pub=benzo.org.uk&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text"><span class="citation journal">Barker, M; Greenwood, KM; Jackson, M; Crowe, SF (2004). "Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: A meta-analysis". <i>Archives of Clinical Neuropsychology</i> <b>19</b> (3): 437–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0887-6177%2803%2900096-9">10.1016/S0887-6177(03)00096-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15033227">15033227</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Persistence+of+cognitive+effects+after+withdrawal+from+long-term+benzodiazepine+use%3A+A+meta-analysis&amp;rft.au=Barker%2C+M&amp;rft.au=Crowe%2C+SF&amp;rft.aufirst=M&amp;rft.au=Greenwood%2C+KM&amp;rft.au=Jackson%2C+M&amp;rft.aulast=Barker&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0887-6177%2803%2900096-9&amp;rft_id=info%3Apmid%2F15033227&amp;rft.issue=3&amp;rft.jtitle=Archives+of+Clinical+Neuropsychology&amp;rft.pages=437-54&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-140">^</a></b></span> <span class="reference-text"><span class="citation journal">Hood HM, Metten P, Crabbe JC, Buck KJ (February 2006). "Fine mapping of a sedative-hypnotic drug withdrawal locus on mouse chromosome 11". <i><a href="/wiki/Genes,_Brain_and_Behavior" title="Genes, Brain and Behavior">Genes, Brain and Behavior</a></i> <b>5</b> (1): 1–10. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1601-183X.2005.00122.x">10.1111/j.1601-183X.2005.00122.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16436183">16436183</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Fine+mapping+of+a+sedative-hypnotic+drug+withdrawal+locus+on+mouse+chromosome+11&amp;rft.au=Hood+HM%2C+Metten+P%2C+Crabbe+JC%2C+Buck+KJ&amp;rft.aulast=Hood+HM%2C+Metten+P%2C+Crabbe+JC%2C+Buck+KJ&amp;rft.date=February+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1601-183X.2005.00122.x&amp;rft_id=info%3Apmid%2F16436183&amp;rft.issue=1&amp;rft.jtitle=Genes%2C+Brain+and+Behavior&amp;rft.pages=1-10&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Vorma2005-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-Vorma2005_141-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Vorma, H; Naukkarinen, Hh; Sarna, Sj; Kuoppasalmi, Ki (2005). "Predictors of benzodiazepine discontinuation in subjects manifesting complicated dependence". <i>Substance Use &amp; Misuse</i> <b>40</b> (4): 499–510. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1081%2FJA-200052433">10.1081/JA-200052433</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15830732">15830732</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Predictors+of+benzodiazepine+discontinuation+in+subjects+manifesting+complicated+dependence&amp;rft.aulast=Vorma%2C+H%3B+Naukkarinen%2C+Hh%3B+Sarna%2C+Sj%3B+Kuoppasalmi%2C+Ki&amp;rft.au=Vorma%2C+H%3B+Naukkarinen%2C+Hh%3B+Sarna%2C+Sj%3B+Kuoppasalmi%2C+Ki&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1081%2FJA-200052433&amp;rft_id=info%3Apmid%2F15830732&amp;rft.issue=4&amp;rft.jtitle=Substance+Use+%26+Misuse&amp;rft.pages=499-510&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=40" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-142">^</a></b></span> <span class="reference-text"><span class="citation journal">McElhatton, Patricia R. (1994). "The effects of benzodiazepine use during pregnancy and lactation". <i>Reproductive Toxicology</i> <b>8</b> (6): 461–75. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0890-6238%2894%2990029-9">10.1016/0890-6238(94)90029-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7881198">7881198</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=The+effects+of+benzodiazepine+use+during+pregnancy+and+lactation&amp;rft.aufirst=Patricia+R.&amp;rft.aulast=McElhatton&amp;rft.au=McElhatton%2C+Patricia+R.&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0890-6238%2894%2990029-9&amp;rft_id=info%3Apmid%2F7881198&amp;rft.issue=6&amp;rft.jtitle=Reproductive+Toxicology&amp;rft.pages=461-75&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-birchley-143"><span class="mw-cite-backlink">^ <a href="#cite_ref-birchley_143-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-birchley_143-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-birchley_143-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Birchley, Giles (2009). "Opioid and benzodiazepine withdrawal syndromes in the paediatric intensive care unit: A review of recent literature". <i>Nursing in Critical Care</i> <b>14</b> (1): 26–37. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1478-5153.2008.00311.x">10.1111/j.1478-5153.2008.00311.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19154308">19154308</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Opioid+and+benzodiazepine+withdrawal+syndromes+in+the+paediatric+intensive+care+unit%3A+A+review+of+recent+literature&amp;rft.au=Birchley%2C+Giles&amp;rft.aufirst=Giles&amp;rft.aulast=Birchley&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1478-5153.2008.00311.x&amp;rft_id=info%3Apmid%2F19154308&amp;rft.issue=1&amp;rft.jtitle=Nursing+in+Critical+Care&amp;rft.pages=26-37&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid14513134-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid14513134_144-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Fontela, Patrícia Scolari; Fontela, Aline; Moraes, Fabrício; Da Silva, Ricardo Bernardi; Sober, Roberta B.; Noer, Francisco; Bruno, Paulo; Einloft, Ana; Garcia, Pedro Celiny Ramos; Piva, Jefferson P. (2003). "Sedation and analgesia in children submitted to mechanical ventilation could be overestimated?". <i>Jornal de Pediatria</i> <b>79</b> (4): 343–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2223%2FJPED.1046">10.2223/JPED.1046</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14513134">14513134</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Sedation+and+analgesia+in+children+submitted+to+mechanical+ventilation+could+be+overestimated%3F&amp;rft.au=Bruno%2C+Paulo&amp;rft.au=Da+Silva%2C+Ricardo+Bernardi&amp;rft.au=Einloft%2C+Ana&amp;rft.aufirst=Patr%C3%ADcia+Scolari&amp;rft.au=Fontela%2C+Aline&amp;rft.au=Fontela%2C+Patr%C3%ADcia+Scolari&amp;rft.au=Garcia%2C+Pedro+Celiny+Ramos&amp;rft.aulast=Fontela&amp;rft.au=Moraes%2C+Fabr%C3%ADcio&amp;rft.au=Noer%2C+Francisco&amp;rft.au=Piva%2C+Jefferson+P.&amp;rft.au=Sober%2C+Roberta+B.&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2223%2FJPED.1046&amp;rft_id=info%3Apmid%2F14513134&amp;rft.issue=4&amp;rft.jtitle=Jornal+de+Pediatria&amp;rft.pages=343-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=79" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16699772-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16699772_145-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Playfor, Stephen; Jenkins, Ian; Boyles, Carolyne; Choonara, Imti; Davies, Gerald; Haywood, Tim; Hinson, Gillian; Mayer, Anton; Morton, Neil; Ralph, Tanya; Wolf, Andrew; United Kingdom Paediatric Intensive Care Society Sedation; Analgesia Neuromuscular Blockade Working Group (2006). "Consensus guidelines on sedation and analgesia in critically ill children". <i>Intensive Care Medicine</i> <b>32</b> (8): 1125–36. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00134-006-0190-x">10.1007/s00134-006-0190-x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16699772">16699772</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Consensus+guidelines+on+sedation+and+analgesia+in+critically+ill+children&amp;rft.au=Analgesia+Neuromuscular+Blockade+Working+Group&amp;rft.au=Boyles%2C+Carolyne&amp;rft.au=Choonara%2C+Imti&amp;rft.au=Davies%2C+Gerald&amp;rft.aufirst=Stephen&amp;rft.au=Haywood%2C+Tim&amp;rft.au=Hinson%2C+Gillian&amp;rft.au=Jenkins%2C+Ian&amp;rft.aulast=Playfor&amp;rft.au=Mayer%2C+Anton&amp;rft.au=Morton%2C+Neil&amp;rft.au=Playfor%2C+Stephen&amp;rft.au=Ralph%2C+Tanya&amp;rft.au=United+Kingdom+Paediatric+Intensive+Care+Society+Sedation&amp;rft.au=Wolf%2C+Andrew&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00134-006-0190-x&amp;rft_id=info%3Apmid%2F16699772&amp;rft.issue=8&amp;rft.jtitle=Intensive+Care+Medicine&amp;rft.pages=1125-36&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17541548-146"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17541548_146-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ista, Erwin; Van Dijk, Monique; Gamel, Claudia; Tibboel, Dick; De Hoog, Matthijs (2007). "Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics: A literature review. 'Assessment remains troublesome<span style="padding-right:0.2em;">'</span>". <i>Intensive Care Medicine</i> <b>33</b> (8): 1396–406. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00134-007-0696-x">10.1007/s00134-007-0696-x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17541548">17541548</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Withdrawal+symptoms+in+children+after+long-term+administration+of+sedatives+and%2For+analgesics%3A+A+literature+review.+%27Assessment+remains+troublesome%27&amp;rft.au=De+Hoog%2C+Matthijs&amp;rft.aufirst=Erwin&amp;rft.au=Gamel%2C+Claudia&amp;rft.au=Ista%2C+Erwin&amp;rft.aulast=Ista&amp;rft.au=Tibboel%2C+Dick&amp;rft.au=Van+Dijk%2C+Monique&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00134-007-0696-x&amp;rft_id=info%3Apmid%2F17541548&amp;rft.issue=8&amp;rft.jtitle=Intensive+Care+Medicine&amp;rft.pages=1396-406&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Baillargeon-2003-147"><span class="mw-cite-backlink">^ <a href="#cite_ref-Baillargeon-2003_147-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Baillargeon-2003_147-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Baillargeon-2003_147-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Baillargeon-2003_147-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Baillargeon-2003_147-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Baillargeon, L; Landreville, P; Verreault, R; Beauchemin, JP; Grégoire, JP; Morin, CM (2003). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC236226">"Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: A randomized trial"</a>. <i>Canadian Medical Association Journal</i> <b>169</b> (10): 1015–20. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC236226">236226</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14609970">14609970</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.atitle=Discontinuation+of+benzodiazepines+among+older+insomniac+adults+treated+with+cognitive-behavioural+therapy+combined+with+gradual+tapering%3A+A+randomized+trial&amp;rft.au=Baillargeon%2C+L&amp;rft.au=Beauchemin%2C+JP&amp;rft.aufirst=L&amp;rft.au=Gr%C3%A9goire%2C+JP&amp;rft.au=Landreville%2C+P&amp;rft.aulast=Baillargeon&amp;rft.au=Morin%2C+CM&amp;rft.au=Verreault%2C+R&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC236226&amp;rft_id=info%3Apmc%2F236226&amp;rft_id=info%3Apmid%2F14609970&amp;rft.issue=10&amp;rft.jtitle=Canadian+Medical+Association+Journal&amp;rft.pages=1015-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=169" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-148"><span class="mw-cite-backlink"><b><a href="#cite_ref-148">^</a></b></span> <span class="reference-text"><span class="citation book">Salzman, Carl (15 May 2004). <a rel="nofollow" class="external text" href="http://books.google.com/?id=RXvpjJ1Un2gC&amp;pg=PA450"><i>Clinical geriatric psychopharmacology</i></a> (4th ed.). USA: Lippincott Williams &amp; Wilkins. pp.&#160;450–3. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-7817-4380-8" title="Special:BookSources/978-0-7817-4380-8">978-0-7817-4380-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABenzodiazepine+withdrawal+syndrome&amp;rft.aufirst=Carl&amp;rft.aulast=Salzman&amp;rft.au=Salzman%2C+Carl&amp;rft.btitle=Clinical+geriatric+psychopharmacology&amp;rft.date=15+May+2004&amp;rft.edition=4th&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2F%3Fid%3DRXvpjJ1Un2gC%26pg%3DPA450&amp;rft.isbn=978-0-7817-4380-8&amp;rft.pages=450-3&amp;rft.place=USA&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit&amp;section=19" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.discoveryplace.info/benzo-withdrawal-ultimate-guide-symptom-relief">Benzodiazepine Withdrawal Symptom Relief</a></li>
<li><a rel="nofollow" class="external text" href="http://www.benzo.org.uk/manual/">Benzodiazepines: How they work and how to withdraw by Professor Heather Ashton</a></li>
<li><a rel="nofollow" class="external text" href="http://www.mindincamden.org.uk/mtproject.htm">The Minor Tranquilliser Project, For support, Camden, UK</a></li>
<li><a rel="nofollow" class="external text" href="https://www.dmoz.org/Health/Mental_Health/Disorders/Substance_Related/Support_Groups/">Benzodiazepine withdrawal syndrome</a> at <a href="/wiki/DMOZ" title="DMOZ">DMOZ</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Psychoactive_substance_use" title="Template:Psychoactive substance use"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Psychoactive_substance_use" title="Template talk:Psychoactive substance use"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Psychoactive_substance_use&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Psychoactive_drug" title="Psychoactive drug">Psychoactive</a> <a href="/wiki/Substance-related_disorder" title="Substance-related disorder">substance-related disorder</a> (<a href="/wiki/ICD-10_Chapter_V:_Mental_and_behavioural_disorders#.28F10.E2.80.93F19.29_Mental_and_behavioural_disorders_due_to_psychoactive_substance_use" title="ICD-10 Chapter V: Mental and behavioural disorders">F10–F19</a>, <a href="/wiki/List_of_ICD-9_codes_290%E2%80%93319:_mental_disorders#Psychoactive_substance" title="List of ICD-9 codes 290–319: mental disorders">291–292; 303–305</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">General</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Substance-related_disorder#Substance-induced_disorders" title="Substance-related disorder">SID</a>
<ul>
<li><a href="/wiki/Substance_intoxication" title="Substance intoxication">Substance intoxication</a> / <a href="/wiki/Drug_overdose" title="Drug overdose">Drug overdose</a></li>
<li><a href="/wiki/Drug_withdrawal" title="Drug withdrawal">Withdrawal</a></li>
<li><a href="/wiki/Substance-induced_psychosis" title="Substance-induced psychosis">Substance-induced psychosis</a></li>
</ul>
</li>
<li><a href="/wiki/Substance_use_disorder" title="Substance use disorder">SUD</a>
<ul>
<li><a href="/wiki/Substance_abuse" title="Substance abuse">Substance abuse</a></li>
<li><a href="/wiki/Physical_dependence" title="Physical dependence">Physical dependence</a> / <a href="/wiki/Substance_dependence" title="Substance dependence">Substance dependence</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Ethanol" title="Ethanol">Alcohol</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">SID</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">Diseases</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">Neurological<br />
disorders</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Alcoholic_hallucinosis" title="Alcoholic hallucinosis">Alcoholic hallucinosis</a></li>
<li><a href="/wiki/Alcohol_withdrawal_syndrome" title="Alcohol withdrawal syndrome">Alcohol withdrawal</a></li>
<li><a href="/wiki/Fetal_alcohol_spectrum_disorder" title="Fetal alcohol spectrum disorder">Fetal alcohol spectrum disorder</a> (FASD)</li>
<li><a href="/wiki/Fetal_alcohol_syndrome" title="Fetal alcohol syndrome" class="mw-redirect">Fetal alcohol syndrome</a> (FAS)</li>
<li><a href="/wiki/Korsakoff%27s_syndrome" title="Korsakoff's syndrome" class="mw-redirect">Korsakoff's syndrome</a></li>
<li><a href="/wiki/Wernicke%E2%80%93Korsakoff_syndrome" title="Wernicke–Korsakoff syndrome">Wernicke–Korsakoff syndrome</a></li>
<li><a href="/wiki/Wernicke%27s_encephalopathy" title="Wernicke's encephalopathy">Wernicke's encephalopathy</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">Digestive<br />
system</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Alcoholic_hepatitis" title="Alcoholic hepatitis">Alcoholic hepatitis</a></li>
<li><a href="/wiki/Alcoholic_liver_disease" title="Alcoholic liver disease">Alcoholic liver disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">Nervous<br />
system</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Alcohol-related_dementia" title="Alcohol-related dementia">Alcohol-related dementia</a></li>
<li><a href="/wiki/Alcoholic_hallucinosis" title="Alcoholic hallucinosis">Alcoholic hallucinosis</a></li>
<li><a href="/wiki/Hangover" title="Hangover">Hangover</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;"><a href="/wiki/Alcohol_and_cardiovascular_disease" title="Alcohol and cardiovascular disease">Cardiovascular<br />
system</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Alcoholic_cardiomyopathy" title="Alcoholic cardiomyopathy">Alcoholic cardiomyopathy</a></li>
<li><a href="/wiki/Alcohol_flush_reaction" title="Alcohol flush reaction">Alcohol flush reaction</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0;padding-right:0;">
<div style="padding:0em 0.75em;">SUD</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Alcoholism" title="Alcoholism">Alcoholism</a></li>
<li><a href="/wiki/Alcohol_dependence" title="Alcohol dependence">Alcohol dependence</a></li>
<li><a href="/wiki/Alcohol_abuse" title="Alcohol abuse">Alcohol abuse</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Opioid" title="Opioid">Opioids</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>SID
<ul>
<li><a href="/wiki/Opioid_overdose" title="Opioid overdose">Opioid overdose</a></li>
</ul>
</li>
<li>SUD
<ul>
<li><a href="/wiki/Opioid_dependence" title="Opioid dependence" class="mw-redirect">Opioid dependence</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Caffeine" title="Caffeine">Caffeine</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>SID
<ul>
<li><a href="/wiki/Effect_of_caffeine_on_memory" title="Effect of caffeine on memory">Effect of caffeine on memory</a></li>
<li><a href="/wiki/Caffeine-induced_sleep_disorder" title="Caffeine-induced sleep disorder">Caffeine-induced sleep disorder</a></li>
</ul>
</li>
<li>SUD
<ul>
<li><a href="/wiki/Caffeine_addiction" title="Caffeine addiction" class="mw-redirect">Caffeine addiction</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cannabis_(drug)" title="Cannabis (drug)">Cannabis</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>SID
<ul>
<li><a href="/wiki/Effects_of_cannabis" title="Effects of cannabis">Effects of cannabis</a></li>
<li><a href="/wiki/Long-term_effects_of_cannabis" title="Long-term effects of cannabis">Long-term effects of cannabis</a></li>
</ul>
</li>
<li>SUD
<ul>
<li><a href="/wiki/Cannabis_dependence" title="Cannabis dependence">Cannabis dependence</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Sedative" title="Sedative">Sedative</a> /<br />
<a href="/wiki/Hypnotic" title="Hypnotic">hypnotic</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepine</a>:</i> SID
<ul>
<li><a href="/wiki/Benzodiazepine_overdose" title="Benzodiazepine overdose">Benzodiazepine overdose</a></li>
<li><strong class="selflink">Benzodiazepine withdrawal</strong></li>
</ul>
</li>
<li>SUD
<ul>
<li><a href="/wiki/Benzodiazepine_misuse" title="Benzodiazepine misuse">Benzodiazepine misuse</a></li>
<li><a href="/wiki/Benzodiazepine_dependence" title="Benzodiazepine dependence">Benzodiazepine dependence</a></li>
</ul>
</li>
<li><i><a href="/wiki/Barbiturate" title="Barbiturate">barbiturate</a>:</i> SID
<ul>
<li><a href="/wiki/Barbiturate_overdose" title="Barbiturate overdose">Barbiturate overdose</a></li>
</ul>
</li>
<li>SUD
<ul>
<li><a href="/wiki/Barbiturate_dependence" title="Barbiturate dependence">Barbiturate dependence</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cocaine" title="Cocaine">Cocaine</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>SID
<ul>
<li><a href="/wiki/Cocaine_intoxication" title="Cocaine intoxication">Cocaine intoxication</a></li>
</ul>
</li>
<li>SUD
<ul>
<li><a href="/wiki/Cocaine_dependence" title="Cocaine dependence">Cocaine dependence</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Stimulant" title="Stimulant">Stimulants</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>SID
<ul>
<li><a href="/wiki/Stimulant_psychosis" title="Stimulant psychosis">Stimulant psychosis</a></li>
</ul>
</li>
<li>SUD
<ul>
<li><a href="/wiki/Amphetamine_dependence" title="Amphetamine dependence">Amphetamine dependence</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hallucinogen" title="Hallucinogen">Hallucinogen</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>SID
<ul>
<li><a href="/wiki/Hallucinogen_persisting_perception_disorder" title="Hallucinogen persisting perception disorder">Hallucinogen persisting perception disorder</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Tobacco" title="Tobacco">Tobacco</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>SID
<ul>
<li><a href="/wiki/Nicotine_poisoning" title="Nicotine poisoning">Nicotine poisoning</a></li>
<li><a href="/wiki/Nicotine_withdrawal" title="Nicotine withdrawal">Nicotine withdrawal</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Solvent" title="Solvent">Volatile<br />
solvent</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Inhalant" title="Inhalant" class="mw-redirect">Inhalant abuse</a>: <a href="/wiki/Toluene_toxicity" title="Toluene toxicity">Toluene toxicity</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Multiple</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Poly_drug_use" title="Poly drug use">Poly drug use</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Psych_navs" title="Template:Psych navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Psych_navs" title="Template talk:Psych navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Psych_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Psychology" title="Psychology">psychology</a> and <a href="/wiki/Psychiatry" title="Psychiatry">psychiatry</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Mental_processes" title="Template:Mental processes">Mental processes</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disorders</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Mental_and_behavioral_disorders" title="Template:Mental and behavioral disorders">Mental and behavioral</a>
<ul>
<li><a href="/wiki/Template:Attention-deficit_hyperactivity_disorder" title="Template:Attention-deficit hyperactivity disorder">ADHD</a></li>
<li><a href="/wiki/Template:Obsessive%E2%80%93compulsive_disorder" title="Template:Obsessive–compulsive disorder">OCD</a></li>
<li><a href="/wiki/Template:Tourette_syndrome" title="Template:Tourette syndrome">Tourette's</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Mood_disorders" title="Template:Mood disorders">Mood</a></li>
<li>Developmental
<ul>
<li><a href="/wiki/Template:Pervasive_developmental_disorders" title="Template:Pervasive developmental disorders">pervasive</a></li>
<li><a href="/wiki/Template:Dyslexia_and_specific_developmental_disorders" title="Template:Dyslexia and specific developmental disorders">dyslexia and specific</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Psychoactive_substance_use" title="Template:Psychoactive substance use">Substance-related</a>
<ul>
<li><a href="/wiki/Template:Alcohol_and_health" title="Template:Alcohol and health">alcohol</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Emotional_and_behavioral_disorders" title="Template:Emotional and behavioral disorders">Emotional and behavioral</a></li>
<li><a href="/wiki/Template:Cognition,_perception,_emotional_state_and_behaviour_symptoms_and_signs" title="Template:Cognition, perception, emotional state and behaviour symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_nervous_system" title="Template:Eponymous medical signs for nervous system">eponymous</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Psychological_and_psychiatric_evaluation_and_testing" title="Template:Psychological and psychiatric evaluation and testing">Evaluation and testing</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Psychotherapy" title="Template:Psychotherapy">Psychotherapy</a>
<ul>
<li><a href="/wiki/Template:Cognitive_behavioral_therapy" title="Template:Cognitive behavioral therapy">CBT</a></li>
</ul>
</li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antidepressants" title="Template:Antidepressants">depression</a></li>
<li><a href="/wiki/Template:Antipsychotics" title="Template:Antipsychotics">antipsychotics</a></li>
<li><a href="/wiki/Template:Anxiolytics" title="Template:Anxiolytics">anxiety</a></li>
<li><a href="/wiki/Template:Anti-dementia_drugs" title="Template:Anti-dementia drugs">dementia</a></li>
<li><a href="/wiki/Template:Hypnotics_and_sedatives" title="Template:Hypnotics and sedatives">hypnotics and sedatives</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1112
CPU time usage: 1.674 seconds
Real time usage: 1.840 seconds
Preprocessor visited node count: 11731/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 400173/2097152 bytes
Template argument size: 24305/2097152 bytes
Highest expansion depth: 16/40
Expensive parser function count: 4/500
Lua time usage: 0.741/10.000 seconds
Lua memory usage: 4.74 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00% 1674.088      1 - -total
 67.00% 1121.597      1 - Template:Reflist
 40.27%  674.097    127 - Template:Cite_journal
  6.89%  115.427      2 - Template:Columns-list
  4.70%   78.625      5 - Template:Navbox
  3.94%   65.978      1 - Template:Infobox_disease
  3.49%   58.487      2 - Template:Registration_required
  3.30%   55.315      1 - Template:Infobox
  3.19%   53.337      3 - Template:Fix
  2.79%   46.702      1 - Template:Psychoactive_substance_use
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:11683572-0!*!0!!en!4!* and timestamp 20150705075453 and revision id 670021438
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;oldid=670021438">https://en.wikipedia.org/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;oldid=670021438</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Pharmacology" title="Category:Pharmacology">Pharmacology</a></li><li><a href="/wiki/Category:Substance_dependence" title="Category:Substance dependence">Substance dependence</a></li><li><a href="/wiki/Category:Addiction_psychiatry" title="Category:Addiction psychiatry">Addiction psychiatry</a></li><li><a href="/wiki/Category:Withdrawal_syndromes" title="Category:Withdrawal syndromes">Withdrawal syndromes</a></li><li><a href="/wiki/Category:Benzodiazepines" title="Category:Benzodiazepines">Benzodiazepines</a></li><li><a href="/wiki/Category:Adverse_effects_of_psychoactive_drugs" title="Category:Adverse effects of psychoactive drugs">Adverse effects of psychoactive drugs</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_German-language_sources_(de)" title="Category:CS1 German-language sources (de)">CS1 German-language sources (de)</a></li><li><a href="/wiki/Category:Pages_with_login_required_references_or_sources" title="Category:Pages with login required references or sources">Pages with login required references or sources</a></li><li><a href="/wiki/Category:CS1_French-language_sources_(fr)" title="Category:CS1 French-language sources (fr)">CS1 French-language sources (fr)</a></li><li><a href="/wiki/Category:Articles_needing_more_detailed_references" title="Category:Articles needing more detailed references">Articles needing more detailed references</a></li><li><a href="/wiki/Category:Wikipedia_articles_needing_page_number_citations_from_October_2013" title="Category:Wikipedia articles needing page number citations from October 2013">Wikipedia articles needing page number citations from October 2013</a></li><li><a href="/wiki/Category:CS1_errors:_chapter_ignored" title="Category:CS1 errors: chapter ignored">CS1 errors: chapter ignored</a></li><li><a href="/wiki/Category:Pages_containing_cite_templates_with_deprecated_parameters" title="Category:Pages containing cite templates with deprecated parameters">Pages containing cite templates with deprecated parameters</a></li><li><a href="/wiki/Category:Use_dmy_dates_from_September_2012" title="Category:Use dmy dates from September 2012">Use dmy dates from September 2012</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_October_2013" title="Category:Articles with unsourced statements from October 2013">Articles with unsourced statements from October 2013</a></li><li><a href="/wiki/Category:Interlanguage_link_template_link_number" title="Category:Interlanguage link template link number">Interlanguage link template link number</a></li><li><a href="/wiki/Category:Articles_with_DMOZ_links" title="Category:Articles with DMOZ links">Articles with DMOZ links</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Benzodiazepine+withdrawal+syndrome&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Benzodiazepine+withdrawal+syndrome" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Benzodiazepine_withdrawal_syndrome"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Benzodiazepine_withdrawal_syndrome"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Benzodiazepine_withdrawal_syndrome" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=edit"  title="You can edit this page. Please use the preview button before saving [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Benzodiazepine_withdrawal_syndrome" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Benzodiazepine_withdrawal_syndrome" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;oldid=670021438" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q6119887" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Benzodiazepine_withdrawal_syndrome&amp;id=670021438" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Benzodiazepine+withdrawal+syndrome">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Benzodiazepine+withdrawal+syndrome&amp;oldid=670021438&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/S%C3%ADndrome_de_abstinencia_de_las_benzodiazepinas" title="Síndrome de abstinencia de las benzodiazepinas – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%86%D8%B4%D8%A7%D9%86%DA%AF%D8%A7%D9%86_%D8%AA%D8%B1%DA%A9_%D8%A8%D9%86%D8%B2%D9%88%D8%AF%DB%8C%D8%A7%D8%B2%D9%BE%DB%8C%D9%86" title="نشانگان ترک بنزودیازپین – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E3%83%99%E3%83%B3%E3%82%BE%E3%82%B8%E3%82%A2%E3%82%BC%E3%83%94%E3%83%B3%E9%9B%A2%E8%84%B1%E7%97%87%E5%80%99%E7%BE%A4" title="ベンゾジアゼピン離脱症候群 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Benzodiazepin-abstinens" title="Benzodiazepin-abstinens – Norwegian" lang="no" hreflang="no">Norsk bokmål</a></li><li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Simptomi_prestanka_uzimanja_benzodiapina" title="Simptomi prestanka uzimanja benzodiapina – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q6119887#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 5 July 2015, at 07:54.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Benzodiazepine_withdrawal_syndrome&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf12/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf12/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf12/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.visualEditor.targetLoader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":109,"wgHostname":"mw1040"});
}</script>
	</body>
</html>
